Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3043723	s-beta-1	g/l (g/l)	11081	25469	0.00%
3043723	s-beta-1	— (—)	1962	2590	100.00%	Distribution not available
3043723	s-beta-1-fraktio	g/l (g/l)	1144	2342	0.00%
3043723	s-beta1	g/l (g/l)	1009	1765	0.00%
3043723	beta1-glob	g/l (g/l)	699	2802	0.00%
3043723	s-beta-1	g/l_______ (g/l)	619	1918	0.00%
3043723	beeta-1	g/l (g/l)	437	904	0.00%
3043723	s-b1glob	g/l (g/l)	411	877	0.00%
3043723	s-beta-1-fraktio	g/l_______ (g/l)	312	693	0.00%
3043723	s-beeta-1	g/l (g/l)	227	261	0.00%
3043723	beeta-1-gl	g/l (g/l)	87	99	0.00%
3043723	s-beta1-globuliini(valetietues-prot-fr)	g/l (g/l)	60	82	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Disorders of lipoprotein metabolism and other lipidaemias

3254

9363

2.19

319.46

2.3

4.22

g/l

0.15

3006

8512

Explicit Sepsis, including avohilmo

2130

7961

2.55

319.07

3.2

2.2

4.11

4.22

g/l

5.95

1948

7228

Septicaemia

2043

7572

2.60

316.35

3.2

2.1

4.11

4.22

g/l

5.56

1867

6800

Explicit Sepsis

2087

7863

2.54

310.79

3.2

2.1

4.11

4.22

g/l

6.02

1909

7136

Codeine

3161

7957

2.21

310.68

2.2

1.9

4.25

4.22

g/l

0.94

2924

7263

Other heart diseases

1447

3033

3.21

310.20

2.4

2.1

4.21

4.24

g/l

0.81

1363

2807

Other anaemias

3458

8087

4.52

307.65

2.5

2.3

4.15

4.21

g/l

2.72

3193

7236

Unspecified kidney failure

846

1804

5.47

307.65

2.6

2.2

4.05

4.18

g/l

3.79

794

1606

Polyarthropathies

3263

7083

3.12

307.65

2.5

2.4

4.22

4.20

g/l

0.41

3056

6479

Renal failure

3945

8168

4.67

307.65

2.5

2.2

4.10

4.21

g/l

10.47

3700

7282

Oral corticosteroids

4607

10950

2.57

307.65

2.2

2.4

4.24

4.21

g/l

1.16

4293

9937

Polyneuropathies and other disorders of the peripheral nervous system

1853

4278

5.07

307.65

2.5

2.3

4.20

4.17

g/l

0.58

1707

3883

Oedema, not elsewhere classified

1571

5268

3.09

307.65

2.3

2.1

4.19

4.25

g/l

1.92

1429

4764

General symptoms and signs

3883

8178

2.46

307.65

2.5

2.1

4.20

4.25

g/l

3.25

3606

7480

Other bacterial diseases, including avohilmo

4474

10794

2.70

307.65

2.9

2.0

4.17

4.25

g/l

6.67

4169

9807

Condition for Implicit Sepsis (Organ dysfunction codes)

3714

10750

2.50

307.65

2.4

2.2

4.14

4.25

g/l

9.64

3393

9850

Bacterial Sepsis

2673

8013

2.95

307.65

3.1

2.2

4.10

4.22

g/l

8.48

2434

7263

Other soft tissue disorders, not elsewhere classified

3635

9243

2.31

307.65

2.3

2.4

4.22

4.21

g/l

0.17

3374

8419

Renal tubulo-interstitial diseases

4774

10945

3.41

307.65

2.4

2.3

4.13

4.25

g/l

13.84

4429

9948

All pneumoniae

4004

11811

2.28

307.65

3.1

2.0

4.19

4.23

g/l

1.67

3726

10780

Anaemias

1130

642

12.18

307.65

2.4

1.2

4.23

4.25

g/l

0.24

1080

598

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3565

9254

2.33

307.65

3.1

1.9

4.19

4.23

g/l

1.13

3320

8431

Other bacterial diseases

4470

11228

2.77

307.65

3.0

2.0

4.16

4.25

g/l

7.97

4158

10206

Influenza and pneumonia

4079

11529

2.26

307.65

3.1

2.0

4.19

4.23

g/l

1.48

3794

10528

Autoimmune diseases excluding thyroid diseases

4130

10085

2.29

307.65

2.0

2.5

4.20

g/l

0.00

3860

9173

Bacterial infection, other or unspecified

3200

8835

3.29

307.65

3.4

2.1

4.11

4.23

g/l

10.04

2963

7949

Osteopathies and chondropathies

2688

10107

2.56

307.65

3.0

2.2

4.20

4.24

g/l

0.93

2410

9216

Systemic connective tissue disorders

2101

6570

3.49

307.65

2.0

2.4

4.20

4.23

g/l

0.82

1939

5913

Metabolic disorders

3771

9854

2.38

307.65

2.4

2.2

4.21

4.22

g/l

0.60

3491

8977

Multiple myeloma, including Hilmo

921

745

23.86

307.65

16.5

1.4

4.24

4.20

g/l

0.24

906

659

Glomerular disorders in diseases classified elsewhere

863

1994

5.00

307.65

2.8

2.3

4.01

4.20

g/l

7.25

819

1830

All kidney diseases

4885

10669

3.24

307.65

2.4

2.2

4.15

4.26

g/l

10.59

4555

9701

Malaise and fatigue

2561

6774

3.14

307.65

2.2

2.1

4.11

4.26

g/l

11.63

2324

6150

First line medication for Crohn's disease

4510

9467

2.66

307.65

3.1

1.6

4.20

4.22

g/l

0.58

4217

8559

Other systemic involvement of connective tissue (FG)

1566

3942

4.28

307.65

1.9

2.6

4.24

4.22

g/l

0.26

1439

3528

Pain in limb

3382

9154

2.44

307.65

2.2

2.4

4.20

4.21

g/l

0.24

3128

8340

Liquid cancers, including Hilmo

2759

6133

4.47

307.65

7.1

1.4

4.12

4.24

g/l

4.19

2641

5501

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

1096

797

29.91

307.65

7.5

1.2

4.35

4.20

g/l

1.96

1034

708

Multiple myeloma and malignant plasma cell neoplasms

929

866

20.07

307.65

16.3

1.6

4.24

4.21

g/l

0.18

913

776

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

610

464

27.59

307.65

19.6

1.5

4.22

g/l

0.00

600

404

Iron deficiency anaemia

2127

8536

2.59

307.65

2.1

2.3

4.32

4.19

g/l

9.32

1920

7712

Other and unspecified anaemias

3442

8031

4.55

307.65

2.6

2.3

4.15

4.21

g/l

2.72

3178

7182

Heart failure, not strict

3769

9269

2.90

307.65

2.6

2.3

4.19

4.24

g/l

2.16

3488

8433

Finngen Rheumatological endpoints

3359

8564

2.29

307.65

2.2

2.4

4.23

4.21

g/l

0.74

3117

7841

Autoimmune diseases excluding thyroid diseases, strict definition

3988

9739

2.30

307.65

2.0

2.5

4.21

4.20

g/l

0.04

3728

8851

Abnormal findings on examination of blood, without diagnosis

2345

8923

2.52

307.65

2.7

2.4

4.28

4.18

g/l

3.24

2187

8154

Other and unspecified polyneuropathies, also in other diseases

1717

3780

5.39

307.65

2.1

2.3

4.20

4.17

g/l

0.48

1578

3426

Gout

1638

4641

3.28

307.65

3.2

2.4

4.13

4.16

g/l

0.53

1533

4201

L04AX Other immunosuppressants

2801

9901

3.01

307.65

5.4

1.7

4.23

g/l

0.08

2652

9059

Second line medication for Crohn's disease

2836

10111

2.97

307.65

5.3

1.7

4.23

g/l

0.09

2685

9250

Multiple myeloma

610

464

27.59

307.65

19.6

1.5

4.22

g/l

0.00

600

404

Acute renal failure

1577

4131

4.29

307.65

2.8

2.2

4.02

4.19

g/l

10.45

1479

3687

Implicit Sepsis, including avohilmo

3788

10802

2.62

307.65

2.5

2.2

4.13

4.25

g/l

9.87

3447

9896

Primary_lymphoid and hematopoietic malignant neoplasms

2189

4598

5.65

307.65

8.5

1.4

4.12

4.20

g/l

1.86

2118

4126

ILD medications

4930

9596

2.89

307.65

3.1

1.7

4.21

4.22

g/l

0.22

4591

8675

Persons encountering health services for specific procedures and health care

3893

11200

2.11

307.65

2.7

2.1

4.18

4.24

g/l

3.10

3642

10184

Pneumonia, organism unspecified

3739

11302

2.35

307.65

3.1

2.0

4.19

4.23

g/l

1.69

3458

10310

Asthma, unspecified (mode), excluding more controls

1951

5290

2.74

307.65

2.1

1.9

4.28

4.23

g/l

1.74

1813

4822

ILD medications: prednisolone, methylprednisolone, prednisone

4705

9567

2.85

307.65

2.2

1.7

4.21

4.22

g/l

0.30

4365

8646

Heart failure,strict

2601

7344

2.62

307.65

2.3

2.4

4.17

4.21

g/l

1.59

2399

6625

Heart failure and antihypertensive medication

1192

2046

4.06

307.65

2.3

2.6

4.20

4.22

g/l

0.21

1113

1861

Inflammatory bowel disease treatment related agents

4711

11013

2.46

307.65

2.1

2.4

4.23

4.21

g/l

0.83

4380

9996

Infections, IBD-co-morbidities

699

712

7.38

307.65

4.3

2.2

4.14

4.13

g/l

0.06

652

654

ILD medications: immunosuppressive drugs

3526

8654

3.96

307.65

4.6

1.7

4.18

4.23

g/l

2.22

3351

7855

Tramadol

3315

7798

2.66

307.65

2.5

2.0

4.21

4.22

g/l

0.16

3056

7111

Other and unspecified iron deficiency

1782

6696

2.83

307.65

2.0

2.4

4.35

4.19

g/l

11.01

1614

6031

Implicit bacterial Sepsis

2388

7471

2.94

307.65

2.9

2.1

4.10

4.22

g/l

6.96

2173

6751

3565

9254

2.33

307.65

3.1

1.9

4.19

4.23

g/l

1.13

3320

8431

Erysipelas, including avohilmo

2986

10057

2.28

307.65

2.3

2.0

4.18

4.24

g/l

3.99

2759

9110

Bacterial infection, other or unspecified, including avohilmo

3413

9188

3.27

307.65

3.3

2.1

4.12

4.23

g/l

9.59

3166

8280

Examination and observation for other reasons

2476

4766

3.06

307.65

2.4

2.2

4.14

4.19

g/l

1.82

2302

4394

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

3765

10432

2.54

307.65

2.4

2.2

4.14

4.26

g/l

9.60

3452

9577

Glomerular diseases

1238

3184

4.39

307.65

2.8

2.3

4.02

4.22

g/l

11.20

1177

2922

Other systemic involvement of connective tissue

1596

5077

3.42

307.65

1.9

2.4

4.24

4.23

g/l

0.15

1468

4579

Chronic kidney disease

2923

6027

5.45

307.65

2.3

4.10

4.19

g/l

5.48

2754

5345

Nutritional anaemias

2429

9849

2.48

307.65

2.1

2.4

4.30

4.19

g/l

8.45

2201

8898

Pneumonias (Asthma/COPD co-morbidities)

3994

11795

2.29

307.65

3.1

2.0

4.19

4.24

g/l

1.88

3714

10764

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

772

1407

6.81

307.65

3.4

2.2

4.49

4.19

g/l

5.90

718

1260

Implicit bacterial Sepsis, including avohilmo

2591

7904

2.92

307.65

2.8

2.2

4.10

4.22

g/l

8.78

2356

7159

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

6041

10348

4.25

307.65

2.5

2.2

4.19

4.23

g/l

2.34

5622

9380

All chronic kidney diseases

3988

7723

4.56

307.65

2.4

2.3

4.10

4.23

g/l

13.41

3752

6953

Fever of other and unknown origin

2697

7448

3.31

307.65

3.9

2.1

4.11

4.26

g/l

12.59

2516

6787

Dialysis, with operation codes

928

1905

5.65

307.65

3.8

2.2

3.80

4.22

g/l

36.97

882

1736

Aplastic and other anaemias

3613

8452

4.39

307.65

2.5

2.3

4.14

4.21

g/l

3.67

3335

7573

Implicit Sepsis

3668

10577

2.69

307.65

2.5

2.2

4.13

4.24

g/l

8.73

3338

9658

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3940

11939

2.28

307.65

3.1

2.0

4.19

4.23

g/l

1.37

3656

10900

Liquid cancers

2586

5393

5.27

307.65

7.5

1.4

4.12

4.22

g/l

3.43

2481

4830

Heart failure, strict

2837

9152

2.27

306.56

2.3

2.4

4.16

4.20

g/l

1.17

2610

8243

Nephropathy related operations

833

2087

4.56

306.43

3.9

2.3

3.78

4.21

g/l

37.60

796

1914

Medical observation and evaluation for suspected diseases and conditions

2319

4814

2.54

304.19

2.3

2.2

4.24

4.18

g/l

1.88

2102

4432

Gout, FINNGEN

1638

6171

2.84

301.38

3.2

2.3

4.13

4.16

g/l

0.51

1533

5564

Care involving dialysis

618

1250

5.82

298.36

2.5

2.1

3.78

4.21

g/l

24.65

586

1148

Autoimmune diseases related-to ILD

3239

13463

2.07

298.10

2.1

2.4

4.22

g/l

0.14

3015

12256

Pure hypercholesterolaemia

3019

9100

2.18

297.81

2.3

4.22

g/l

0.09

2788

8260

Hypertension, essential

2569

6387

2.34

293.07

2.2

2.3

4.26

4.22

g/l

1.51

2401

5827

All-cause Heart Failure

2772

9042

2.24

292.02

2.3

2.4

4.17

4.20

g/l

0.93

2551

8137

Osteoporosis

1516

5131

2.94

290.64

2.3

2.2

4.20

4.23

g/l

0.80

1315

4579

Persons encountering health services for other counselling and medical advice, not elsewhere classified

4059

11362

1.95

286.45

2.2

2.4

4.25

4.20

g/l

3.10

3812

10270

Hypertensive diseases (excluding secondary)

1533

3069

3.00

284.58

2.2

2.1

4.28

4.24

g/l

0.99

1446

2834

Asthma, unspecified (mode)

2026

6056

2.50

282.20

2.1

1.9

4.28

4.23

g/l

1.77

1877

5511

Implicit viral Sepsis, including avohilmo

1521

5746

2.81

278.83

2.8

2.1

4.09

4.22

g/l

4.87

1389

5197

Dental caries

1219

3853

3.17

276.10

3.9

2.1

4.11

4.20

g/l

2.63

1134

3551

Reimbursement for rheumatic diseases

2345

10782

2.25

272.40

1.8

2.4

4.25

4.23

g/l

0.52

2194

9785

Diseases of oesophagus, stomach and duodenum

3820

11964

1.94

271.12

2.2

2.3

4.25

4.21

g/l

2.27

3488

10971

Provisional assignment of new diseases of uncertain etiology

2229

10046

2.29

270.30

2.9

2.1

4.13

4.22

g/l

5.90

2057

9141

Codes for special purposes

2231

10063

2.29

269.94

2.9

2.1

4.13

4.22

g/l

5.92

2058

9157

Diseases of arteries, arterioles and capillaries (FINNGEN)

1005

1974

3.72

268.58

2.4

2.3

4.19

4.24

g/l

0.68

943

1801

Other septicaemia, including avohilmo

1820

7130

2.52

267.85

2.9

2.0

4.11

4.21

g/l

4.22

1662

6388

Transplanted organ and tissue status

635

1430

5.04

267.19

5.9

2.2

3.93

4.24

g/l

11.77

615

1314

Opioids

3151

7991

2.09

267.10

2.5

1.9

4.21

4.22

g/l

0.22

2921

7295

Diverticular disease of intestine

2960

9050

2.11

266.62

2.5

2.3

4.20

4.22

g/l

0.81

2719

8241

Other septicaemia

1786

7002

2.54

265.40

2.9

2.0

4.11

4.22

g/l

4.39

1629

6263

Other arthritis (FG)

1325

4779

2.92

265.27

2.3

2.5

4.25

4.22

g/l

0.71

1237

4359

Certain infectious and parasitic diseases

3172

7854

2.07

262.16

2.5

1.9

4.18

4.25

g/l

4.17

2946

7116

Caries of dentine

1101

3477

3.26

260.95

3.8

2.1

4.12

4.20

g/l

1.96

1023

3212

Pain in joint

2133

5675

2.38

258.23

2.1

2.3

4.23

4.21

g/l

0.53

1952

5172

Dyspnoea

3429

13096

1.95

257.26

2.4

2.3

4.22

4.21

g/l

0.22

3150

11957

Acute tubulo-interstitial nephritis

2369

9376

2.21

256.47

2.4

2.3

4.14

4.24

g/l

6.11

2145

8453

Hypertensive diseases

2486

6437

2.24

256.25

2.1

2.3

4.26

4.22

g/l

1.37

2323

5872

Codeine or tramadol medication

3960

11687

1.89

255.84

2.2

2.3

4.24

4.20

g/l

2.41

3658

10654

Hypertension

2481

6437

2.23

254.39

2.2

2.3

4.26

4.22

g/l

1.35

2318

5872

GASTRO-related operations

2315

5115

2.32

252.67

2.3

1.9

4.21

4.25

g/l

1.02

2130

4690

Any gastric operation

2315

5115

2.32

252.67

2.3

1.9

4.21

4.25

g/l

1.02

2130

4690

Abnormalities of breathing

2938

8364

2.06

247.27

2.3

2.2

4.23

4.21

g/l

0.68

2716

7651

Autoimmune diseases

3717

10125

1.91

244.56

2.1

2.5

4.20

4.21

g/l

0.05

3455

9209

Other specific joint derangements/joint disorders

2440

7138

2.19

244.56

2.1

2.4

4.23

4.20

g/l

0.70

2242

6560

Polymyalgia rheumatica

898

2762

3.65

244.01

1.9

2.4

4.25

4.19

g/l

0.89

812

2465

Other diseases of blood and blood-forming organs, wide

1150

4051

3.07

243.90

3.4

2.3

4.10

4.22

g/l

4.44

1083

3694

Erysipelas

2287

9330

2.20

243.86

2.3

2.1

4.17

4.23

g/l

3.06

2113

8432

Covid-19 confirmed case

1758

7585

2.44

243.02

3.0

2.2

4.09

4.21

g/l

6.20

1610

6879

Pain, not elsewhere classified

1137

3977

3.00

240.27

2.7

2.1

4.23

4.27

g/l

0.55

1056

3624

Used for control exclusion in common control thyroid runs

3477

9270

1.94

238.69

2.2

2.5

4.20

g/l

0.18

3224

8437

Other heart diseases, wide

2905

8914

2.02

235.63

2.3

4.21

4.24

g/l

1.52

2715

8178

Persons encountering health services in other circumstances, wide

3986

11412

1.84

234.69

2.2

2.4

4.25

4.20

g/l

2.86

3726

10308

Asthma, excluding more controls

2310

5419

2.25

234.03

2.1

1.9

4.30

4.23

g/l

3.11

2154

4947

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

476

567

6.33

233.69

2.4

4.12

4.10

g/l

0.20

456

514

Low back pain

2726

9285

2.04

230.65

2.6

2.2

4.22

4.21

g/l

0.31

2517

8468

Oxycodone

1726

6376

2.42

229.94

4.7

2.0

4.19

4.22

g/l

0.54

1560

5770

Other specified/unspecified arthritis

1179

4329

2.87

228.52

2.2

2.4

4.26

4.21

g/l

0.96

1097

3957

L04AA Selective immunosuppressants

1027

3564

3.08

222.53

1.8

2.3

4.07

4.25

g/l

9.11

988

3283

Other diseases of intestines

3393

10234

1.89

222.35

2.3

2.2

4.22

g/l

0.00

3127

9375

Complications of surgical and medical care, not elsewhere classified

3588

13403

1.83

221.18

2.3

4.20

4.22

g/l

0.53

3296

12230

Cardiovascular diseases (excluding rheumatic etc)

1509

3415

2.58

214.68

2.2

2.0

4.25

4.24

g/l

0.17

1434

3165

Other disorders of fluid, electrolyte and acid-base balance

1454

5716

2.53

214.51

2.5

2.3

4.15

4.22

g/l

1.63

1321

5129

Pain in throat and chest

2741

8323

2.00

214.11

2.3

2.2

4.20

4.21

g/l

0.31

2545

7610

Asthma (only as main-diagnosis), excluding more controls

2115

5419

2.21

211.63

2.1

1.9

4.29

4.23

g/l

2.56

1971

4947

Type 2 diabetes, wide definition

2999

10135

1.92

210.89

2.0

2.5

4.34

4.16

g/l

21.91

2769

9217

L04AD Calcineurin inhibitors

587

1486

4.37

210.74

2.5

3.86

4.26

g/l

22.41

572

1384

Continuous positive airway pressure

836

2150

3.44

210.09

2.3

2.4

4.27

4.17

g/l

2.80

760

1971

Diabetic nephropathy, excluding more controls

843

2152

3.51

209.20

1.8

2.2

4.15

4.31

g/l

5.25

797

1951

Viral Sepsis

1049

3813

2.94

208.86

3.2

2.1

4.06

4.21

g/l

6.34

962

3449

Headache

2036

7461

2.16

208.63

2.1

4.24

4.26

g/l

0.67

1881

6829

Spondylopathies

2869

8941

1.95

208.40

2.6

2.2

4.24

4.21

g/l

0.91

2656

8131

Hypertensive heart and/or renal disease

1235

3432

2.78

208.32

2.0

2.5

4.16

4.18

g/l

0.29

1141

3048

Implicit viral Sepsis

1046

3808

2.93

207.64

3.2

2.1

4.06

4.21

g/l

6.53

959

3444

Non-Hodgkin lymphoma, all, including Hilmo

765

2347

3.59

207.21

3.0

1.4

4.01

4.21

g/l

7.47

730

2105

Cerebrovascular diseases (FINNGEN)

1023

2435

3.06

206.96

2.1

2.3

4.20

4.25

g/l

0.87

940

2233

Symptoms and signs involving the skin and subcutaneous tissue

2686

13551

1.93

205.99

2.4

2.3

4.21

g/l

0.02

2470

12370

Asthma

2437

6198

2.08

204.57

2.1

1.9

4.29

4.22

g/l

2.62

2274

5647

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2705

12616

1.93

203.63

2.5

2.3

4.21

g/l

0.02

2495

11454

Asthma (mode)

2411

6248

2.08

203.20

2.1

1.9

4.28

4.22

g/l

1.93

2252

5694

Disorders of calcium metabolism

457

988

5.33

203.18

3.9

2.4

4.11

4.22

g/l

1.33

413

906

Gout, idiopatic and unspecified

1336

5566

2.58

203.06

2.1

2.4

4.15

4.17

g/l

0.30

1245

5057

Disorders of mineral metabolism

533

1298

4.60

202.53

3.5

2.3

4.13

4.21

g/l

1.10

483

1186

Other disorders of skin and subcutaneous tissue

2826

12976

1.90

201.36

2.3

2.4

4.18

4.22

g/l

1.72

2598

11801

Enlarged lymph nodes

715

2132

3.58

199.45

2.1

2.2

4.22

4.26

g/l

0.37

681

1947

Coagulation defects, purpura and other haemorrhagic conditions

948

3360

3.02

198.11

2.5

2.3

4.15

4.21

g/l

1.33

888

3063

Symptoms and signs involving cognition, perception, emotional state and behaviour

3367

12772

1.80

198.08

2.1

2.4

4.20

4.22

g/l

0.69

3071

11734

Rheumatoid arthritis

1323

4829

2.54

197.05

1.9

2.5

4.26

4.21

g/l

1.14

1238

4374

Exposure to unspecified factor

3506

13735

1.78

196.76

2.3

4.18

4.22

g/l

2.59

3177

12599

Syncope and collapse

1672

6331

2.28

196.27

2.3

2.2

4.17

4.25

g/l

1.94

1490

5738

Follow-up examination after treatment for conditions other than malignant neoplasms

1478

4153

2.45

193.65

2.4

2.1

4.22

4.19

g/l

0.51

1363

3825

Symptoms and signs involving the urinary system

2886

12013

1.87

192.10

2.2

2.4

4.20

4.22

g/l

0.28

2614

10952

Ulcer of lower limb, not elsewhere classified

864

2984

3.17

191.58

2.4

2.2

4.08

4.20

g/l

3.79

798

2686

Diseases of arteries, arterioles and capillaries

2743

10960

1.90

190.51

2.2

2.4

4.15

4.21

g/l

3.16

2517

9918

Disorders resulting from impaired renal tubular function

320

538

7.38

190.49

2.3

2.5

3.93

4.23

g/l

6.25

310

497

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3238

11605

1.80

188.44

2.8

2.2

4.18

4.23

g/l

1.76

2994

10664

Heart failure and bmi 25plus

1506

4387

2.41

186.06

2.2

2.5

4.19

4.25

g/l

1.99

1376

3903

Preparatory care for dialysis

364

710

6.27

185.13

2.3

2.7

3.83

4.17

g/l

8.69

347

659

Small fibre neuropathy

294

471

8.03

184.84

2.6

2.3

4.21

4.17

g/l

0.26

269

430

Dorsalgia

3162

9374

1.83

184.61

2.4

2.2

4.24

4.21

g/l

0.83

2917

8548

Disturbances of skin sensation

1072

4176

2.69

184.43

2.0

2.3

4.26

4.24

g/l

0.15

993

3850

Asthma (only as main-diagnosis)

2219

6198

2.05

183.81

2.1

1.9

4.29

4.22

g/l

2.54

2064

5647

Disorders of thyroid, IBD co-morbidities

491

729

4.78

183.59

2.1

2.3

4.21

4.14

g/l

0.89

458

667

Cardiovascular diseases

1304

2719

2.59

183.48

2.1

1.9

4.26

g/l

0.09

1233

2527

Atrial fibrillation and flutter

1007

2311

2.92

183.48

2.6

2.3

4.25

4.24

g/l

0.16

946

2115

Gout, unspecified

1106

4434

2.69

182.93

2.2

2.3

4.16

4.17

g/l

0.19

1038

4019

Glomerulonephritis

563

1556

4.02

179.25

2.9

2.4

4.01

4.21

g/l

5.20

542

1432

Other CVD (FINNGEN)

565

1131

4.11

176.54

2.8

2.2

4.09

4.22

g/l

2.72

506

1010

Certain infectious and parasitic diseases, including avohilmo

2201

5514

2.05

176.46

2.4

1.9

4.19

4.25

g/l

2.76

2054

4984

Gout, strict definition

1011

3978

2.75

174.35

2.2

2.5

4.14

4.17

g/l

0.50

944

3614

Symptoms and signs concerning food and fluid intake

548

1513

3.92

172.36

2.0

2.2

4.13

4.25

g/l

2.29

508

1368

Lower back pain or/and sciatica

3621

13511

1.70

171.74

2.5

2.3

4.23

4.21

g/l

0.37

3331

12337

Non-ischemic cardiomyopathy

1472

5326

2.31

171.64

2.3

2.4

4.16

4.21

g/l

1.21

1344

4749

Fall on same level

3572

11366

1.71

166.78

2.2

2.3

4.21

4.22

g/l

0.41

3199

10598

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1159

2925

2.56

166.32

2.4

2.2

4.27

4.25

g/l

0.29

1088

2700

Cardiac arrhythmias

1670

5050

2.17

166.23

2.4

4.25

4.21

g/l

1.08

1563

4660

Other necrotizing vasculopathies (FG)

382

853

5.10

162.89

1.6

2.9

4.16

4.20

g/l

0.35

351

767

Osteoporosis with pathological fracture (FG)

451

1143

4.44

162.86

2.1

2.6

4.29

4.26

g/l

0.17

380

996

Neurological diseases, wide definition

623

820

3.90

162.63

2.1

4.26

4.14

g/l

1.96

586

755

Extracorporeal dialysis

409

970

4.87

162.59

2.5

2.4

3.70

4.19

g/l

20.30

388

900

Other pulmonary diagnosis

2363

6252

1.93

162.58

2.6

1.9

4.21

4.23

g/l

0.38

2198

5696

Secondary hypertension

375

802

5.00

162.10

2.1

2.3

4.00

4.20

g/l

4.60

358

723

Excluding asthma or asthma-COPD overlap

2358

6252

1.93

161.22

2.6

1.9

4.22

4.23

g/l

0.16

2195

5696

Endocrine, nutritional and metabolic diseases

2087

5356

2.00

159.75

2.2

2.4

4.27

4.16

g/l

5.43

1946

4923

Hyperlipidaemia, other/unspecified

1598

7014

2.13

159.19

2.3

4.21

4.20

g/l

0.10

1459

6319

Benign neoplasm of colon, rectum, anus and anal canal

2551

12244

1.82

158.91

2.4

4.22

4.21

g/l

0.16

2297

11144

Other special examinations and investigations of persons without complaint or reported diagnosis

1919

4814

2.06

158.35

2.4

2.2

4.23

4.18

g/l

1.36

1776

4432

Purpura and other haemorrhagic conditions

684

2307

3.21

157.10

2.5

2.4

4.14

4.21

g/l

1.03

641

2098

Other dorsopathies, not elsewhere classified

3100

9381

1.75

157.00

2.3

2.2

4.23

4.21

g/l

0.53

2863

8555

Bleeding

2994

12368

1.74

156.95

2.3

2.4

4.18

4.22

g/l

1.56

2736

11263

Care involving use of rehabilitation procedures

2162

10543

1.89

156.67

2.4

2.2

4.23

4.24

g/l

0.18

2076

9566

Complications of medical and surgical care

2638

13655

1.78

156.62

2.5

2.3

4.21

g/l

0.10

2431

12437

Seropositive rheumatoid arthritis

980

3938

2.60

156.44

1.9

2.6

4.29

4.22

g/l

1.59

916

3530

Diseases of the skin and subcutaneous tissue

3049

8870

1.76

155.71

2.4

2.2

4.20

4.21

g/l

0.09

2810

8074

Malignant neoplasm, including Hilmo

2709

8941

1.80

155.50

3.6

1.4

4.19

4.25

g/l

2.55

2536

8150

COPD/asthma/ILD related infections

3149

9254

1.74

154.36

2.9

1.9

4.22

4.23

g/l

0.22

2906

8431

COPD/asthma related infections

3149

9254

1.74

154.36

2.9

1.9

4.22

4.23

g/l

0.22

2906

8431

COPD differential diagnosis

2330

6250

1.91

153.93

2.6

1.9

4.22

g/l

0.18

2171

5696

ILD differential diagnosis

2328

6248

1.91

153.51

2.6

1.9

4.21

4.22

g/l

0.19

2169

5694

Other and unspecified dermatitis

1921

10185

1.95

152.82

2.2

2.3

4.25

4.22

g/l

0.68

1779

9275

Symptoms and signs involving the nervous and musculoskeletal systems

2154

11863

1.87

151.98

2.2

2.4

4.22

4.21

g/l

0.16

1989

10789

Valvular heart disease excluding rheumatic fever

1744

6281

2.05

151.12

2.5

2.4

4.19

4.23

g/l

1.24

1598

5683

Malignant neoplasm, wide definition

2704

8995

1.79

150.85

3.6

1.4

4.20

4.25

g/l

2.19

2535

8198

Asthma (diagnoses ohter than nonallergic)

2920

14049

1.72

150.05

2.0

2.4

4.27

4.20

g/l

4.16

2698

12813

Pain (limb, back, neck, head abdominally)

2217

5901

1.92

149.98

2.3

4.20

4.21

g/l

0.04

2049

5356

Malignant neoplasm

2668

8917

1.79

149.88

3.8

1.4

4.19

4.25

g/l

2.57

2500

8123

Dermatitis

2226

12140

1.84

149.78

2.2

2.4

4.25

4.21

g/l

1.46

2058

11064

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

845

1454

2.98

149.30

2.2

1.9

4.18

4.26

g/l

1.64

791

1333

Malignant neoplasm

2667

8931

1.79

148.87

3.8

1.4

4.19

4.25

g/l

2.48

2501

8135

Atrial fibrillation and flutter with reimbursement

863

1990

2.85

148.87

2.6

2.3

4.30

4.23

g/l

0.87

808

1810

Constipation

3106

12669

1.70

148.87

2.7

2.3

4.18

4.22

g/l

1.75

2808

11618

Non-rheumatic valve diseases

1735

6268

2.04

148.73

2.5

2.4

4.19

4.23

g/l

1.18

1589

5671

Nephrotic syndrome

241

389

7.47

148.43

2.8

2.5

3.79

4.20

g/l

6.54

234

361

Dermatitis and eczema

3655

13482

1.64

148.33

2.2

2.3

4.24

4.20

g/l

1.84

3385

12288

Diabetic nephropathy

850

3306

2.76

146.36

1.8

2.1

4.14

4.30

g/l

5.90

803

3026

Symptoms and signs involving the circulatory and respiratory systems

2877

8370

1.75

145.96

2.2

4.23

4.21

g/l

0.41

2675

7657

Asthma, hospital admission 2, infections

2067

11114

1.86

144.00

2.3

4.24

4.21

g/l

1.15

1914

10084

Asthma-related infections

2067

11114

1.86

144.00

2.3

4.24

4.21

g/l

1.15

1914

10084

Hypothyroidism (congenital or acquired)

482

663

4.16

142.78

2.5

1.2

4.28

4.25

g/l

0.23

459

618

Other necrotizing vasculopathies

446

1235

4.07

142.67

1.7

2.6

4.14

4.20

g/l

0.74

412

1123

Myelodysplastic syndrome, including Hilmo

262

481

6.65

142.24

2.3

1.4

3.93

4.16

g/l

3.70

245

424

Any reimbursement code in KELA

1299

2868

2.31

141.55

2.5

1.5

4.30

4.21

g/l

2.19

1231

2590

Dizziness and giddiness

2609

11903

1.75

141.40

2.1

2.4

4.21

4.22

g/l

0.29

2376

10907

Abnormalities of gait and mobility

677

2419

3.06

141.26

1.9

2.3

4.15

4.19

g/l

0.71

627

2205

Complications of procedures, not elsewhere classified

2744

13171

1.72

141.10

2.2

2.3

4.21

4.22

g/l

0.05

2526

12013

Hypothyroidism, levothyroxine purchases

478

661

4.14

140.93

2.4

1.2

4.29

4.25

g/l

0.31

455

616

Hypothyroidism and >3 levothyroxin purchases

478

661

4.14

140.93

2.4

1.2

4.29

4.25

g/l

0.31

455

616

Spinal stenosis

1984

7913

1.91

140.83

2.3

4.22

4.20

g/l

0.39

1800

7155

Soft tissue disorders

3030

9281

1.70

139.06

2.3

2.4

4.19

4.21

g/l

0.38

2803

8453

Other disorders of urethra and urinary system

2377

9445

1.79

138.49

2.2

2.3

4.21

g/l

0.02

2184

8620

Parasetamol

1946

5141

1.95

137.94

2.4

2.0

4.23

4.18

g/l

1.53

1793

4764

Intestinal infectious diseases

3064

14021

1.66

136.59

2.9

2.2

4.16

4.22

g/l

2.90

2829

12791

Amyloidosis

219

353

7.86

136.59

7.4

2.2

4.09

4.16

g/l

0.26

212

323

Amyloidosis, other/unspecified

200

296

8.94

136.15

7.8

2.2

4.07

4.19

g/l

0.46

194

270

Haemorrhage from respiratory passages

1365

5901

2.12

135.10

2.2

2.3

4.23

4.20

g/l

0.62

1257

5314

Diabetes, varying definitions

3122

11093

1.66

134.63

2.0

2.5

4.35

4.17

g/l

15.57

2877

10113

Diabetes mellitus

3132

11094

1.66

134.48

2.0

2.5

4.34

4.17

g/l

15.65

2886

10115

Heart failure and coronary heart disease

1869

7053

1.93

134.46

2.1

2.5

4.17

4.20

g/l

0.56

1728

6303

Spondylosis

1972

8479

1.87

133.79

2.2

4.23

4.21

g/l

0.69

1812

7713

Diseases of the musculoskeletal system and connective tissue

1324

3033

2.23

132.93

2.2

4.22

4.20

g/l

0.49

1233

2777

Intestinal infectious diseases, including avohilmo, including avohilmo

3699

13185

1.59

132.38

2.8

2.2

4.18

4.22

g/l

1.57

3414

12022

Disorders of other endocrine glands

1531

7764

2.00

132.35

2.3

4.18

4.24

g/l

1.76

1402

7052

Depression medications

510

676

3.87

132.11

1.7

1.2

4.32

4.25

g/l

0.81

492

631

Gastro-oesophageal reflux disease

2313

11327

1.76

132.02

2.1

2.4

4.24

4.21

g/l

0.94

2071

10389

Persons encountering health services for examination and investigation

1841

4814

1.96

131.44

2.2

4.22

4.18

g/l

0.85

1692

4432

Speech therapy

1094

5044

2.28

129.94

2.2

2.3

4.25

4.21

g/l

0.62

1059

4567

Disorders of parathyroid gland

951

4094

2.43

129.70

2.3

4.18

4.23

g/l

0.97

862

3667

Type 2 diabetes

3073

10965

1.65

129.67

2.0

2.5

4.37

4.17

g/l

18.96

2830

9990

Diarrhoea and gastroenteritis of presumed infectious origin

2287

11909

1.75

129.20

2.8

2.1

4.16

4.23

g/l

3.01

2111

10855

Hypertensive Heart Disease

1001

3297

2.41

129.02

2.0

2.5

4.19

4.18

g/l

0.17

913

2925

Chronic gastritis

1164

5514

2.21

128.93

2.2

2.4

4.20

4.19

g/l

0.10

1052

4989

ILD medications: azathioprine

507

1601

3.33

128.39

1.8

1.6

4.13

4.22

g/l

1.41

478

1469

Kidney transplant status

297

656

5.10

128.10

1.7

2.4

3.70

4.23

g/l

18.60

291

615

Genitourinary diseases

1538

3804

2.07

127.96

2.1

2.3

4.16

4.26

g/l

4.18

1442

3501

Rheumatoid arthritis, including avohilmo

1459

7510

2.02

127.95

1.9

2.4

4.26

4.23

g/l

0.73

1363

6773

Neoplasms

1875

5228

1.91

127.62

2.7

1.2

4.22

4.24

g/l

0.27

1761

4794

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

250

488

6.23

127.08

2.5

1.4

4.01

4.20

g/l

2.62

236

429

Chronic lymphocytic leukaemia

250

488

6.23

127.08

2.5

1.4

4.01

4.20

g/l

2.62

236

429

Chronic lymphocytic leukaemia, helper endpoint

250

488

6.23

127.08

2.5

1.4

4.01

4.20

g/l

2.62

236

429

Certain disorders involving the immune mechanism

791

3209

2.61

126.32

2.7

2.2

4.21

4.23

g/l

0.34

748

2949

Hypercalcemia

324

785

4.85

126.22

4.0

2.5

4.09

4.21

g/l

1.25

297

709

Other functional intestinal disorders

1595

7672

1.94

125.16

2.6

2.3

4.22

g/l

0.08

1456

6946

Bacterial pneumoniae

1524

6987

1.98

124.51

3.6

2.0

4.15

4.21

g/l

2.03

1449

6312

Myalgia

842

3533

2.48

123.46

2.2

2.3

4.23

g/l

0.04

775

3222

Other/unspecified dorsalgia

1291

6348

2.07

123.08

2.7

2.2

4.25

4.23

g/l

0.45

1181

5761

Dipeptidyl peptidase 4 (DPP-4) inhibitors

2181

9964

1.77

122.88

2.2

2.5

4.31

4.15

g/l

15.69

1995

9003

Cardiomyopathy

751

3010

2.64

122.81

2.5

2.3

4.07

4.19

g/l

4.40

706

2716

Bacterial pneumonia, not elsewhere classified

1460

6634

2.00

122.62

3.6

2.0

4.15

4.21

g/l

2.10

1394

5991

Non-follicular lymphoma

535

1823

3.24

122.17

2.6

2.5

4.01

4.20

g/l

5.93

510

1658

Acquired haemolytic anaemia

213

373

7.09

121.96

3.3

2.2

3.89

4.21

g/l

4.75

203

339

Other diseases of urinary system

3091

10875

1.62

121.17

2.3

4.20

4.21

g/l

0.14

2850

9982

Diseases of liver

1326

6730

2.05

121.11

1.8

2.5

4.35

4.21

g/l

4.69

1191

6199

Diaphragmatic hernia

1459

7659

1.98

121.09

2.3

4.21

4.23

g/l

0.52

1317

6918

Fracture of lumbar spine and pelvis

1028

4753

2.27

120.71

2.3

2.2

4.13

4.20

g/l

1.45

874

4253

Adjustment and management of implanted device

864

3733

2.46

120.57

2.6

2.1

4.12

4.17

g/l

1.13

804

3322

Hypertensive Renal Disease

262

551

5.47

120.54

1.9

2.7

4.03

4.16

g/l

1.21

253

494

Asthma-related pneumonia

1430

7448

1.98

119.55

2.3

4.21

4.19

g/l

0.22

1338

6674

STROKE

1799

6647

1.87

119.13

2.4

2.5

4.21

4.23

g/l

0.19

1637

6053

Asthma-related pneumonia or sepsis

1430

7460

1.98

118.95

2.3

4.21

4.19

g/l

0.22

1338

6684

Asthma, hospital admissions 3, pneumonia

1430

7460

1.98

118.95

2.3

4.21

4.19

g/l

0.22

1338

6684

Neurological diseases

2334

6799

1.75

118.85

2.2

2.4

4.26

4.19

g/l

3.63

2148

6249

Other antidepressants

3228

10434

1.61

118.69

2.1

2.4

4.22

4.20

g/l

0.52

2926

9598

Nerve, nerve root and plexus disorders

3428

13333

1.57

118.62

2.2

2.3

4.25

4.20

g/l

2.31

3160

12163

Benign neoplasm: Colon

2130

11792

1.75

118.17

2.4

4.20

4.21

g/l

0.08

1911

10728

Arthropathies

2464

7353

1.72

117.96

2.2

2.4

4.23

4.20

g/l

0.75

2286

6741

Antihypertensive medication - note that there are other indications

1249

3076

2.16

117.46

2.0

2.3

4.25

4.23

g/l

0.51

1177

2846

Haemolytic anaemias

243

493

5.76

117.06

3.1

2.2

3.93

4.20

g/l

4.46

232

447

Hypothyroidism, drug reimbursement

325

512

4.57

117.03

2.3

1.2

4.18

4.25

g/l

0.73

310

472

Disorders of lens

2281

8367

1.73

115.30

2.5

2.4

4.21

4.22

g/l

0.18

2092

7752

Other disorders involving the immune mechanism, not elsewhere classified

215

396

6.34

115.12

2.3

2.4

4.24

4.21

g/l

0.15

206

371

Insulin medication

2079

10100

1.75

115.12

2.1

2.5

4.25

4.16

g/l

5.45

1923

9160

Other disorders of kidney and ureter

642

2478

2.79

114.89

2.3

2.4

4.06

4.19

g/l

3.91

613

2265

Gastrointestinal diseases

1460

3689

2.02

114.28

2.4

1.9

4.23

4.22

g/l

0.27

1351

3404

Any event in cancer register

2675

9611

1.65

113.89

3.4

1.6

4.19

4.25

g/l

2.83

2500

8796

Abnormal findings on diagnostic imaging of lung

1905

10447

1.78

113.36

2.5

2.4

4.22

4.20

g/l

0.27

1746

9449

Use of hypnotics and sedatives

3332

12370

1.57

112.60

2.7

2.2

4.23

4.21

g/l

0.39

3046

11352

3568

11864

1.55

112.25

3.1

2.0

4.22

4.21

g/l

0.15

3283

10789

Lymphoid leukaemia

348

962

4.10

111.96

2.8

2.6

3.99

4.18

g/l

3.69

332

877

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2897

10842

1.61

111.91

2.0

2.5

4.35

4.17

g/l

22.26

2666

9876

Injuries to the abdomen, lower back, lumbar spine and pelvis

1507

8059

1.90

111.73

2.4

2.2

4.17

4.22

g/l

1.24

1314

7314

Intracranial trauma

1552

5600

1.91

110.89

2.2

2.4

4.23

4.20

g/l

0.46

1404

5169

Other arrhythmias

1908

8176

1.78

110.66

2.2

2.3

4.19

4.25

g/l

1.41

1756

7480

Dorsopathies

2943

9386

1.61

110.14

2.4

2.2

4.20

4.21

g/l

0.09

2715

8559

Thrombocytopenia, unspecified

397

1206

3.63

109.63

2.1

2.4

4.07

4.18

g/l

1.36

370

1111

Other intervertebral disc disorders

2511

9179

1.66

109.01

2.3

2.2

4.26

4.21

g/l

1.43

2308

8360

Chronic lower respiratory diseases

3608

12607

1.53

108.44

2.1

2.4

4.26

4.20

g/l

3.95

3347

11509

Disorders of choroid and retina

2807

12542

1.60

107.34

2.3

2.4

4.19

4.21

g/l

0.71

2527

11466

Other joint disorders

2351

7351

1.69

107.31

2.1

2.4

4.24

4.20

g/l

1.26

2169

6739

1423

7628

1.90

106.33

2.4

2.3

4.26

4.22

g/l

1.11

1317

6946

Sicca syndrome [Sjögren]

417

1331

3.41

105.82

1.8

2.5

4.22

4.26

g/l

0.51

388

1208

Other disorders of white blood cells

317

852

4.17

105.77

2.2

2.4

4.12

4.20

g/l

0.74

293

784

Azathioprine

507

1801

2.95

104.61

1.8

2.5

4.13

4.21

g/l

1.12

478

1659

Other and unspecified diseases of blood and blood-forming organs

205

400

6.15

103.97

5.3

2.5

4.04

4.22

g/l

1.68

196

375

All influenza

936

4422

2.20

103.50

4.6

2.0

4.20

4.22

g/l

0.38

861

4003

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2095

12524

1.68

102.39

2.3

4.21

g/l

0.01

1935

11380

Abnormal weight loss

484

1718

3.06

102.13

2.0

2.4

4.12

4.20

g/l

1.20

447

1566

Chronic periodontitis, including avohilmo

3170

13355

1.54

101.88

2.5

2.3

4.19

4.22

g/l

0.88

2860

12261

Chronic apical periodontitis

3409

12742

1.52

101.82

2.4

2.2

4.23

4.21

g/l

0.59

3099

11680

Gonarthrosis [arthrosis of knee](FG)

2251

7846

1.68

101.78

2.2

2.5

4.26

4.20

g/l

2.14

2077

7156

Coxarthrosis [arthrosis of hip](FG)

1797

7124

1.78

101.77

2.2

2.6

4.22

4.20

g/l

0.54

1642

6476

Disorders of eyelid, lacrimal system and orbit

2826

13414

1.57

101.69

2.4

2.3

4.21

g/l

0.12

2568

12266

Venous thromboembolism

1988

11544

1.70

101.65

2.7

2.3

4.22

4.20

g/l

0.46

1833

10429

Presence of cardiac and vascular implants and grafts

1750

7416

1.79

101.56

1.8

2.4

4.20

4.18

g/l

0.24

1557

6736

Weight loss

505

1838

2.97

101.43

2.1

2.4

4.12

4.20

g/l

1.23

467

1671

Periodontitis

3167

13351

1.54

100.92

2.5

2.3

4.20

4.22

g/l

0.83

2860

12255

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

194

367

6.14

100.86

2.1

2.4

4.17

4.22

g/l

0.29

186

343

Cough

1331

6673

1.91

100.34

2.5

2.2

4.22

g/l

0.00

1226

6058

Unspecified haematuria

1603

7400

1.82

99.94

2.2

2.5

4.16

4.19

g/l

0.66

1467

6748

Other autoimmune haemolytic anaemias

136

187

9.90

99.30

2.6

2.3

3.89

4.19

g/l

2.36

131

170

Other arthrosis

1708

6534

1.79

99.25

2.1

2.5

4.27

4.20

g/l

1.20

1575

5973

Injuries to the hip and thigh

1820

9644

1.74

99.21

2.2

2.3

4.14

4.21

g/l

2.35

1533

8808

Bacterial pneumonia (organism specified)

1634

8493

1.79

99.06

3.8

2.1

4.14

4.20

g/l

1.75

1552

7630

Dialysis

221

474

5.26

98.88

2.4

2.0

3.75

4.23

g/l

9.11

213

442

Injuries to the head

3384

13474

1.51

98.83

2.3

4.19

4.22

g/l

1.19

3064

12378

Infections of the skin and subcutaneous tissue

1842

10779

1.72

98.70

2.6

2.3

4.18

4.22

g/l

1.40

1718

9907

Other medical care

1720

8382

1.77

98.69

3.4

2.2

4.13

4.22

g/l

2.65

1582

7532

Hyperparathyroidism

798

3586

2.32

98.49

2.4

2.2

4.15

4.23

g/l

1.58

725

3198

Isolated proteinuria

190

361

6.14

98.47

3.0

2.6

4.24

4.17

g/l

0.42

183

333

Paroxysmal tachycardia

613

2009

2.61

98.01

2.0

2.2

4.18

4.24

g/l

1.03

568

1830

Sulfasalazine

904

4302

2.17

97.83

1.8

2.5

4.28

4.22

g/l

1.11

849

3911

Type 2 diabetes, definitions combined

2865

10825

1.57

97.36

2.1

2.5

4.39

4.17

g/l

21.85

2623

9855

Viral pneumonia

544

2089

2.75

97.33

4.0

1.9

4.15

4.22

g/l

1.16

511

1892

General examination and investigation of persons without complaint and reported diagnosis

1658

4805

1.82

97.09

2.3

2.2

4.28

4.19

g/l

3.04

1497

4425

Type 2 diabetes, strict (exclude DM1)

2880

10903

1.56

97.04

2.1

2.5

4.39

4.17

g/l

22.06

2638

9927

Senile cataract

2124

7849

1.69

96.81

2.6

2.4

4.21

4.22

g/l

0.17

1941

7262

COPD (mode)

1107

4379

2.04

96.51

1.8

2.0

4.23

4.22

g/l

0.09

1002

3947

Seronegative rheumatoid arthritis

456

1616

2.99

95.19

2.2

2.8

4.16

4.21

g/l

0.51

427

1469

Diabetes, insulin treatment (Kela reimbursement)

3119

12365

1.53

94.73

2.0

2.4

4.34

4.17

g/l

19.02

2878

11259

Benign neoplasms

2794

9843

1.57

94.62

2.3

2.2

4.22

4.21

g/l

0.25

2572

9053

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

3045

12798

1.53

94.48

2.4

2.3

4.23

4.20

g/l

0.59

2800

11711

Hernia of abdominal wall, postoperative

620

2538

2.52

94.44

2.4

2.1

4.23

4.26

g/l

0.42

574

2337

483

1773

2.85

93.68

2.3

4.10

4.25

g/l

3.20

447

1625

Bronchitis

3345

13590

1.50

93.67

3.2

2.1

4.21

g/l

0.20

3089

12385

Cerebrovascular diseases

2594

11646

1.58

93.45

2.3

2.4

4.16

4.22

g/l

3.16

2322

10647

Falls/tendency to fall

2980

9793

1.55

93.28

2.2

2.4

4.20

4.23

g/l

0.61

2694

9148

Hernia

2876

12617

1.54

93.11

2.4

2.3

4.20

4.23

g/l

1.11

2625

11514

Streptococcal septicaemia, including avohilmo

429

1496

3.08

92.93

4.5

2.1

4.08

4.20

g/l

2.45

391

1346

Sciatica+with lumbago

1604

8246

1.76

92.36

2.2

4.25

4.22

g/l

0.53

1480

7528

Other bacterial intestinal infections, including avohilmo

889

4316

2.14

91.97

3.5

2.1

4.12

4.22

g/l

2.46

815

3911

Hyperkalaemia

326

977

3.67

91.92

2.4

2.2

4.10

4.21

g/l

0.98

300

872

Symptoms and signs involving the digestive system and abdomen

2957

9750

1.54

91.52

2.3

4.19

4.21

g/l

0.47

2730

8875

Explicit bacterial Sepsis, including avohilmo

483

1806

2.84

91.38

4.6

2.1

4.08

4.21

g/l

2.44

441

1646

Other nutritional deficiencies

2001

11297

1.65

91.09

1.9

2.4

4.42

4.20

g/l

24.31

1851

10419

Other cataract

1578

6786

1.78

90.00

2.6

2.4

4.18

4.21

g/l

0.72

1440

6257

Hard cardiovascular diseases

2568

9802

1.58

90.00

2.3

2.5

4.22

4.24

g/l

0.66

2379

8954

Insulin, combination of fast acting with intermediate-acting or long-acting

2079

11813

1.63

89.98

2.1

2.4

4.25

4.19

g/l

2.66

1923

10747

DVT of lower extremities and pulmonary embolism

1566

9155

1.76

89.36

2.8

2.3

4.23

4.20

g/l

0.61

1442

8262

Insulin, intermediate and long-acting

1881

11146

1.67

89.35

2.0

2.4

4.27

4.19

g/l

3.61

1738

10154

Other diseases of intestine

639

2754

2.44

89.33

2.4

2.3

4.18

4.21

g/l

0.41

605

2512

Other external causes of accidental injury

2251

7011

1.63

88.78

2.3

4.21

4.23

g/l

0.51

2040

6546

Arthrosis

2069

6946

1.66

88.54

2.1

2.4

4.25

4.20

g/l

1.41

1914

6350

Type 2 diabetes, definitions combined, including avohilmo

2814

10748

1.54

88.34

2.0

2.5

4.39

4.16

g/l

22.05

2580

9792

Viral hepatitis, IBD co-morbidity

149

243

6.42

87.88

2.0

4.32

4.21

g/l

0.55

138

231

Hypo-osmolality and hyponatraemia

719

3253

2.30

87.69

2.7

2.2

4.11

4.23

g/l

3.22

647

2892

Other bacterial intestinal infections

732

3371

2.27

87.22

3.6

2.1

4.10

4.21

g/l

2.95

671

3047

Diabetes medication

3064

12078

1.50

86.93

1.9

2.4

4.35

4.17

g/l

16.97

2814

11002

Diseases of the digestive system

1648

9800

1.71

86.81

2.3

4.20

g/l

0.07

1519

8872

Other and unspecified disorders of white blood cells

241

615

4.44

86.78

2.1

2.5

4.11

4.23

g/l

0.94

226

566

SLE (Finngen)

191

404

5.30

86.77

1.7

2.4

4.12

4.26

g/l

1.35

180

371

Streptococcal septicaemia

411

1455

3.03

86.61

4.6

2.1

4.07

4.21

g/l

2.60

375

1306

Diseases of the eye and adnexa

1950

5890

1.68

86.43

2.2

2.1

4.23

4.24

g/l

0.23

1823

5481

Diseases of the respiratory system

1801

5334

1.72

86.25

2.5

1.9

4.22

g/l

0.06

1666

4839

Non-Hodgkin lymphoma, all

267

736

4.06

86.03

3.7

1.4

3.94

4.20

g/l

3.07

258

645

Factors influencing health status and contact with health services

784

1738

2.31

85.59

2.4

1.9

4.19

4.20

g/l

0.03

724

1588

Peripheral artery disease

1711

8146

1.71

85.58

2.1

2.4

4.16

4.19

g/l

0.57

1567

7322

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

2737

14253

1.52

85.52

2.8

2.2

4.19

4.22

g/l

0.82

2513

13048

Pruritus

474

1814

2.76

85.48

2.1

2.3

4.23

4.24

g/l

0.10

441

1656

IgA nephropathy (IgA glomerulonephritis)

161

300

6.29

85.37

1.9

2.5

4.12

4.26

g/l

0.95

153

279

Other diseases of blood and blood-forming organs

348

1139

3.34

84.94

4.2

2.5

4.09

4.20

g/l

1.44

323

1051

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

3045

13281

1.49

84.68

2.6

2.2

4.17

4.22

g/l

1.91

2808

12111

Other retinal disorders

2264

11091

1.59

84.41

2.3

2.4

4.16

4.21

g/l

1.46

2026

10086

Explicit bacterial Sepsis

463

1766

2.78

84.24

4.7

2.1

4.09

4.21

g/l

2.48

423

1611

Accidents

2219

7011

1.61

82.58

2.2

2.3

4.21

4.23

g/l

0.31

2011

6546

Polyarthrosis

776

3334

2.18

82.57

2.3

2.6

4.22

4.23

g/l

0.06

691

3001

Other diseases of pleura

1721

9146

1.68

82.50

2.4

2.3

4.15

4.19

g/l

1.11

1578

8266

Concussion

1287

5569

1.82

82.42

2.1

2.4

4.22

4.20

g/l

0.30

1162

5139

Vocal cord dysfunction

371

1092

3.09

82.17

2.5

4.19

4.18

g/l

0.11

338

1017

Other acute lower respiratory infections

1719

10034

1.67

81.79

3.2

2.2

4.20

4.21

g/l

0.43

1600

9112

Need for other prophylactic measures

285

848

3.68

81.19

2.6

2.4

4.11

4.23

g/l

1.62

280

778

Obesity related asthma

1156

6392

1.86

81.05

1.9

2.4

4.38

4.22

g/l

8.12

1069

5866

Polyuria

894

4563

2.04

81.02

2.0

2.5

4.13

4.17

g/l

0.96

811

4159

Fracture of rib(s), sternum and thoracic spine

1176

6558

1.86

80.68

2.6

2.3

4.21

g/l

0.02

1053

5976

Giant cell arteritis

263

754

3.96

80.54

1.7

2.6

4.18

4.20

g/l

0.17

237

677

Benzodiazepine use

3032

14082

1.47

80.23

2.2

2.3

4.25

4.21

g/l

1.47

2722

12935

Abdominal and pelvic pain

2882

9750

1.51

79.86

2.3

4.20

4.21

g/l

0.32

2667

8875

Disorders of gallbladder, biliary tract and pancreas

3059

13107

1.47

79.72

2.3

4.25

4.20

g/l

1.88

2792

11981

Cystitis

2499

9807

1.54

79.47

2.3

4.22

4.21

g/l

0.33

2270

8959

Acute myeloid leukaemia and myelodysplastic syndromes

171

359

5.57

79.44

1.9

1.4

3.92

4.24

g/l

4.42

160

318

Abnormalities of heart beat

1128

6019

1.86

79.43

2.2

4.23

4.22

g/l

0.09

1025

5422

Myelodysplastic syndrome

124

195

8.10

79.41

2.1

1.3

3.91

4.15

g/l

2.29

114

171

Seropositive rheumatoid arthritis, wide

980

5197

1.96

79.11

1.9

2.4

4.29

4.24

g/l

1.14

916

4698

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1909

12111

1.61

78.83

2.2

2.4

4.23

4.21

g/l

0.30

1759

11014

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

956

5038

1.97

78.69

1.9

2.4

4.29

4.24

g/l

1.19

894

4556

Obesity and other hyperalimentation

1851

10951

1.62

78.67

1.8

2.4

4.42

4.20

g/l

22.00

1715

10097

Injuries to the thorax

1609

9828

1.68

78.52

2.4

2.3

4.20

g/l

0.10

1448

8979

Obesity

1840

10894

1.62

78.46

1.8

2.4

4.42

4.20

g/l

21.94

1706

10047

Urinary track infection

1456

4167

1.78

78.45

2.2

4.26

4.30

g/l

1.04

1336

3790

Other/unspecified seropositive rheumatoid arthritis

969

5149

1.96

77.76

1.9

2.4

4.29

4.24

g/l

1.07

905

4652

Nausea and vomiting

930

4734

1.97

77.61

2.9

2.3

4.22

4.23

g/l

0.19

857

4243

Pulmonary heart disease, diseases of pulmonary circulation

1223

6980

1.81

77.59

2.5

2.3

4.22

4.20

g/l

0.35

1131

6289

Fibromyalgia

322

1054

3.22

77.16

2.1

4.40

4.32

g/l

1.02

304

980

Sleep apnoea

2909

12595

1.48

77.04

2.0

2.4

4.33

4.18

g/l

13.00

2687

11555

Secondary and unspecified malignant neoplasm of lymph nodes

384

1402

2.94

76.62

1.7

1.4

4.04

4.21

g/l

1.41

365

1252

Statin medication

1673

5677

1.68

76.49

2.1

2.5

4.25

4.21

g/l

0.67

1560

5185

Mood disorders, excluding more controls

2752

10968

1.50

76.48

2.1

2.4

4.24

4.21

g/l

1.08

2512

10111

Undetermined asthma, excluding more controls

434

1673

2.70

76.32

2.1

1.7

4.29

4.26

g/l

0.39

402

1506

Abnormal findings on examination of urine, without diagnosis

237

653

4.03

76.21

3.2

2.5

4.27

4.17

g/l

0.83

227

603

Implicit fungal Sepsis, including avohilmo

343

1184

3.13

76.04

3.0

2.2

4.09

4.23

g/l

2.01

310

1080

Bacterial intestinal infections, IBD co-morbidities

727

3525

2.16

75.96

3.7

2.1

4.11

4.21

g/l

2.29

667

3194

Idiopathic gout

455

1825

2.68

75.64

2.1

2.3

4.12

4.16

g/l

0.47

418

1661

Sleep disorders (combined)

3251

11864

1.45

75.57

2.0

2.4

4.29

4.18

g/l

8.44

2970

10838

Coxarthrosis

1613

6305

1.69

75.29

2.2

2.5

4.24

4.20

g/l

0.78

1470

5740

Other disorders of lacrimal gland

1229

7079

1.79

75.05

2.7

2.3

4.21

4.24

g/l

0.76

1109

6445

Irritable bowel syndrome

824

4179

2.03

74.97

2.3

2.2

4.19

4.25

g/l

1.40

750

3814

Dysphagia

937

4986

1.95

74.60

2.3

2.5

4.20

4.22

g/l

0.34

852

4520

Episodal and paroxysmal disorders

3054

10710

1.46

74.42

2.0

2.4

4.27

4.18

g/l

4.71

2794

9800

Asthma, hospital admissions , main diagnosis only

2402

14068

1.51

74.02

2.0

2.3

4.29

4.20

g/l

5.03

2219

12837

Shoulder lesions

2234

8769

1.55

73.72

2.2

2.4

4.23

4.21

g/l

0.31

2051

7979

Fracture of femur

1098

5530

1.85

73.66

2.3

2.2

4.11

4.19

g/l

1.78

877

4980

Gonarthrosis

1891

6719

1.62

73.63

2.1

2.5

4.26

4.20

g/l

2.02

1749

6134

Fibrosis and cirrhosis of liver

372

1369

2.94

73.47

1.6

2.5

4.42

4.18

g/l

4.03

344

1265

Other specified/unspecified systemic involvement of connective tissue

264

798

3.60

73.25

1.8

2.7

4.22

4.24

g/l

0.21

252

724

Postmenopausal osteoporosis with pathological fracture

356

1289

3.04

73.18

2.1

2.3

4.28

4.30

g/l

0.10

296

1153

Conduction disorders

1041

4564

1.88

72.80

2.2

2.3

4.16

4.21

g/l

1.19

936

4095

Ischemic heart diseases

2537

10194

1.51

72.80

2.3

2.5

4.23

g/l

0.03

2362

9263

Asthma, including avohilmo

3431

13451

1.42

72.53

2.1

2.4

4.27

4.20

g/l

5.02

3178

12264

Systemic lupus erythematosus

191

467

4.56

72.50

1.7

2.3

4.12

4.30

g/l

1.93

180

430

Depression or dysthymia

2018

7059

1.59

72.19

2.3

2.5

4.23

4.20

g/l

0.80

1819

6551

Percutaneous Coronary Intervention

2450

10016

1.51

72.09

2.1

2.5

4.22

4.23

g/l

0.17

2299

9094

Other disorders of veins

1364

8035

1.71

72.07

2.2

2.3

4.22

4.23

g/l

0.14

1226

7310

Other symptoms and signs involving cognitive functions and awareness

1664

9253

1.63

71.85

2.2

2.4

4.14

4.21

g/l

2.57

1459

8396

Persons encountering health services for specific procedures, not carried out

326

1125

3.06

71.45

2.2

2.0

4.13

4.25

g/l

1.93

309

1038

Acute bronchitis

1350

7941

1.71

70.57

3.2

2.2

4.21

g/l

0.04

1254

7170

Other gastritis (incl. Duodenitis)

814

4226

2.00

69.99

2.3

2.4

4.17

4.19

g/l

0.27

738

3850

Atherosclerosis, excluding cerebral and coronary sclerosis

1584

7743

1.65

69.92

2.0

2.4

4.16

4.18

g/l

0.39

1454

6956

Chronic rhinitis, nasopharyngitis and pharyngitis

997

5510

1.86

69.78

2.1

2.3

4.21

4.24

g/l

0.57

911

5052

Emergency coronary revascularization (for ACS)

2697

11230

1.47

69.64

2.1

2.5

4.22

g/l

0.02

2522

10164

Biological medication for rheuma

521

2286

2.36

69.21

1.6

2.3

4.41

4.25

g/l

3.26

501

2144

Pulmonary embolism

1100

6306

1.80

68.78

2.6

2.3

4.21

4.20

g/l

0.19

1017

5700

Marginal zone B-cell lymphoma, including Hilmo

128

238

6.55

68.78

2.6

1.4

4.15

4.24

g/l

0.63

123

207

Osteonecrosis

302

1031

3.18

68.56

7.6

2.1

4.12

4.23

g/l

1.59

284

956

Diseases of oral cavity, salivary glands and jaws

1819

5914

1.61

68.54

2.3

2.1

4.17

4.19

g/l

0.33

1637

5397

Pulmonary heart disease

1100

6313

1.80

68.52

2.6

2.3

4.21

4.20

g/l

0.18

1017

5707

Soft tissue disorders related to use, overuse and pressure

919

4993

1.90

68.32

2.4

2.5

4.18

4.23

g/l

1.16

846

4546

Enterocolitis due to Clostridium difficile

468

1990

2.49

67.98

4.2

2.2

4.10

4.18

g/l

1.32

435

1797

Solid cancers, including Hilmo

2294

8945

1.52

67.95

2.3

1.4

4.20

4.25

g/l

2.12

2132

8149

Other diseases of anus and rectum

1016

5682

1.83

67.73

2.3

4.22

4.21

g/l

0.11

896

5130

Cardiomyopathy in other diseases

14.04

67.69

7.5

2.0

4.00

4.06

g/l

0.21

Coronary revascularization (ANGIO or CABG)

2425

10020

1.50

67.30

2.1

2.5

4.23

g/l

0.02

2275

9097

Immunodeficiency with predominantly antibody defects

153

335

5.19

67.13

4.9

2.1

4.12

4.27

g/l

0.71

145

319

Retention of urine

1265

6075

1.73

67.08

2.1

2.5

4.16

g/l

0.08

1146

5529

Other CVD

849

4544

1.95

67.08

2.5

2.3

4.10

4.17

g/l

1.74

742

4059

Hypokalaemia

471

2016

2.45

67.01

2.6

2.2

4.31

4.23

g/l

0.78

433

1808

Immunodeficiencies

222

638

3.80

66.74

4.4

2.3

4.16

4.25

g/l

0.53

209

594

Diffuse large B-cell lymphoma, helper endpoint

256

809

3.49

66.68

1.8

1.4

3.88

4.24

g/l

8.72

240

722

Diffuse large B-cell lymphoma, including Hilmo

256

809

3.49

66.68

1.8

1.4

3.88

4.24

g/l

8.72

240

722

Diffuse large B-cell lymphoma

256

809

3.49

66.68

1.8

1.4

3.88

4.24

g/l

8.72

240

722

Visual disturbances and blindness

1686

10828

1.59

66.54

2.3

4.20

4.23

g/l

0.66

1524

9832

Obesity, other/unspecified

950

5249

1.85

66.46

1.7

2.3

4.44

4.21

g/l

11.99

889

4858

Unspecified privation

421

1724

2.58

66.24

2.0

2.3

4.09

4.20

g/l

2.11

393

1582

Temporal arteritis

222

648

3.88

66.22

1.6

2.7

4.19

4.20

g/l

0.08

199

577

Disorders of lacrimal system

1422

8648

1.66

66.12

2.6

2.3

4.22

4.23

g/l

0.29

1279

7858

Other diseases of pericardium

219

628

3.81

66.05

1.7

2.4

4.07

4.21

g/l

1.36

200

561

Obesity due to excess calories

1326

8059

1.68

65.85

1.8

2.4

4.45

4.21

g/l

17.63

1228

7446

Asthma/COPD (KELA code 203)

2698

12605

1.45

65.51

2.1

2.4

4.27

4.20

g/l

4.27

2472

11508

Insulin, fast-acting

1149

6744

1.75

65.40

1.9

2.4

4.19

4.20

g/l

0.18

1072

6166

Chronic nephritic syndrome

200

546

4.06

65.24

2.6

4.00

4.17

g/l

1.82

192

507

Lumbar disc prolapse

1818

8740

1.57

65.10

2.4

2.2

4.25

4.21

g/l

0.96

1686

7995

Undetermined asthma

434

1806

2.50

65.07

2.1

1.7

4.29

4.26

g/l

0.42

402

1634

Type 1 diabetes

720

3656

2.02

65.06

1.7

2.4

4.07

4.16

g/l

2.18

681

3367

Hypotension

759

3958

2.01

65.06

2.6

2.3

4.09

4.18

g/l

2.00

656

3536

Zoster [herpes zoster], including avohilmo

1746

10974

1.57

64.81

3.0

2.3

4.19

4.22

g/l

0.78

1580

9946

Major coronary heart disease event

2588

10753

1.46

64.32

2.2

2.5

4.23

g/l

0.02

2413

9761

ILD, hospital admission 2, with pulmonary infections

426

1784

2.53

64.10

2.4

1.9

4.12

4.21

g/l

1.37

403

1606

Other diseases of liver

639

3145

2.11

64.02

2.0

2.4

4.39

4.22

g/l

4.01

585

2905

Other (not insulin) diabetes medications

2857

11852

1.43

63.96

1.9

2.5

4.40

4.17

g/l

24.23

2615

10788

Any mental disorder

3129

11206

1.42

63.42

2.1

2.4

4.24

4.21

g/l

1.15

2842

10324

Primary hyperparathyroidism

478

2122

2.40

63.21

2.6

2.4

4.22

4.24

g/l

0.23

432

1913

GI-bleeding

1177

7045

1.72

62.78

2.3

4.20

4.17

g/l

0.46

1084

6354

Other (seronegative) rheumatoid arthritis, wide

695

3556

2.04

62.68

2.0

2.3

4.18

4.23

g/l

0.73

646

3211

Viral infections characterized by skin and mucous membrane lesions

1285

7847

1.67

62.66

3.4

2.2

4.18

4.23

g/l

1.12

1194

7174

Sleep apnoea, including avohilmo

2942

12700

1.42

62.65

2.0

2.4

4.33

4.18

g/l

13.07

2716

11650

Other diseases of hard tissues of teeth

1765

5858

1.59

62.55

2.3

2.1

4.18

4.19

g/l

0.25

1583

5349

SLE, ICD10

179

467

4.27

62.35

1.7

2.0

4.10

4.32

g/l

2.48

169

432

SLE, strict definition

179

467

4.27

62.35

1.7

2.0

4.10

4.32

g/l

2.48

169

432

Cutaneous abscess, furuncle and carbuncle

810

4352

1.91

62.31

2.2

2.3

4.17

4.22

g/l

0.83

760

4013

Visual disturbances

1548

9913

1.60

62.27

2.3

4.20

4.23

g/l

0.66

1419

9036

Other diseases of the digestive system

1173

7034

1.72

62.18

2.3

4.21

4.18

g/l

0.55

1076

6352

Endocarditis

181

476

4.18

62.05

2.2

2.4

4.06

4.18

g/l

0.69

171

430

External causes of morbidity and mortality

1715

5461

1.60

62.04

2.3

4.23

4.22

g/l

0.20

1564

5087

Other abnormal findings of blood chemistry

223

680

3.56

61.13

3.0

2.4

4.10

4.22

g/l

1.31

214

628

Cardiomyopathy, other and unspecified

319

1189

2.86

61.07

2.3

4.07

4.24

g/l

3.81

301

1069

Urticaria and erythema

1019

5899

1.77

60.80

2.2

4.30

4.24

g/l

1.21

944

5411

Other dialysis

170

438

4.38

60.53

2.5

2.7

3.79

4.22

g/l

6.35

164

408

Idiopathic thrombocytopenic purpura

164

412

4.45

60.22

2.4

4.16

4.19

g/l

0.17

155

375

Malignant neoplasm of skin, including Hilmo

1659

7181

1.58

59.99

2.6

1.4

4.16

4.24

g/l

2.17

1510

6482

AV-block

685

3006

2.02

59.16

2.3

4.18

g/l

0.07

614

2659

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

575

2820

2.14

58.71

1.5

2.4

4.34

4.17

g/l

3.92

517

2609

Early onset COPD, excluding more controls

619

3098

2.06

58.66

2.0

1.9

4.28

4.23

g/l

0.80

573

2833

Systemic lupus erythematosus, unspecified

158

394

4.49

58.63

1.8

2.0

4.12

4.32

g/l

1.85

150

366

Cirrhosis of liver, NAS

274

971

3.08

58.50

1.6

2.6

4.39

4.14

g/l

3.19

257

895

Giant cell arteritis with polymyalgia rheumatica

222

702

3.57

58.47

1.6

2.5

4.19

4.22

g/l

0.19

199

629

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1556

6738

1.59

58.26

2.6

1.4

4.17

4.24

g/l

1.40

1410

6054

Chronic periodontitis, complicated

1817

11911

1.52

58.00

2.5

2.4

4.20

4.22

g/l

0.40

1656

10950

Anxiety disorders, excluding more controls

2252

9940

1.47

57.96

2.3

2.4

4.25

4.23

g/l

0.49

2072

9186

Anaemia in chronic diseases classified elsewhere

148

356

4.74

57.93

1.8

2.5

4.06

4.16

g/l

0.53

139

325

Noninfective enteritis and colitis

1337

8399

1.62

57.84

2.4

2.3

4.21

4.23

g/l

0.39

1231

7689

Agranulocytosis

424

1864

2.40

57.02

4.1

2.3

4.09

4.23

g/l

2.91

411

1708

Solid cancers

2197

8860

1.47

56.92

2.2

1.4

4.19

4.25

g/l

2.96

2037

8065

Insulin, fast-acting or short human

1153

7032

1.68

56.81

1.9

2.3

4.19

4.21

g/l

0.31

1076

6425

Biguanides

2799

12166

1.41

56.79

1.9

2.4

4.40

4.16

g/l

35.23

2571

11081

Other headache syndromes

1160

7062

1.67

56.46

1.9

2.5

4.25

4.22

g/l

0.86

1059

6475

Iron deficiency anaemia secondary to blood loss (chronic)

602

3040

2.06

56.40

2.1

2.3

4.27

4.17

g/l

1.89

537

2742

Unspecified fall

1605

10382

1.55

56.39

2.2

2.3

4.19

4.22

g/l

0.56

1401

9473

Convulsions, not elsewhere classified

596

2948

2.04

55.96

1.8

2.2

4.17

4.24

g/l

1.33

551

2704

Volume depletion

381

1613

2.48

55.71

1.9

2.2

4.15

4.18

g/l

0.26

334

1436

Ischaemic heart disease, wide definition

2404

10438

1.44

55.47

2.4

2.5

4.21

4.23

g/l

0.33

2239

9476

Mood disorders

2857

13270

1.39

55.37

2.1

2.4

4.25

4.22

g/l

0.92

2614

12156

Calcific aortic valvular stenosis, including rheumatic fever

1161

6886

1.67

55.18

2.3

4.20

4.16

g/l

1.15

1058

6145

Mood [affective] disorders

2849

13261

1.39

55.11

2.1

2.4

4.24

4.22

g/l

0.85

2606

12148

Later onset COPD, excluding more controls

786

3280

1.89

55.01

1.6

2.0

4.20

4.19

g/l

0.05

707

2900

Calcific aortic valvular stenosis, operated

1157

6870

1.67

55.01

2.4

2.3

4.21

4.16

g/l

1.16

1054

6131

Calcific aortic valvular stenosis

1157

6870

1.67

55.01

2.4

2.3

4.21

4.16

g/l

1.16

1054

6131

Methotrexate

444

2012

2.29

54.97

1.9

2.5

4.31

4.21

g/l

1.56

419

1823

Calcific aortic valvular stenosis, diagnosis (helper)

1156

6866

1.67

54.89

2.4

2.3

4.21

4.16

g/l

1.20

1053

6127

Operations 2 for CAVS

1156

6866

1.67

54.89

2.4

2.3

4.21

4.16

g/l

1.20

1053

6127

Arthropathies in other diseases classified elsewhere

166

448

4.04

54.78

2.4

2.7

4.10

4.20

g/l

0.72

154

411

Chronic ulcer of skin, not elsewhere classified

310

1210

2.74

54.48

2.1

2.2

4.24

4.19

g/l

0.38

287

1094

Abnormal findings on diagnostic imaging of other body structures

539

2653

2.12

54.35

2.8

2.4

4.22

4.23

g/l

0.08

505

2411

Gingivitis and periodontal diseases

2855

10675

1.40

54.32

2.4

2.2

4.20

4.21

g/l

0.29

2576

9762

Other and unspecified coagulation defects

205

640

3.44

53.87

2.6

2.5

4.17

4.23

g/l

0.53

195

591

COPD

1558

8342

1.55

53.65

1.9

2.5

4.23

4.18

g/l

1.84

1419

7555

Malignant neoplasm of skin

1573

6977

1.56

53.63

2.6

1.4

4.16

4.24

g/l

2.02

1426

6283

Type 1 diabetes, wide definition, subgroup 1

559

2785

2.06

53.48

1.7

2.3

4.07

4.17

g/l

1.99

524

2585

Cardiomyopathies, Primary/intrinsic

438

2006

2.28

53.18

1.9

2.3

4.05

4.20

g/l

3.93

408

1804

Symptoms and signs involving speech and voice

1088

6666

1.68

53.02

2.5

2.3

4.15

4.23

g/l

2.34

990

6059

Secondary uncertain malignant neoplasm

494

2375

2.17

53.00

1.9

1.4

4.05

4.21

g/l

1.79

462

2123

Non-allergic asthma (mode), excluding more controls

512

2461

2.12

52.70

2.0

1.8

4.24

4.25

g/l

0.06

474

2224

Anxiety (asthma-related co-morbidities)

1461

7206

1.56

52.52

1.9

2.3

4.24

g/l

0.04

1351

6703

Other neurological diseases

2297

12678

1.43

52.38

2.2

2.4

4.19

4.21

g/l

0.43

2061

11549

Injuries to the shoulder and upper arm

2536

14146

1.40

52.36

2.5

2.3

4.22

4.21

g/l

0.15

2274

12964

Rotator cuff syndrome

1812

8462

1.50

52.33

2.3

2.4

4.25

4.21

g/l

0.65

1659

7707

Motor neuron disease ALS

117

253

5.23

52.14

1.4

2.2

4.19

4.05

g/l

1.23

111

235

Other anxiety disorders

1086

5622

1.67

52.12

1.9

2.2

4.24

4.25

g/l

0.17

1003

5223

Other respiratory diseases principally affecting the interstitium

710

3895

1.90

52.09

2.4

2.3

4.13

4.18

g/l

0.92

672

3509

Benign neoplasm: Colon, unspecified

937

5563

1.74

52.08

2.4

4.18

4.19

g/l

0.24

821

5055

Prurigo nodularis

145

373

4.40

51.88

1.7

2.8

4.29

4.24

g/l

0.27

133

340

Diseases of pulp and periapical tissues and dental caries

2009

7062

1.48

51.87

2.2

2.3

4.18

4.19

g/l

0.20

1814

6429

Isolated proteinuria with specified morphological lesion

150

7.12

51.72

4.3

2.6

4.24

4.31

g/l

0.19

138

Motor neuron disease (with DMD)

117

256

5.14

51.33

1.4

2.1

4.19

4.06

g/l

1.23

111

238

Cardiomyopathy (excluding other)

448

2100

2.23

51.32

1.9

2.3

4.05

4.19

g/l

3.33

418

1889

Diabetic retinopathy, excluding more controls

847

2661

1.84

51.01

1.8

2.1

4.21

4.33

g/l

3.71

779

2420

Dental caries, including avohilmo

2208

7915

1.45

50.96

2.2

2.3

4.19

g/l

0.00

1995

7221

Amputation

431

2003

2.27

50.87

2.3

4.05

4.16

g/l

2.03

396

1795

Persons with potential health hazards related to communicable diseases

815

4610

1.78

50.78

2.3

2.1

4.16

4.25

g/l

2.74

787

4303

Basal cell carcinoma, including Hilmo

1487

6601

1.56

50.76

2.6

1.4

4.16

4.24

g/l

1.65

1336

5927

ILD, hospital admissions 3, with pneumonia sepsis

365

1587

2.44

50.68

2.3

2.0

4.10

4.18

g/l

1.14

345

1432

Mycoses, including avohilmo

2590

14386

1.39

50.39

2.3

4.21

4.22

g/l

0.24

2351

13202

Selective serotonin reuptake inhibitors

2750

10435

1.39

49.84

2.2

2.4

4.23

4.20

g/l

0.92

2518

9599

Seropositive rheumatoid arthritis, strict definition

528

2662

2.07

49.83

1.7

2.3

4.34

4.23

g/l

2.33

493

2428

Nonalcoholic fatty liver disease

352

1515

2.44

49.59

1.9

2.5

4.51

4.22

g/l

5.58

326

1409

Other coagulation defects

275

1056

2.75

49.55

2.5

2.4

4.15

4.21

g/l

0.66

258

966

Depression

2580

12588

1.39

49.06

2.1

2.4

4.24

4.22

g/l

0.56

2361

11563

Other disorders of skin and subcutaneous tissue, not elsewhere classified

516

2594

2.07

49.04

2.1

2.2

4.30

4.22

g/l

0.94

465

2349

Other reaction to severe stress, and adjustment disorders

842

4905

1.74

48.82

2.5

2.2

4.22

4.26

g/l

0.70

793

4559

Amputation of toe

322

1351

2.55

48.75

2.2

2.4

4.05

4.15

g/l

1.25

296

1230

Other diseases of arteries and capillaries

354

1544

2.42

48.61

2.3

2.4

4.03

4.21

g/l

3.23

323

1408

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1465

6561

1.55

48.57

2.6

1.4

4.16

4.24

g/l

1.55

1324

5891

Open wound of head

1671

10738

1.49

48.54

2.2

2.3

4.18

4.21

g/l

0.50

1493

9829

Diseases of pulp and periapical tissues, including avohilmo

2915

11153

1.37

48.52

2.2

2.3

4.22

4.19

g/l

1.02

2647

10187

Other and unspecified immunodeficiencies with predominantly antibody defects

145

6.85

48.46

5.2

2.3

3.97

4.35

g/l

2.08

137

All anxiety disorders

1474

7583

1.53

48.20

1.9

2.3

4.24

4.25

g/l

0.20

1364

7026

Tumor necrosis factor alpha inhibitors

426

2000

2.19

48.08

1.5

2.3

4.44

4.26

g/l

3.39

407

1877

Zoster [herpes zoster]

679

3764

1.87

47.95

4.0

2.3

4.17

4.21

g/l

0.68

613

3389

Fungal Sepsis

202

674

3.25

47.90

3.5

2.2

4.01

4.22

g/l

2.13

187

620

Candidiasis, including avohilmo

886

5280

1.72

47.89

2.5

2.2

4.22

4.24

g/l

0.28

798

4812

Other noninfective gastroenteritis and colitis

754

4298

1.80

47.81

2.7

2.3

4.19

4.22

g/l

0.41

694

3905

Pericarditis

161

467

3.74

47.75

1.9

2.2

4.00

4.22

g/l

2.53

148

422

Exposure to other specified factors

2198

13570

1.41

47.56

2.1

2.3

4.20

4.23

g/l

0.96

1988

12501

Subjective visual disturbances

803

4676

1.76

47.48

2.4

2.3

4.21

4.23

g/l

0.35

739

4271

Disorder of lipoprotein metabolism, unspecified

478

2367

2.11

47.47

1.9

2.3

4.21

4.20

g/l

0.06

442

2127

Abnormal involuntary movements

472

2326

2.11

47.40

2.2

2.3

4.20

4.21

g/l

0.02

428

2129

Other diseases of upper respiratory tract

3130

12243

1.35

47.37

2.3

4.22

4.21

g/l

0.32

2874

11154

Pleural effusion

613

3311

1.93

47.34

2.6

2.3

4.11

4.17

g/l

0.93

576

2990

Covid-19 suspected case

561

2924

1.97

47.33

2.5

2.2

4.24

4.26

g/l

0.22

533

2710

Functional dyspepsia

791

4587

1.77

47.28

2.4

2.3

4.22

4.23

g/l

0.05

735

4208

Sequelae of external causes of morbidity and mortality

856

5084

1.73

47.23

2.3

2.4

4.21

4.20

g/l

0.08

810

4634

Trochanteric bursitis

486

2421

2.08

47.19

2.2

2.4

4.20

4.26

g/l

0.85

442

2195

Osteomyelitis

267

1043

2.73

46.82

2.4

2.2

4.09

4.18

g/l

0.92

248

969

Urticaria

777

4501

1.76

46.40

2.2

4.30

4.25

g/l

0.97

717

4141

Caries of dentine, including avohilmo

2312

8488

1.41

46.26

2.2

2.3

4.20

4.19

g/l

0.29

2091

7751

Peripheral artery operations in Hilmo

504

2568

2.05

46.24

2.4

2.3

4.12

4.16

g/l

0.51

460

2311

Other and unspecified types of non-Hodgkin lymphoma, hilmo

207

718

3.16

46.14

3.0

2.6

3.89

4.19

g/l

4.77

194

653

Deforming dorsopathies

781

4542

1.76

46.03

2.4

2.2

4.22

4.24

g/l

0.34

711

4126

Type 1 diabetes, wide definition

574

3041

1.93

45.94

1.7

2.3

4.06

4.17

g/l

2.36

538

2809

Psychiatric diseases

2705

9987

1.37

45.86

2.2

2.4

4.24

4.21

g/l

1.06

2455

9233

Conjunctivitis

1982

11329

1.43

45.75

2.3

4.23

4.24

g/l

0.04

1813

10380

Coronary atherosclerosis

2009

8978

1.44

45.64

2.4

2.5

4.20

4.23

g/l

0.54

1865

8108

Stroke, including SAH

2063

10583

1.42

45.63

2.3

2.4

4.15

4.21

g/l

2.28

1850

9643

Non-invasive ventilation

580

2646

1.93

45.48

3.1

2.4

4.35

4.18

g/l

5.42

540

2430

Neurotic, stress-related and somatoform disorders

2316

11593

1.39

45.47

2.2

2.3

4.24

4.23

g/l

0.23

2134

10664

Disorders of continuity of bone

319

1369

2.43

45.10

3.9

2.1

4.22

4.24

g/l

0.10

294

1271

ILD, hospital admissions

601

3280

1.91

45.07

2.4

2.3

4.13

4.18

g/l

1.00

571

2968

Injury, poisoning and certain other consequences of external causes

1338

4342

1.56

44.86

2.3

4.22

4.23

g/l

0.03

1225

4026

Lichen simplex chronicus and prurigo

256

1001

2.72

44.77

1.9

2.6

4.29

4.20

g/l

0.81

236

912

Substance abuse, excluding more controls

1520

8635

1.49

44.74

1.6

2.4

4.28

4.19

g/l

3.69

1362

8025

Anxiety disorders

2340

11717

1.38

44.68

2.2

2.3

4.25

4.23

g/l

0.32

2154

10772

Stroke, excluding SAH

1991

10255

1.43

44.58

2.3

2.4

4.15

4.21

g/l

2.23

1782

9334

Acute upper respiratory infections of multiple and unspecified sites

2074

10853

1.41

44.47

3.4

2.1

4.21

4.22

g/l

0.18

1920

9936

Presence of other functional implants

1888

9126

1.44

44.39

2.3

4.21

g/l

0.04

1700

8305

Rare circulating lymphoid malignancy, including Hilmo

139

385

3.96

44.38

4.6

1.4

4.08

4.20

g/l

0.89

133

343

Disorders of conjunctiva

2240

12638

1.39

44.28

2.3

4.23

g/l

0.08

2050

11577

Implicit fungal Sepsis

186

620

3.26

44.24

3.7

2.2

4.02

4.22

g/l

1.85

171

570

Other interstitial pulmonary diseases

605

3329

1.90

44.17

2.4

2.3

4.13

4.18

g/l

0.94

575

3008

Other chronic obstructive pulmonary disease

1464

8125

1.51

44.16

1.8

2.5

4.23

4.17

g/l

1.86

1333

7361

Fitting and adjustment of other devices

1216

7003

1.56

44.04

2.4

2.2

4.33

4.21

g/l

3.58

1077

6257

Interstitial lung disease

605

3337

1.89

43.83

2.4

2.3

4.13

4.18

g/l

0.99

575

3016

Interstitial lung disease endpoints

605

3337

1.89

43.83

2.4

2.3

4.13

4.18

g/l

0.99

575

3016

Other inflammation of eyelid, including avohilmo

1135

7331

1.57

43.79

2.6

2.3

4.18

4.24

g/l

1.86

1029

6758

Dental operations

1882

6774

1.45

43.77

2.3

2.1

4.19

4.18

g/l

0.24

1699

6177

Spondylopathies (FG)

346

1553

2.29

43.67

1.8

2.6

4.33

4.23

g/l

1.17

331

1433

Injuries to the knee and lower leg

3277

13558

1.32

43.63

2.0

2.4

4.23

4.21

g/l

0.41

2985

12425

Acute upper respiratory infections

2964

13445

1.33

43.61

3.1

2.1

4.24

4.21

g/l

1.09

2727

12244

Chronic sinusitis

1177

7672

1.56

43.47

2.5

2.3

4.23

g/l

0.08

1095

7044

Gastroduodenal ulcer

880

5363

1.68

43.42

2.1

2.4

4.22

4.16

g/l

1.02

804

4859

L01XX Other antineoplastic agents

273

1124

2.62

43.37

3.4

2.5

4.11

4.20

g/l

0.86

255

1030

Secondary right heart disease

207

744

3.03

43.21

1.9

2.4

4.28

4.19

g/l

0.91

194

678

Artrosis, including avohilmo

2239

8877

1.40

43.18

2.1

2.5

4.23

4.20

g/l

1.20

2049

8174

Basal cell carcinoma

1407

6438

1.52

43.17

2.6

1.4

4.16

4.24

g/l

1.53

1268

5775

Major coronary heart disease event excluding revascularizations

1927

9053

1.43

43.05

2.2

2.5

4.18

4.22

g/l

1.13

1764

8164

Meniscus derangement

1476

6623

1.50

43.03

2.2

2.5

4.24

4.21

g/l

0.52

1356

6059

Diabetic neuropathy

466

2369

2.07

43.01

2.0

2.1

4.22

4.30

g/l

1.10

435

2168

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1363

8786

1.51

42.96

2.1

2.2

4.24

4.25

g/l

0.19

1240

8052

Psoriatic and enteropathic arthropathies

325

1435

2.34

42.84

1.8

2.6

4.35

4.22

g/l

1.82

307

1326

Pacemaker

1312

8178

1.53

42.84

2.1

2.3

4.15

4.17

g/l

0.53

1169

7339

Ischaemic Stroke, excluding all haemorrhages

1893

9939

1.43

42.71

2.3

2.4

4.15

4.20

g/l

1.88

1693

9023

Drug-induced osteoporosis with pathological fracture

115

291

4.63

42.69

1.7

2.6

4.30

4.28

g/l

0.03

264

Cellulitis

689

3965

1.79

42.55

3.0

2.3

4.16

4.21

g/l

1.04

647

3635

Fracture of shoulder and upper arm

1117

7243

1.57

42.48

2.7

2.3

4.19

4.23

g/l

0.68

978

6581

Cholelithiasis, broad definition with cholecystitis

2524

12508

1.36

42.45

2.4

4.26

4.20

g/l

2.78

2303

11407

L04AC Interleukin inhibitors

211

765

2.90

42.43

1.6

2.3

4.39

4.27

g/l

1.27

203

717

Rash and other nonspecific skin eruption

336

1518

2.32

42.35

2.4

2.3

4.20

4.22

g/l

0.16

318

1384

Missing teeth due to accident, extraction or parodontitis

1956

12611

1.41

42.18

2.3

2.4

4.23

4.21

g/l

0.19

1698

11602

Special screening examination for infectious and parasitic diseases

457

1644

2.06

42.07

2.4

2.2

4.18

4.23

g/l

0.60

416

1569

Spondyloarthritis

518

2744

1.94

41.85

2.2

2.3

4.24

4.22

g/l

0.20

493

2502

Other symptoms and signs involving the nervous and musculoskeletal systems

1176

7745

1.55

41.76

2.2

2.4

4.26

4.23

g/l

0.71

1092

7076

Asthma and allergy, excluding more controls

256

1012

2.55

41.41

2.0

1.5

4.28

4.30

g/l

0.16

236

934

Adverse effects, not elsewhere classified

533

2861

1.91

41.31

2.3

4.24

4.25

g/l

0.11

508

2646

Voice disturbances

828

5049

1.68

41.30

2.7

2.3

4.13

4.23

g/l

2.97

763

4609

Eosinophilic disease (BM)

149

5.94

41.04

2.5

1.6

4.14

4.20

g/l

0.15

138

Non-allergic asthma (mode)

512

2690

1.93

41.03

2.0

1.9

4.24

4.25

g/l

0.08

474

2432

Overexertion and strenuous or repetitive movements

324

1462

2.31

40.88

2.6

2.4

4.11

4.21

g/l

1.27

296

1358

Open wound of lower leg

494

2605

1.96

40.73

2.0

2.3

4.17

4.20

g/l

0.47

445

2372

Allergic conjunctivitis

1407

9270

1.48

40.68

2.0

2.3

4.24

4.25

g/l

0.20

1281

8510

Viral pneumonia (unknown virus, not influenza)

243

969

2.64

40.63

3.4

2.4

4.14

4.19

g/l

0.42

231

893

Superficial injury of head

757

4534

1.71

40.17

2.1

2.3

4.19

4.22

g/l

0.45

675

4113

Other infectious diseases, including avohilmo

334

1541

2.27

40.11

2.5

2.3

4.21

4.19

g/l

0.15

317

1412

Complications of internal orthopaedic prosthetic devices, implants and grafts

797

4864

1.69

39.92

2.1

2.3

4.20

4.21

g/l

0.09

719

4358

Other abnormalities of plasma proteins

230

4.89

39.81

5.1

2.7

3.98

4.23

g/l

1.48

208

Rheumatism, unspecified

409

2038

2.08

39.76

2.2

2.5

4.33

4.26

g/l

0.95

383

1838

Other disorders of bone

525

2840

1.90

39.74

3.7

2.0

4.23

4.25

g/l

0.22

486

2647

Allergic asthma (mode), excluding more controls

469

2374

1.96

39.72

1.9

1.7

4.29

4.27

g/l

0.30

439

2180

Need for immunization against other single viral diseases

100

238

4.71

39.60

3.1

2.4

3.96

4.27

g/l

2.02

221

Reactive arthropathies, FINNGEN

212

798

2.78

39.60

2.3

2.7

4.26

4.19

g/l

0.59

193

730

Diseases of the myoneural junction and muscle

441

2273

2.02

39.27

1.7

2.3

4.15

4.19

g/l

0.59

384

2062

ILD, hospital admissions 1, main diag only

534

2940

1.90

39.07

2.4

4.13

4.18

g/l

0.84

506

2662

Cholelithiasis

2412

12356

1.35

38.69

2.4

2.3

4.26

4.20

g/l

2.96

2198

11258

Myeloproliferative diseases

328

1531

2.26

38.55

2.7

2.4

4.18

4.20

g/l

0.20

300

1395

Hypothyroidism, strict autoimmune

1824

8589

1.41

38.43

2.1

2.5

4.27

4.20

g/l

1.45

1661

7772

Other pulmonary heart/vessel disease

214

837

2.76

37.86

1.9

2.4

4.28

4.17

g/l

1.18

199

763

All influenza (not pneumonia)

414

2105

2.02

37.83

4.7

1.9

4.22

4.23

g/l

0.05

381

1928

Somatoform disorder

460

2427

1.95

37.74

2.4

2.3

4.29

4.25

g/l

0.56

420

2242

Hypoparathyroidism

172

602

3.11

37.74

1.7

2.3

4.30

4.27

g/l

0.12

152

548

Migraine without aura

400

2009

2.03

37.43

2.2

4.22

4.25

g/l

0.32

377

1879

Paralytic ileus and intestinal obstruction

795

4913

1.65

37.39

2.9

2.3

4.21

g/l

0.04

731

4445

DVT of lower extremities

627

3653

1.77

37.35

3.1

2.3

4.28

4.20

g/l

1.05

571

3320

Injuries to the elbow and forearm

1933

12151

1.38

37.29

2.1

2.3

4.19

4.24

g/l

1.48

1725

11140

Acute sinusitis

1288

8012

1.48

37.16

3.4

2.1

4.22

4.23

g/l

0.15

1188

7378

Phlebitis and thrombophlebitis (not including DVT)

697

4181

1.71

37.12

2.9

2.3

4.24

4.22

g/l

0.17

642

3812

Diseases of spleen

243

4.53

36.86

2.0

2.1

4.10

4.23

g/l

0.58

224

Coxibs

768

2397

1.71

36.85

2.1

2.3

4.22

4.15

g/l

1.67

703

2195

Other degenerative diseases of the nervous system

846

3837

1.64

36.83

1.9

2.4

4.15

4.18

g/l

0.46

743

3495

Pain in thoracic spine

422

2180

1.99

36.82

2.8

2.2

4.20

4.25

g/l

0.74

397

1983

In situ neoplasms

1252

8585

1.49

36.80

2.4

2.3

4.15

4.22

g/l

2.37

1135

7747

Gastric ulcer

603

3490

1.78

36.78

2.1

2.4

4.22

4.15

g/l

1.07

545

3156

Asthma and allergy

256

1070

2.41

36.72

2.0

1.5

4.28

4.30

g/l

0.16

236

982

Other chronic obstructive pulmonary disease, including avohilmo

1757

10462

1.40

36.68

1.8

2.5

4.23

4.19

g/l

0.96

1597

9528

Hypocalcemia

123

359

3.81

36.67

4.6

2.6

4.13

4.20

g/l

0.26

109

336

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

502

2759

1.88

36.55

1.9

1.4

4.11

4.22

g/l

1.04

476

2493

Haemorrhage, not elsewhere classified

162

557

3.11

36.33

2.8

2.4

4.11

4.25

g/l

1.26

152

501

Myocardial infarction

1555

7697

1.44

36.32

2.2

2.5

4.16

4.21

g/l

1.74

1413

6927

Papulosquamous disorders

1145

7732

1.51

36.29

2.2

2.4

4.32

4.22

g/l

3.16

1061

7092

Nonorganic sleeping disorders, excluding more controls

496

2711

1.87

36.18

1.7

2.3

4.23

4.22

g/l

0.07

460

2533

Other general symptoms and signs

149

482

3.19

35.95

1.4

2.5

4.08

4.28

g/l

2.05

138

445

Charcot foot

231

4.54

35.72

2.3

2.9

3.99

4.19

g/l

1.15

210

Abnormal serum enzyme levels

986

6252

1.56

35.72

2.2

2.4

4.19

4.16

g/l

0.43

924

5739

Myeloproliferative diseases (CML excluded)

299

1388

2.28

35.71

2.8

2.4

4.19

4.20

g/l

0.09

273

1267

Other inflammation of eyelid

467

2528

1.91

35.68

3.0

2.3

4.17

4.24

g/l

1.29

409

2313

Personality disorders, excluding more controls

530

2962

1.82

35.50

1.7

2.3

4.23

4.24

g/l

0.06

495

2790

Benign neoplasm of other and ill-defined parts of digestive system

606

3560

1.76

35.23

2.2

2.4

4.23

4.21

g/l

0.25

558

3237

Other symptoms and signs involving the urinary system

367

1846

2.07

35.08

2.5

2.4

4.22

4.18

g/l

0.21

350

1680

Other diseases of lip and oral mucosa

1195

8191

1.48

35.07

2.6

2.4

4.25

4.24

g/l

0.18

1082

7513

Adalimumab

264

1167

2.34

34.83

1.4

2.4

4.48

4.27

g/l

2.52

253

1096

Atopic dermatitis

1327

7334

1.46

34.79

1.8

2.3

4.23

4.24

g/l

0.35

1217

6775

Disorders of synovium and tendon

1354

8025

1.45

34.69

1.9

2.4

4.24

4.22

g/l

0.28

1237

7331

Other viral diseases, including avohilmo

840

5295

1.59

34.57

3.3

2.1

4.11

4.25

g/l

5.90

807

4919

Systemic atrophies primarily affecting the central nervous system

186

710

2.82

34.54

1.6

2.6

4.24

4.17

g/l

0.60

175

648

Acetic acid derivatives and related substances

763

2385

1.68

34.39

2.1

2.3

4.20

4.15

g/l

1.02

700

2183

Superficial injury of lower leg

706

4327

1.66

34.35

1.9

2.3

4.21

4.23

g/l

0.32

631

3955

Budesonide

374

1900

2.02

34.29

2.0

2.4

4.16

4.20

g/l

0.43

342

1740

Intracranial injury

1634

11047

1.40

34.23

2.2

2.3

4.20

4.21

g/l

0.12

1460

10086

Disorders of sclera, cornea, iris and ciliary body

1510

10844

1.41

34.12

2.3

4.24

4.22

g/l

0.22

1401

9917

Peripheral arterial reconstruction

634

3812

1.72

33.94

2.1

2.4

4.18

4.15

g/l

0.25

583

3424

Bipolar affective disorders

422

2237

1.93

33.94

1.9

2.3

4.27

4.25

g/l

0.17

396

2096

Phobic anxiety disorders

262

1161

2.30

33.81

2.1

4.28

g/l

0.00

249

1095

Recurrent or chronic depression

935

4199

1.57

33.76

2.1

2.4

4.23

4.25

g/l

0.17

859

3949

Valvular operations

450

2451

1.90

33.69

1.6

2.3

4.21

4.18

g/l

0.33

412

2196

Polyarthritis, unspecified

141

468

3.22

33.63

2.6

2.5

4.29

4.25

g/l

0.16

135

429

Reactive arthropathies

252

1110

2.35

33.63

2.1

2.5

4.28

4.23

g/l

0.37

228

1026

Allergic asthma (mode)

469

2513

1.85

33.43

1.9

1.7

4.29

4.26

g/l

0.32

439

2310

Other extrapyramidal and movement disorders in other diseases

784

4975

1.62

33.41

2.2

2.3

4.20

4.22

g/l

0.23

709

4538

Other peripheral vascular diseases

280

1296

2.26

33.40

1.9

2.3

4.14

4.21

g/l

0.73

258

1191

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

292

1373

2.21

33.37

3.5

2.3

4.21

4.22

g/l

0.13

273

1258

Stomatitis and related lesions

566

3307

1.75

33.22

2.6

2.3

4.25

4.23

g/l

0.24

525

3032

Other disorders of eye and adnexa

415

2213

1.93

33.12

1.9

2.3

4.15

4.24

g/l

1.71

390

2038

Etanercept

199

796

2.61

33.02

1.5

2.3

4.43

4.27

g/l

1.79

193

745

Other and unspecified effects of external causes

669

4086

1.67

32.94

2.2

4.23

g/l

0.09

630

3775

1577

10224

1.40

32.79

1.6

2.4

4.24

4.19

g/l

1.77

1423

9471

Other viral diseases

665

4049

1.66

32.60

3.6

2.1

4.07

4.24

g/l

7.13

641

3756

Mycoses

810

5205

1.59

32.51

2.9

2.4

4.20

4.22

g/l

0.26

749

4760

Alcohol use disorder, Swedish definition

1504

9867

1.40

32.51

1.7

2.4

4.24

4.18

g/l

1.62

1356

9144

Other enthesopathies

768

4868

1.61

32.46

2.0

2.4

4.25

4.24

g/l

0.05

703

4466

Persons encountering health services in other circumstances

1024

6833

1.50

32.37

2.3

4.28

4.21

g/l

1.96

960

6174

1636

10423

1.38

32.07

1.6

2.4

4.24

4.19

g/l

1.64

1478

9660

Cervicalgia

578

3428

1.72

32.06

2.2

2.3

4.17

4.23

g/l

1.16

525

3119

Any death

1991

10484

1.35

31.92

3.0

2.3

4.08

4.24

g/l

11.48

1801

9577

Localized swelling, mass and lump of skin and subcutaneous tissue

895

5905

1.54

31.80

2.3

2.4

4.16

4.22

g/l

1.23

825

5387

Other metabolic disorders

348

1773

2.02

31.72

3.5

2.2

4.16

4.26

g/l

1.71

334

1624

Degeneration of macula and posterior pole

1638

9275

1.39

31.68

2.3

2.4

4.19

g/l

0.06

1443

8367

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

919

6105

1.53

31.60

2.3

4.19

4.25

g/l

1.36

849

5581

Psoriasis

800

5167

1.58

31.41

1.9

2.4

4.35

4.21

g/l

3.78

744

4752

Pyogenic arthritis

222

957

2.42

31.36

2.9

2.5

4.18

4.19

g/l

0.08

209

872

Disease of hard tissues of teeth, NOS

1510

5659

1.42

31.25

2.2

2.1

4.24

4.19

g/l

1.35

1371

5178

Extrapyramidal and movement disorders

1212

8532

1.45

31.08

2.1

2.4

4.18

4.21

g/l

0.60

1088

7751

Superficial injury of hip and thigh

493

2832

1.79

30.89

2.0

2.3

4.09

4.21

g/l

2.56

431

2580

Fracture of lower leg, including ankle

1507

10796

1.39

30.80

2.0

2.4

4.27

4.23

g/l

0.94

1364

9882

Viral pneumonia (known virus, not influenza)

129

431

3.25

30.74

6.6

2.6

4.10

4.15

g/l

0.25

120

390

Sequelae with surgical and medical care as external cause

655

4067

1.66

30.71

2.1

2.3

4.17

4.20

g/l

0.34

617

3694

Metatarsalgia

281

1346

2.16

30.50

2.3

4.23

4.26

g/l

0.32

258

1238

Noninfectious colitis NAS

404

2197

1.89

30.40

2.6

2.2

4.18

4.22

g/l

0.32

377

2008

Raynaud syndrome

268

1265

2.20

30.34

1.6

2.5

4.06

4.26

g/l

3.96

249

1166

Non-selective monoamine reuptake inhibitors

1046

6894

1.48

30.24

2.3

2.5

4.28

4.23

g/l

1.15

956

6284

Hypertrophic cardiomyopathy

174

687

2.71

30.23

2.6

2.7

4.02

4.21

g/l

2.37

164

633

Sub-endpoint used in defining T1D endpoints

760

4807

1.58

30.22

1.7

2.2

4.09

4.21

g/l

3.50

715

4394

Sequelae of cerebrovascular disease

1224

7387

1.44

30.18

2.1

2.3

4.17

4.19

g/l

0.24

1057

6695

Postprocedural endocrine and metabolic disorders, not elsewhere classified

322

1627

2.03

30.10

3.5

2.2

4.16

4.27

g/l

1.82

308

1488

Systemic sclerosis (FG)

279

3.81

30.08

1.9

3.0

4.06

4.28

g/l

1.52

255

Other complications of surgical and medical care, not elsewhere classified

305

1525

2.07

29.61

2.4

2.3

4.24

g/l

0.02

281

1400

Decubitus ulcer and pressure area

246

1139

2.27

29.59

1.8

2.3

4.04

4.18

g/l

1.90

217

1025

Gonarthrosis,primary

2656

12607

1.28

29.54

2.1

2.4

4.26

4.20

g/l

2.51

2415

11499

Myocardial infarction, strict

1434

7356

1.40

29.51

2.1

2.5

4.17

4.21

g/l

1.24

1306

6619

Elevated blood glucose level

266

1267

2.18

29.48

2.0

2.2

4.23

4.19

g/l

0.31

238

1163

Disorders of muscles

296

1467

2.08

29.32

1.7

2.2

4.19

4.22

g/l

0.22

279

1353

Enthesopathies of lower limb, excluding foot

583

3548

1.68

29.27

2.4

2.2

4.17

4.24

g/l

1.75

535

3246

Essential (haemorrhagic) thrombocythaemia

153

576

2.84

29.19

2.5

1.4

4.10

4.27

g/l

2.25

137

513

Other pleural conditions

384

2093

1.91

29.11

2.9

2.3

4.09

4.17

g/l

1.24

354

1880

Carpal tunnel syndrome

1683

10896

1.35

29.09

2.3

2.4

4.26

4.22

g/l

1.15

1567

9935

Vascular disorders of the intestines

261

1245

2.20

29.00

2.4

2.1

4.18

4.19

g/l

0.07

244

1110

Myocardial infarction, without ST-elevation

1355

8869

1.40

28.89

2.1

2.4

4.15

4.18

g/l

0.63

1223

7990

Mental and behavioural disorders due to psychoactive substance use

1565

10625

1.36

28.68

1.7

2.4

4.27

4.19

g/l

3.62

1403

9825

COPD, early/later onset

1480

9133

1.38

28.67

1.8

2.4

4.23

4.18

g/l

1.55

1346

8291

Other infectious diseases

268

1297

2.16

28.66

2.6

2.3

4.20

4.18

g/l

0.08

254

1186

Nonischemic cardiomyopathy

344

1815

1.97

28.66

2.3

4.09

4.19

g/l

1.77

323

1641

Other skin changes

628

3934

1.64

28.39

3.2

2.3

4.22

4.20

g/l

0.15

563

3575

Other enthesopathy of foot (+metatarsalgia)

292

1457

2.07

28.39

2.3

4.23

4.26

g/l

0.28

267

1340

Disorders of the thyroid gland

2514

12822

1.28

28.37

2.2

2.4

4.23

4.20

g/l

0.48

2299

11731

Progressive vascular leukoencephalopathy

191

815

2.52

28.30

2.2

2.4

4.06

4.19

g/l

1.48

165

731

Other and unspecified acquired haemolytic anaemias

142

5.26

28.12

3.0

1.7

3.85

4.24

g/l

1.92

132

Diseases of external ear

1015

7045

1.47

28.08

2.3

4.24

4.21

g/l

0.28

869

6462

Substance abuse

1520

10459

1.37

28.07

1.6

2.4

4.28

4.19

g/l

3.59

1362

9678

COPD related to multimorbidity

1321

8094

1.41

28.06

1.8

2.4

4.23

4.17

g/l

1.97

1195

7338

Recurrent aphthous stomatitis , including avohilmo

422

2385

1.82

28.04

2.6

2.3

4.25

4.23

g/l

0.23

391

2180

Special screening examination for other diseases and disorders

300

1514

2.03

28.00

2.6

2.3

4.38

4.19

g/l

2.36

286

1399

Psoriatic arthropathies

273

1337

2.11

27.94

1.9

2.5

4.38

4.23

g/l

1.71

255

1238

Neuromuscular dysfunction of bladder

297

1505

2.05

27.89

2.1

2.5

4.15

4.21

g/l

0.66

276

1377

Migraine with aura

506

2999

1.71

27.87

1.7

2.4

4.16

4.23

g/l

1.60

470

2783

Cervical disc disorders

969

6673

1.48

27.87

2.4

2.2

4.24

4.22

g/l

0.28

882

6104

Other hammer toe(s) (acquired)

508

2748

1.73

27.70

2.0

2.6

4.15

4.23

g/l

1.60

442

2458

Migraine

1069

5788

1.45

27.69

2.0

2.4

4.21

4.23

g/l

0.46

992

5359

Other or unspecified ileus, impaction or obstruction

559

3420

1.67

27.67

2.8

2.2

4.23

4.19

g/l

0.44

517

3091

Conjunctivitis (acute, non atopic), including avohilmo

2666

12770

1.27

27.63

2.3

4.22

4.21

g/l

0.04

2459

11696

Generalized anxiety disorder

317

1634

1.97

27.62

1.8

2.2

4.23

4.26

g/l

0.34

295

1527

Oxicams

653

2301

1.64

27.44

2.4

4.19

4.16

g/l

0.36

588

2102

Substance use, excluding alcohol

479

2819

1.73

27.36

1.6

2.3

4.33

4.22

g/l

2.03

418

2649

5-aminosalicylic acid

464

2705

1.75

27.32

1.9

2.4

4.26

4.21

g/l

0.42

433

2490

COPD, hospital admissions

1456

9066

1.38

27.32

1.8

2.4

4.23

4.18

g/l

1.68

1324

8232

Panic disorder

299

1521

2.00

27.25

1.7

2.3

4.29

4.27

g/l

0.12

278

1425

Inflammatory bowel disease

781

5181

1.53

27.05

2.1

2.3

4.23

g/l

0.01

723

4788

Injuries to unspecified part of trunk, limb or body region

321

1690

1.97

26.90

2.1

2.4

4.08

4.22

g/l

2.33

290

1548

Diseases of salivary glands

873

5936

1.50

26.87

2.3

4.23

4.24

g/l

0.20

794

5438

Oter anti-inflammatory and antirheumatic agents, non-steroids

652

2232

1.64

26.85

2.4

4.18

4.16

g/l

0.32

589

2033

Angina pectoris

1688

8434

1.35

26.80

2.4

2.5

4.21

4.22

g/l

0.10

1571

7607

Injuries to the ankle and foot

1728

11191

1.33

26.76

2.2

2.3

4.24

4.23

g/l

0.24

1595

10344

Diabetic maculopathy, excluding more controls

321

1692

1.96

26.74

1.5

2.4

4.12

4.14

g/l

0.19

298

1548

Other disorders of ear

2535

12993

1.27

26.70

2.3

4.20

4.22

g/l

0.41

2287

11935

Protozoal diseases

130

473

2.97

26.66

6.3

2.6

4.05

4.18

g/l

0.97

124

436

Spondylolisthesis/Spondylolysis

499

2995

1.71

26.63

2.6

2.3

4.23

4.24

g/l

0.11

459

2728

Hydronephrosis

338

1817

1.92

26.50

1.9

2.1

4.14

4.21

g/l

0.96

314

1648

Paracetamol or NSAID medication

340

876

1.98

26.28

2.4

1.9

4.15

g/l

0.03

314

820

Disorders of skin appendages

1181

8463

1.40

26.20

2.2

2.3

4.28

4.23

g/l

0.75

1107

7795

Sequelae of other external causes

195

862

2.37

26.17

2.8

2.6

4.35

4.22

g/l

0.93

188

791

Cerebral palsy and other paralytic syndromes

328

1755

1.93

26.11

2.2

2.3

4.17

4.20

g/l

0.30

303

1614

Heart failure and hypertrophic cardiomyopathy

304

3.55

26.08

3.0

2.6

4.00

4.13

g/l

0.83

276

Fracture of forearm

1472

9853

1.36

26.08

2.1

2.4

4.17

4.25

g/l

2.58

1304

8973

Unspecified acute lower respiratory infection

432

2511

1.76

26.00

3.2

2.2

4.14

4.20

g/l

0.95

409

2304

Caries of enamel

2450

12707

1.27

25.91

2.7

2.3

4.21

4.23

g/l

0.64

2243

11721

Restless leg syndrome

435

2547

1.76

25.66

2.0

2.3

4.22

4.23

g/l

0.05

392

2335

Collagenous colitis

297

1550

1.99

25.66

2.9

2.4

4.19

4.22

g/l

0.21

273

1416

Mixed connective tissue disease

223

3.93

25.51

1.9

2.5

4.05

4.31

g/l

1.77

206

Disorders of adult personality and behaviour

571

3575

1.62

25.48

1.8

2.2

4.23

4.25

g/l

0.22

535

3354

Use of pramipexole

683

4479

1.56

25.38

1.9

2.3

4.22

4.21

g/l

0.11

600

4058

Fissure and fistula of anal and rectal regions

613

3914

1.59

25.35

2.3

4.24

4.22

g/l

0.25

557

3589

Eosinophilia

221

3.95

25.18

2.5

2.3

4.14

4.21

g/l

0.23

206

Crystal arthropathies, rheuma endpoint

289

3.52

25.17

1.6

3.1

4.05

4.14

g/l

0.47

258

Protozoal diseases, including avohilmo

131

494

2.85

25.08

6.2

2.7

4.05

4.19

g/l

1.05

125

456

Atopic dermatitis, strict definition with reimbursement

555

3321

1.63

25.05

1.9

2.1

4.25

4.27

g/l

0.25

511

3090

Conjunctivitis (acute, non atopic)

679

4427

1.55

24.99

2.8

2.2

4.23

4.24

g/l

0.19

629

4077

Cardiodefibrillation

1158

8396

1.40

24.87

2.3

2.4

4.14

4.18

g/l

0.85

1075

7608

Coxarthrosis, primary

1873

12066

1.31

24.83

2.2

2.4

4.23

4.20

g/l

0.53

1689

10925

Other encephalitis

106

359

3.16

24.60

1.9

2.6

3.97

4.24

g/l

1.95

335

Benign neoplasm: Transverse colon

385

2215

1.81

24.50

2.7

2.4

4.20

4.19

g/l

0.03

345

2023

Hallux valgus (acquired)

821

3976

1.50

24.45

2.2

2.6

4.24

4.23

g/l

0.06

733

3602

Malignant neoplasm of urinary organs, including Hilmo

370

2101

1.82

24.44

2.0

1.4

4.21

g/l

0.05

341

1876

Other symptoms and signs involving the circulatory and respiratory systems

200

917

2.26

24.43

2.5

2.3

4.22

4.26

g/l

0.19

180

829

Other embolism and thrombosis

391

2255

1.79

24.39

2.8

2.2

4.13

4.21

g/l

1.05

367

2043

Other and unspecified urticaria

473

2866

1.68

24.30

2.2

4.24

4.25

g/l

0.03

433

2643

Other disorders of glucose regulation and pancreatic internal secretion

248

1239

2.07

24.22

1.9

2.3

4.15

4.20

g/l

0.47

225

1134

Other and unspecified drugs and medicaments

265

1357

2.03

24.22

3.4

2.4

4.22

g/l

0.03

248

1241

Amputation of foot

121

449

2.93

24.04

2.4

2.6

4.03

4.10

g/l

0.38

112

409

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

327

1800

1.88

24.00

1.9

1.4

4.22

4.20

g/l

0.12

302

1608

Benign neoplasm of other and unspecified endocrine glands

403

2362

1.76

23.79

2.5

2.3

4.19

4.21

g/l

0.27

365

2177

Ankylosing spondylitis

231

1131

2.11

23.76

1.7

2.2

4.37

4.23

g/l

1.36

222

1046

Other disorders of eyelid

1364

9643

1.35

23.74

2.1

2.4

4.20

4.21

g/l

0.04

1236

8727

Hyperplasia of prostate

1065

4262

1.43

23.73

2.5

4.10

4.17

g/l

1.99

986

3960

Bullous disorders

215

1033

2.19

23.68

1.9

2.5

4.17

4.20

g/l

0.22

204

943

Other/unspecified reactive arthropathies

197

912

2.25

23.62

2.3

2.4

4.27

4.23

g/l

0.24

180

848

Other respiratory disorders and diseases

657

4341

1.55

23.61

2.0

2.3

4.25

4.17

g/l

1.64

589

3919

Other diseases of the respiratory system

657

4341

1.55

23.61

2.0

2.3

4.25

4.17

g/l

1.64

589

3919

Faecal incontinence

303

1637

1.92

23.59

1.7

2.4

4.14

4.29

g/l

2.26

277

1462

Mixed and other personality disorders

185

833

2.29

23.51

1.7

2.1

4.28

g/l

0.02

178

787

Benign neoplasm: Sigmoid colon

620

4055

1.57

23.47

2.5

2.3

4.22

4.19

g/l

0.35

566

3690

Migraine without aura and triptan purchases

303

1629

1.89

23.45

1.6

2.0

4.21

4.33

g/l

2.16

287

1516

Thyroiditis, ILD-related definition

286

1515

1.94

23.42

2.3

2.4

4.20

4.27

g/l

0.84

261

1385

KRA_PSY_EATING, excluding more controls

119

430

2.79

23.42

1.8

4.23

4.32

g/l

0.49

113

406

Encephalitis

109

386

3.01

23.35

1.9

2.5

3.99

4.24

g/l

1.86

360

Sarcoidosis

385

2240

1.77

23.31

1.9

2.3

4.22

4.24

g/l

0.19

362

2066

Herpesviral [herpes simplex] infections, including avohilmo

591

3814

1.57

23.30

2.8

2.2

4.19

4.26

g/l

1.50

549

3506

Other specified and unspecified disorders of eye and adnexa

139

559

2.63

23.21

2.3

2.4

4.06

4.26

g/l

2.70

131

515

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1448

9976

1.33

23.15

2.0

2.3

4.18

4.24

g/l

1.90

1342

9211

Chronic pancreatitis

388

2269

1.76

23.13

1.8

2.4

4.06

4.17

g/l

1.75

356

2091

Diabetic retinopathy

1092

4885

1.42

23.10

1.8

2.1

4.19

4.32

g/l

5.39

995

4496

Cramp and spasm

152

638

2.50

23.02

2.6

2.3

4.23

4.22

g/l

0.07

140

593

Nonorganic sleeping disorders

496

3082

1.64

23.02

1.7

2.2

4.23

4.25

g/l

0.21

460

2861

Pneumonia derived septicemia

128

497

2.73

22.98

6.3

2.4

4.17

4.19

g/l

0.11

112

455

Open wound of ankle and foot

290

1555

1.92

22.97

2.4

2.3

4.15

4.19

g/l

0.46

266

1444

Fracture of foot, except ankle

594

3855

1.57

22.88

2.5

2.2

4.21

4.23

g/l

0.20

546

3575

Ulcerative colitis

602

3921

1.56

22.85

2.2

2.3

4.25

4.22

g/l

0.29

556

3626

Exclusions for E4_PCOS_BROAD

427

2561

1.70

22.81

2.9

2.3

4.19

4.24

g/l

0.65

399

2374

Pneumococcal septicemia

123

471

2.77

22.72

6.2

2.5

4.17

4.15

g/l

0.07

108

432

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

530

3310

1.60

22.63

1.9

2.2

4.31

4.23

g/l

1.36

483

3107

Haemorrhoids and perianal venous thrombosis

916

6455

1.43

22.41

2.4

2.3

4.19

4.22

g/l

0.44

832

5841

Radiculopathy

461

2839

1.66

22.41

2.5

2.2

4.21

4.20

g/l

0.08

424

2565

Diseases of inner ear

1567

11546

1.31

22.39

2.0

2.4

4.22

g/l

0.04

1413

10490

Ascites

253

1314

2.00

22.31

1.5

2.4

4.08

4.20

g/l

1.13

234

1198

Vitamin B12 deficiency anaemia

334

1893

1.82

22.24

2.1

2.4

4.16

4.17

g/l

0.05

305

1713

Idiopathic urticaria

238

3.54

22.22

1.3

2.0

4.26

4.29

g/l

0.13

226

Primary biliary cholangitis, wide definition

300

3.26

22.21

1.5

2.3

4.40

4.20

g/l

1.41

275

Diagnoses used for exclusion with ILD

749

5143

1.48

22.18

2.3

4.21

4.20

g/l

0.13

683

4680

Other crystal arthropathies

313

3.24

22.10

1.6

2.4

4.05

4.14

g/l

0.50

278

Chronic tubulo-interstitial nephritis

127

500

2.67

22.08

2.2

2.1

3.95

4.26

g/l

3.37

115

455

Transient ischemic attack

1611

9913

1.31

22.06

2.2

2.4

4.18

4.20

g/l

0.36

1441

8995

Disorders of vestibular function (Vertigo)

1364

10070

1.34

22.01

2.1

2.4

4.23

g/l

0.08

1226

9117

Retinal detachments and breaks

1076

7889

1.39

21.92

2.6

2.4

4.19

4.21

g/l

0.29

978

7189

Carcinoma in situ of skin of other and unspecified parts of face

341

1962

1.81

21.90

2.2

2.4

4.13

4.20

g/l

0.77

314

1752

Scoliosis

213

1043

2.10

21.90

2.4

2.2

4.16

4.24

g/l

0.70

190

943

Abnormality of white blood cells, not elsewhere classified

115

5.04

21.86

2.2

2.1

4.20

4.41

g/l

0.55

108

Amiodarone users

350

2027

1.79

21.85

2.1

2.4

4.08

4.17

g/l

1.63

333

1846

Disorders of vitreous body and globe

1531

11157

1.31

21.83

2.4

4.18

4.23

g/l

0.88

1397

10169

Respiratory insufficiency

252

1311

1.98

21.78

1.6

1.7

4.26

4.21

g/l

0.34

221

1171

Autoimmune hepatitis, wide definition

139

575

2.52

21.69

1.7

2.6

4.22

4.21

g/l

0.05

128

519

Systemic sclerosis

343

3.07

21.60

1.9

2.2

4.06

4.32

g/l

2.31

315

Cyst of kidney

256

1353

1.98

21.59

2.4

2.5

4.21

4.19

g/l

0.15

242

1240

Vitreous haemorrhage

320

1811

1.83

21.48

2.1

2.4

3.98

4.21

g/l

6.10

300

1661

COPD, hospital admission 2, with asthma infections

1030

6459

1.40

21.45

1.9

2.4

4.21

4.16

g/l

1.13

933

5862

Persistent mood disorders

484

3047

1.62

21.40

2.1

2.3

4.26

4.23

g/l

0.34

448

2794

Other and unspecified myopathies

296

1640

1.87

21.40

1.8

2.3

4.17

4.19

g/l

0.15

250

1486

Psoriasis vulgaris

506

3224

1.60

21.37

1.8

2.3

4.32

4.21

g/l

2.49

469

2987

Barrett oesophagus

180

841

2.25

21.34

2.3

2.7

4.33

4.18

g/l

1.61

164

776

Congenital malformations, deformations and chromosomal abnormalities

1266

9027

1.34

21.18

2.0

2.3

4.19

4.24

g/l

1.61

1179

8337

Other diseases of pancreas

283

1553

1.89

21.13

2.2

2.4

4.07

4.17

g/l

1.35

260

1426

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1314

9597

1.33

21.11

2.3

4.25

4.22

g/l

0.76

1211

8830

Iridocyclitis

601

3995

1.53

20.90

2.4

2.3

4.27

4.22

g/l

0.67

558

3654

Vasomotor and allergic rhinitis

800

5478

1.44

20.85

2.3

2.2

4.25

g/l

0.02

731

5052

Special screening examination for neoplasms

186

884

2.17

20.81

2.8

2.2

4.12

4.20

g/l

0.55

169

821

Suppurative and necrotic conditions of lower respiratory tract

195

949

2.15

20.77

2.7

2.4

4.11

4.15

g/l

0.28

183

869

Personality disorders

530

3430

1.57

20.64

1.7

2.1

4.23

4.25

g/l

0.21

495

3214

Cutaneous lupus erythematosus

358

2.97

20.60

2.1

4.31

4.30

g/l

0.04

328

Disorders of vitreous body

1485

10934

1.31

20.55

2.4

4.17

4.23

g/l

0.99

1355

9972

1359

9353

1.33

20.52

2.8

2.3

4.13

4.19

g/l

1.66

1212

8396

COPD, hospital admissions 3, with asthma pneumonia sepsis

894

5497

1.42

20.46

1.9

2.4

4.20

4.15

g/l

1.14

812

4962

Problems related to lifestyle

242

1271

1.95

20.35

1.5

2.4

4.38

4.22

g/l

1.39

226

1169

Agoraphobia

215

3.47

20.30

1.8

4.30

4.42

g/l

0.53

206

Demyelinating diseases of the central nervous system

200

986

2.09

20.24

1.6

2.1

4.18

4.29

g/l

1.56

188

920

Candidiasis

387

2342

1.69

20.22

3.1

2.2

4.22

4.24

g/l

0.18

353

2143

Heartburn

307

1743

1.81

20.21

2.1

2.3

4.21

4.24

g/l

0.22

274

1586

Folate deficiency anaemia

168

4.10

20.12

2.7

1.9

4.46

4.14

g/l

0.86

152

Fall on and from stairs and steps

715

4960

1.47

20.06

2.2

2.3

4.22

4.23

g/l

0.06

638

4538

Pyothorax

154

693

2.34

20.06

3.0

2.6

4.10

4.14

g/l

0.22

143

636

Abnormal results of function studies

252

1352

1.92

20.06

2.4

2.5

4.23

4.24

g/l

0.07

233

1253

Misadventures to patients during surgical and medical care

418

2587

1.66

20.05

2.1

2.2

4.23

4.22

g/l

0.05

383

2354

Other viral diseases, not elsewhere classified, including avohilmo

561

3679

1.54

19.98

3.1

2.2

4.12

4.25

g/l

3.68

536

3406

Lesion of ulnar nerve

382

2312

1.69

19.97

2.1

2.2

4.22

4.23

g/l

0.02

361

2146

Other and unspecified local infections of skin and subcutaneous tissue

281

1562

1.85

19.97

3.2

2.4

4.20

4.21

g/l

0.03

259

1435

Fibroblastic disorders

639

4342

1.50

19.96

2.3

2.4

4.20

g/l

0.01

582

3947

Traumatic subdural haemorrhage

417

2410

1.66

19.90

2.3

4.13

4.14

g/l

0.08

364

2188

Dilated cardiomyopathy

380

2307

1.70

19.87

1.9

2.4

4.05

4.17

g/l

2.61

354

2115

Other local infections of skin and subcutaneous tissue

295

1666

1.82

19.87

3.1

2.4

4.21

4.20

g/l

0.05

268

1527

Other shoulder lesions

241

1276

1.94

19.86

1.5

2.3

4.30

4.23

g/l

0.56

224

1181

Intestinal stricture

923

6719

1.40

19.72

2.8

2.3

4.22

4.20

g/l

0.16

844

6084

Diseases of the ear and mastoid process

2834

11733

1.22

19.65

2.3

4.22

4.21

g/l

0.19

2593

10806

Mixed hyperlipidaemia

135

579

2.45

19.61

1.5

2.2

4.36

4.18

g/l

1.60

123

532

Herpesviral [herpes simplex] infections

312

1797

1.78

19.59

3.2

2.3

4.15

4.24

g/l

1.26

296

1649

Other diseases of stomach and duodenum

214

1099

2.02

19.58

2.2

2.5

4.27

4.21

g/l

0.41

201

1002

Skin changes due to chronic exposure to nonionizing radiation

1302

9028

1.33

19.58

2.9

2.3

4.11

4.19

g/l

2.74

1163

8093

Actinic keratosis

1277

8877

1.33

19.56

2.9

2.3

4.11

4.19

g/l

3.02

1139

7955

Allergic urticaria

205

1034

2.04

19.52

2.2

2.4

4.31

4.24

g/l

0.71

191

953

Primary biliary cholangitis (PBC)

292

3.12

19.37

1.7

2.0

4.42

4.23

g/l

0.81

268

Memory loss

317

1849

1.78

19.36

2.1

2.4

4.06

4.21

g/l

2.98

278

1686

Primary gonarthrosis, bilateral

1562

10248

1.29

19.34

2.0

2.5

4.25

4.19

g/l

1.87

1408

9292

Bronchiectasis

274

1533

1.86

19.32

2.8

2.5

4.26

4.18

g/l

0.63

254

1376

Intestinal malabsorption

150

677

2.32

19.31

2.0

2.5

4.11

4.21

g/l

0.70

141

621

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

297

1698

1.80

19.29

2.9

2.5

4.15

4.18

g/l

0.30

280

1563

Congenital malformations of the urinary system

156

716

2.26

19.16

2.0

2.5

3.91

4.21

g/l

5.31

149

666

Benign neoplasm: Stomach

318

1861

1.77

19.14

2.5

2.4

4.21

g/l

0.02

291

1696

Congenital malformations of the urinary system, including avohilmo

165

775

2.21

19.12

2.0

2.5

3.93

4.21

g/l

5.13

157

722

Acute pancreatitis

553

3688

1.53

19.05

2.0

2.3

4.20

4.19

g/l

0.11

511

3375

Mucosal proctocolitis

296

1691

1.79

19.04

2.2

2.4

4.26

4.22

g/l

0.30

285

1580

Diseases of male genital organs

1251

4741

1.34

19.04

2.2

2.4

4.11

4.18

g/l

2.11

1172

4421

Delirium, not induced by alcohol and other psychoactive substances

430

2714

1.63

18.99

2.1

2.3

4.08

4.18

g/l

1.68

379

2442

Other inflammatory liver diseases

198

1002

2.05

18.87

1.8

2.6

4.32

4.19

g/l

0.74

177

920

Thyrotoxicosis, other and/or unspecified

506

3315

1.55

18.87

2.0

2.3

4.23

4.24

g/l

0.17

468

3031

Juvenile arthritis (FINNGEN)

304

2.94

18.81

1.9

2.2

4.40

4.30

g/l

0.28

285

Oesophageal varices

145

655

2.33

18.76

1.6

2.4

4.31

4.17

g/l

0.98

133

601

Internal derangement of knee

845

6040

1.40

18.70

2.2

2.5

4.33

4.21

g/l

1.43

753

5544

Transport accidents

1017

6270

1.36

18.63

1.9

2.3

4.21

4.24

g/l

0.46

938

5870

Migraine with aura and triptan purchases

288

1639

1.78

18.63

1.6

2.0

4.17

4.32

g/l

3.07

274

1515

Thoracic aortic aneurysm

457

2947

1.59

18.60

2.4

2.5

4.12

4.17

g/l

0.85

411

2723

Carcinoma in situ of skin of scalp and neck

131

574

2.46

18.55

2.1

2.6

4.00

4.12

g/l

1.07

120

517

Fracture of skull and facial bones

543

3624

1.52

18.54

2.9

2.3

4.15

4.21

g/l

0.99

488

3356

Adhesive capsulitis of shoulder

439

2800

1.60

18.52

2.0

2.4

4.21

4.22

g/l

0.15

404

2556

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

411

2564

1.63

18.35

2.4

1.4

4.04

4.18

g/l

3.13

370

2259

Injury of unspecified body region

230

1236

1.92

18.32

1.8

2.5

4.09

4.20

g/l

1.31

204

1130

Alcoholic liver disease

305

1784

1.76

18.32

1.3

2.4

4.28

4.17

g/l

1.23

258

1659

Hypoglycaemia, other or unspecified

191

964

2.05

18.28

1.7

2.3

4.16

4.22

g/l

0.44

175

883

Pain associated with micturition

336

2016

1.71

18.24

2.5

2.3

4.26

4.21

g/l

0.52

300

1840

Thyrotoxicosis

646

4479

1.47

18.22

1.9

2.3

4.22

4.26

g/l

0.54

591

4077

Familial hypercholesterolemia

438

2807

1.60

18.21

2.5

2.3

4.29

4.19

g/l

1.23

393

2507

Other/unspecified rheumatoid arthritis

380

2358

1.66

18.21

1.9

2.3

4.22

g/l

0.03

347

2119

Viral hepatitis, including avohilmo

174

849

2.11

18.17

2.3

2.1

4.31

4.25

g/l

0.40

161

798

Mental and behavioural disorders due to alcohol

1287

9462

1.31

18.10

1.6

2.4

4.26

4.18

g/l

2.69

1164

8777

Guillain-Barre syndrome

214

3.45

18.08

3.1

2.1

4.08

4.21

g/l

0.64

199

Hypothyroidism, other/unspecified

2237

12028

1.23

18.08

2.2

2.4

4.25

4.21

g/l

1.07

2045

10988

Dermatitis due to substances taken internally

155

727

2.21

18.07

4.2

2.6

4.26

4.23

g/l

0.19

145

668

Epilepsy

765

5455

1.42

18.02

2.0

2.5

4.15

4.19

g/l

0.55

685

4995

Personal history of malignant neoplasm

242

1328

1.88

18.01

2.5

2.0

4.06

4.28

g/l

5.39

222

1216

Other viral hepatitis, including avohilmo

147

675

2.24

17.95

2.4

2.1

4.32

4.27

g/l

0.28

138

642

Chronic laryngitis and laryngotracheitis

395

2480

1.63

17.91

1.9

2.2

4.34

4.22

g/l

2.08

348

2262

Other viral diseases, not elsewhere classified

411

2592

1.61

17.84

3.4

2.2

4.07

4.24

g/l

4.34

395

2396

Fenamates

378

1572

1.67

17.81

2.2

2.3

4.15

4.19

g/l

0.38

345

1426

Artificial joint operation, meniscal resection

2526

13397

1.22

17.77

2.2

2.4

4.25

4.21

g/l

1.34

2300

12240

Atopic dermatitis, strict definition

515

3346

1.52

17.71

1.9

2.1

4.25

4.28

g/l

0.31

480

3136

therapeutic use

124

541

2.44

17.57

2.0

2.5

4.28

4.20

g/l

0.31

103

491

Systemic sclerosis, icd10

378

2.75

17.54

2.0

2.1

4.07

4.34

g/l

2.74

350

Benign neoplasm: Ascending colon

462

3029

1.57

17.53

2.3

2.4

4.19

g/l

0.01

418

2749

Early onset COPD

619

4296

1.47

17.51

2.0

2.5

4.28

4.19

g/l

1.84

573

3947

Hypermobility syndrome

108

438

2.54

17.50

2.1

1.9

4.42

4.30

g/l

0.83

103

420

Other viral hepatitis

141

644

2.25

17.47

2.3

2.0

4.31

4.29

g/l

0.09

132

611

Viral hepatitis

167

817

2.10

17.35

2.2

2.1

4.29

4.25

g/l

0.24

154

767

Exclusions for E4_PCOS_CONSORTIUM

1569

7729

1.28

17.33

2.2

4.30

4.25

g/l

0.84

1421

7051

Insulin, fast-acting (human)

307

1821

1.72

17.27

1.7

2.1

3.91

4.20

g/l

9.52

288

1694

Diplopia

376

2358

1.63

17.19

2.1

2.3

4.20

g/l

0.02

345

2167

Alcohol induced polyneuropathy

143

4.05

17.16

1.4

2.0

4.11

4.18

g/l

0.18

130

COPD-related respiratory insufficiency

394

2505

1.62

17.15

2.0

2.5

4.30

4.17

g/l

2.25

351

2252

Poisoning by drugs, medicaments and biological substances

480

3172

1.53

17.12

2.0

2.2

4.35

4.25

g/l

1.84

439

2961

Hernia of abdominal wall

1241

9627

1.30

17.10

2.4

4.26

4.20

g/l

1.45

1154

8812

Spirochaetal infections, other/unspecified

268

1543

1.79

17.09

2.4

4.14

4.22

g/l

0.68

230

1420

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

392

2407

1.61

17.05

1.8

2.3

4.06

4.23

g/l

3.83

365

2224

Neuralgia and neuritis, unspecified

148

698

2.20

17.05

2.4

4.18

4.23

g/l

0.40

133

646

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

364

2193

1.64

17.02

1.8

2.4

4.05

4.23

g/l

4.15

340

2031

Hypothyreosis and Thyroxine purchase for inclusion criteria

2332

12625

1.22

16.98

2.2

2.3

4.25

4.21

g/l

0.95

2129

11526

Ocular pain

220

1193

1.89

16.98

1.6

2.5

4.23

4.25

g/l

0.19

206

1094

Intestinal adhesions without obstruction

253

1435

1.82

16.93

3.8

2.2

4.20

4.19

g/l

0.07

228

1302

Inflammatory diseases of the central nervous system

226

1240

1.88

16.85

2.8

2.5

4.12

4.22

g/l

0.94

202

1142

Other lack of coordination

229

3.25

16.80

2.0

2.7

4.14

4.24

g/l

0.38

208

Other specified/unspecified bacterial intestinal infections

204

1087

1.95

16.79

3.1

2.4

4.12

4.20

g/l

0.76

184

999

Acute posthaemorrhagic anaemia

115

493

2.44

16.78

3.1

2.6

4.09

4.17

g/l

0.38

100

443

Ankylosing spondylitis, ICD10

220

1198

1.89

16.77

1.7

2.4

4.36

4.22

g/l

1.37

211

1119

Other and unspecified visual disturbances

300

1789

1.72

16.76

2.4

2.3

4.23

g/l

0.02

280

1646

Malignant neoplasm of kidney, except renal pelvis

273

1590

1.77

16.71

1.9

1.4

4.21

4.20

g/l

0.05

253

1420

Vitamin deficiency, wide

145

685

2.20

16.69

2.3

2.4

4.41

4.16

g/l

2.42

130

627

Vitamin deficiency

145

685

2.20

16.69

2.3

2.4

4.41

4.16

g/l

2.42

130

627

Biomechanical lesions, not elsewhere classified

168

841

2.09

16.67

2.3

2.5

4.16

4.22

g/l

0.50

159

772

Dermatophytosis, including avohilmo

1648

12981

1.25

16.63

2.3

4.20

4.22

g/l

0.27

1490

11931

Allergic rhinitis

570

3870

1.47

16.60

2.4

2.1

4.27

g/l

0.01

524

3599

Social phobias

137

629

2.21

16.59

1.9

4.29

4.33

g/l

0.22

131

599

Sequelae of injuries, of poisoning and of other consequences of external causes

581

4021

1.47

16.59

2.6

2.3

4.24

4.23

g/l

0.03

529

3727

Poisoning by medicine

434

2827

1.56

16.58

2.0

2.2

4.35

4.25

g/l

1.78

399

2647

Other disorders of the musculoskeletal system and connective tissue

431

2816

1.57

16.53

2.5

2.3

4.17

4.21

g/l

0.61

407

2576

Keratitis

883

6566

1.36

16.43

2.2

2.3

4.21

4.23

g/l

0.23

814

6016

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1121

8551

1.31

16.34

1.6

2.4

4.27

4.19

g/l

2.61

1011

7933

Acute nephritic syndrome

276

2.98

16.31

2.3

2.5

3.98

4.25

g/l

1.46

254

Malignant neoplasm of urinary organs

295

1767

1.72

16.28

1.8

1.4

4.21

4.20

g/l

0.07

274

1572

Other disorders of bladder

359

2259

1.63

16.27

2.2

2.4

4.14

4.18

g/l

0.23

323

2054

Speech disturbances, not elsewhere classified

283

1678

1.74

16.26

1.9

2.4

4.19

g/l

0.03

248

1529

Other/unspecified enthesopathies of lower limb, excluding foot

180

927

1.99

16.24

2.3

2.1

4.14

4.27

g/l

1.53

169

854

Cervicobrachial syndrome

503

3397

1.50

16.24

2.2

4.19

4.24

g/l

1.01

475

3095

Other and unspecified mood [affective] disorders

135

625

2.21

16.11

1.8

2.1

4.27

4.25

g/l

0.06

127

586

Nummular dermatitis

246

1406

1.80

16.09

2.4

2.5

4.16

4.20

g/l

0.28

226

1285

Cystic kidney disease

102

423

2.54

16.07

2.0

2.5

3.79

4.22

g/l

6.48

391

Benign neoplasm: Rectum, anus and anal canal

613

4321

1.45

16.06

2.3

2.4

4.22

4.19

g/l

0.21

558

3930

Olecranon bursitis

184

962

1.98

16.03

2.6

2.3

4.15

4.17

g/l

0.13

168

893

Other and unspecified nerve root and plexus disorders, also in other diseases

517

3525

1.49

15.99

2.5

2.4

4.30

4.22

g/l

1.32

471

3257

Fentanyl

292

1747

1.71

15.95

5.5

1.8

4.23

4.19

g/l

0.22

256

1553

Drug-induced polyneuropathy

123

4.19

15.84

15.1

1.5

3.94

4.35

g/l

1.92

116

Myocarditis

106

447

2.44

15.83

2.6

2.1

4.11

4.23

g/l

0.77

101

404

Benign neoplasm: Caecum

355

2248

1.63

15.82

2.8

2.4

4.18

4.19

g/l

0.08

328

2051

Other diseases of oesophagus

280

1668

1.72

15.75

2.3

2.5

4.25

4.17

g/l

0.77

262

1524

Invasive ventilation

221

1233

1.85

15.74

2.5

2.4

4.03

4.19

g/l

2.44

205

1131

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

733

5256

1.39

15.67

2.1

2.2

4.31

4.25

g/l

1.20

679

4908

Cholecystectomy

1898

13223

1.23

15.62

2.3

4.30

4.20

g/l

3.07

1737

12022

Other specified/unspecified hearing loss

284

1707

1.71

15.53

2.5

2.3

4.16

4.18

g/l

0.16

271

1557

Microscopic polyangiitis

4.73

15.51

1.4

2.0

3.91

4.26

g/l

1.32

Sequelae of injuries of lower limb

238

1361

1.79

15.47

2.3

2.4

4.25

4.23

g/l

0.13

224

1263

Lesion of lateral popliteal nerve

144

701

2.13

15.37

2.5

2.3

4.23

4.20

g/l

0.20

131

651

Crohn disease

291

1759

1.69

15.34

1.7

2.3

4.21

4.23

g/l

0.14

274

1629

Emotionally unstable personality disorder

203

1105

1.87

15.33

1.7

1.9

4.30

4.29

g/l

0.07

189

1046

Impingement syndrome of shoulder

588

4143

1.44

15.30

2.4

2.5

4.23

4.22

g/l

0.10

525

3806

Benign neoplasm: Adrenal gland

245

1423

1.78

15.27

2.2

2.6

4.18

4.22

g/l

0.43

221

1308

Alcohol-induced chronic pancreatitis

182

965

1.95

15.25

1.8

2.4

4.07

4.19

g/l

1.04

161

903

Other bursopathies

350

2221

1.61

15.24

2.2

2.3

4.25

4.21

g/l

0.24

325

2019

Pollen allergy

299

1792

1.66

15.22

2.6

2.1

4.27

4.28

g/l

0.07

270

1697

Aortic aneurysm

705

5033

1.40

15.20

2.3

2.4

4.12

4.15

g/l

0.62

633

4585

Cystic kidney disease, including avohilmo

105

453

2.43

15.15

2.0

2.5

3.79

4.20

g/l

6.18

100

418

Benign thyroid growths and nodules

880

6151

1.35

15.13

2.2

2.4

4.17

4.24

g/l

1.78

799

5539

Drug-induced cataract

334

2.71

15.11

2.4

2.5

4.22

4.24

g/l

0.05

309

Pemphigoid

113

507

2.37

15.11

1.5

2.4

4.22

4.17

g/l

0.27

106

457

Ventral hernia

657

4734

1.41

15.08

2.7

2.3

4.27

4.22

g/l

0.69

609

4300

Macular pucker

513

3547

1.48

15.07

2.0

2.5

4.10

4.19

g/l

2.07

452

3218

Coeliac disease

296

1809

1.67

15.02

2.4

2.2

4.20

4.23

g/l

0.29

275

1658

Viral and other specified intestinal infections, including avohilmo

505

3328

1.47

15.01

2.2

2.1

4.22

4.26

g/l

0.43

483

3071

Other demyelinating diseases of the central nervous system

380

2.54

15.01

1.7

2.0

4.16

4.36

g/l

1.92

360

Open wound of forearm

252

1478

1.75

14.98

2.2

2.3

4.18

4.20

g/l

0.09

228

1362

Squamous cell neoplasms and carcinomas of the skin

324

2033

1.64

14.89

2.5

1.4

4.03

4.18

g/l

2.90

291

1781

Dementia in Alzheimer disease

294

3928

0.61

14.87

1.6

2.3

4.17

4.15

g/l

0.15

224

3505

Cardiac arrest

166

721

2.00

14.85

2.1

2.3

4.17

4.18

g/l

0.04

150

641

Tubulo-interstitial nephritis, not specified as acute or chronic

181

965

1.93

14.82

2.7

2.1

4.16

4.25

g/l

0.65

167

880

Hyperhidrosis

294

2.75

14.80

2.2

2.3

4.25

4.43

g/l

1.16

269

Benign paroxysmal vertigo

822

6156

1.36

14.79

2.1

2.4

4.23

g/l

0.00

741

5579

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

402

2648

1.55

14.79

2.7

2.3

4.11

4.22

g/l

2.76

379

2440

Arthropathic psoriasis

291

1780

1.67

14.78

1.8

2.4

4.37

4.21

g/l

2.34

272

1653

Acute pancreatitis (for exclusion)

553

3883

1.45

14.77

2.0

2.3

4.20

g/l

0.01

511

3553

Glucagon-like peptide-1 (GLP-1) analogues

757

5596

1.37

14.76

1.7

2.6

4.51

4.18

g/l

24.96

709

5187

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

757

5596

1.37

14.76

1.7

2.6

4.51

4.18

g/l

24.96

709

5187

Anosmia

143

3.53

14.73

3.5

1.3

4.05

4.21

g/l

0.82

127

Chronic viral hepatitis

111

495

2.31

14.65

2.0

1.9

4.32

4.34

g/l

0.07

103

475

Striking against or struck by other objects

740

5443

1.37

14.64

1.9

2.3

4.17

4.22

g/l

1.13

664

5062

Ptosis of eyelid

346

2221

1.60

14.51

2.5

2.4

4.14

4.21

g/l

1.16

324

2022

Trigger finger

352

2261

1.59

14.50

1.6

2.4

4.30

4.24

g/l

0.27

327

2080

Cervicocranial syndrome

264

1581

1.71

14.50

1.9

2.2

4.25

g/l

0.01

246

1429

Otitis externa

560

3952

1.44

14.46

2.3

2.2

4.32

4.22

g/l

0.67

494

3655

Anterior Iridocyclitis

508

3525

1.47

14.44

2.5

2.3

4.30

4.23

g/l

1.01

471

3237

Other localized connective tissue disorders

273

2.85

14.34

2.7

2.0

4.10

4.32

g/l

1.14

251

Ulcerative colitis, NAS

319

2008

1.62

14.34

2.0

2.3

4.21

4.22

g/l

0.10

300

1858

Superficial injury of abdomen, lower back and pelvis

376

2459

1.56

14.28

2.1

2.2

4.22

g/l

0.00

340

2259

Acute generalized exanthematous pustulosis

134

654

2.13

14.27

4.4

2.6

4.30

4.21

g/l

0.67

126

601

Temporomandibular joint disorders, including avohilmo

887

6519

1.33

14.25

2.2

4.26

g/l

0.02

819

6018

Postviral fatigue syndrome

5.77

14.24

1.2

2.3

4.74

4.47

g/l

0.19

Speech and linguistic disorders, excluding more controls

128

569

2.14

14.23

2.1

2.3

4.21

4.20

g/l

0.08

119

521

Autoimmune hepatitis

4.36

14.20

1.6

2.6

4.32

4.15

g/l

0.63

Synovial cyst of popliteal space [Baker]

207

1168

1.82

14.19

2.5

2.2

4.39

4.21

g/l

1.03

192

1062

Injuries to the neck

519

3631

1.45

14.03

2.6

2.2

4.24

4.23

g/l

0.08

475

3361

Specific personality disorders

432

2916

1.50

14.00

1.8

2.2

4.23

4.26

g/l

0.40

402

2731

Acute and subacute iridocyclitis

474

3267

1.48

13.97

2.5

2.2

4.31

4.23

g/l

1.05

438

3000

Hallux rigidus

353

2291

1.57

13.97

2.2

2.6

4.22

4.21

g/l

0.05

307

2085

Benign neoplasm: Rectum

544

3861

1.44

13.83

2.3

2.4

4.16

4.20

g/l

0.49

494

3512

Other disorders of adrenal gland

125

601

2.16

13.82

2.6

2.5

4.13

4.25

g/l

0.92

117

564

Alcohol use disorder, ICD-based

1020

7938

1.30

13.80

1.7

2.4

4.28

4.18

g/l

3.20

926

7371

Mouth breathing

961

7413

1.31

13.77

2.4

4.29

4.22

g/l

1.79

904

6877

Cluster headache, strict

365

2.49

13.76

1.7

2.8

4.20

4.18

g/l

0.09

339

Personal history of other diseases and conditions

194

1074

1.83

13.71

4.1

2.0

4.22

4.29

g/l

0.66

172

997

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

366

2.49

13.69

1.6

1.9

3.98

4.35

g/l

4.40

353

Fall on same level involving ice and snow

1479

12021

1.24

13.64

2.1

2.4

4.20

4.23

g/l

0.88

1325

10994

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

125

601

2.12

13.63

1.6

1.9

4.34

4.30

g/l

0.26

111

575

Other and unspecified injuries of head

210

1206

1.79

13.56

1.8

2.3

4.12

4.23

g/l

1.34

183

1097

Other hearing loss

892

6628

1.32

13.55

2.4

2.3

4.13

4.18

g/l

1.25

792

5986

Infections with a predominantly sexual mode of transmission

526

3701

1.43

13.50

2.1

4.20

4.26

g/l

1.08

486

3458

Additional codes for the location of defect, injury or illness

165

883

1.93

13.49

1.4

2.5

4.33

4.23

g/l

1.05

159

816

Acute peritonitis

189

1056

1.85

13.48

2.4

2.5

3.88

4.19

g/l

5.54

183

968

Unspecified urinary incontinence

261

1595

1.68

13.44

1.5

2.4

4.31

4.24

g/l

0.61

206

1433

Left bundle-branch block

212

1226

1.78

13.38

1.7

2.3

4.12

4.24

g/l

1.24

183

1097

Fall involving bed

125

612

2.15

13.38

2.4

2.5

4.18

4.17

g/l

0.05

108

550

Supplementary factors related to causes of morbidity and mortality classified elsewhere

762

5729

1.35

13.31

2.0

2.3

4.32

4.21

g/l

1.34

662

5251

Cluster headache, wide

408

2.38

13.30

1.8

2.7

4.27

4.17

g/l

0.46

377

Erosion of teeth , including avohilmo

549

3917

1.42

13.28

2.3

2.2

4.18

4.24

g/l

0.76

513

3643

Benign neoplasm of mouth and pharynx

299

1896

1.62

13.22

3.3

2.4

4.26

4.22

g/l

0.46

271

1741

Gingival hyperplasia

107

494

2.26

13.19

3.4

2.5

3.93

4.21

g/l

2.94

458

Benign neoplasm: Rectosigmoid junction

142

733

2.03

13.11

2.1

2.6

4.22

4.19

g/l

0.16

127

672

Other spirochaetal diseases, including avohilmo

854

6542

1.32

13.10

2.5

2.4

4.17

4.25

g/l

1.68

769

6012

Eating disorder

119

568

2.12

13.10

1.8

1.7

4.23

4.34

g/l

0.69

113

542

Psoriatic arthropathies, ICD10

267

1651

1.66

13.07

1.9

2.4

4.39

4.23

g/l

1.95

249

1532

Adrenocortical insufficiency

107

497

2.24

13.00

2.7

2.6

4.15

4.25

g/l

0.69

101

463

Hepatic failure, not elsewhere classified

118

571

2.16

12.95

1.8

2.7

4.05

4.17

g/l

0.59

107

523

Unstable angina pectoris

1088

6743

1.28

12.92

2.4

4.18

4.19

g/l

0.30

1006

6023

Polycythaemia vera

111

526

2.21

12.90

2.5

1.4

4.31

4.24

g/l

0.26

103

464

Pneumonia due to Streptococcus pneumoniae

113

537

2.18

12.89

5.2

1.9

4.19

g/l

0.02

100

485

Other spirochaetal diseases

843

6464

1.32

12.86

2.5

2.4

4.17

4.25

g/l

1.56

759

5939

Umbilical hernia

682

5077

1.36

12.81

2.0

2.3

4.23

4.22

g/l

0.20

639

4707

Acute gastritis

210

1228

1.76

12.78

2.0

2.5

4.29

4.20

g/l

0.84

187

1120

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

120

588

2.13

12.76

2.5

2.4

4.20

4.25

g/l

0.27

111

543

Enteropathic arthropathies

237

2.82

12.71

1.4

2.4

4.26

4.24

g/l

0.06

222

Other symptoms and signs involving the digestive system and abdomen

410

2801

1.49

12.68

2.3

2.4

4.32

4.28

g/l

0.44

356

2538

Mental disorders, not otherwise specified

166

905

1.87

12.66

1.8

2.2

4.32

4.26

g/l

0.50

160

847

Spirochaetal infections, other/unspecified, including avohilmo

841

6461

1.32

12.66

2.5

2.4

4.16

4.25

g/l

1.69

757

5935

Background retinopathy and retinal vascular changes

316

2.58

12.58

1.8

2.8

4.20

4.18

g/l

0.10

293

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

443

3078

1.46

12.57

2.8

2.3

4.12

4.22

g/l

2.66

420

2827

Other congenital malformations, including avohilmo

254

1562

1.65

12.56

2.0

2.4

4.12

4.26

g/l

2.15

239

1451

Bacterial, viral and other infectious agents, including avohilmo

200

1157

1.77

12.54

3.3

2.3

4.12

4.23

g/l

1.24

189

1084

Artificial joint re-operation

228

1375

1.72

12.54

2.0

2.5

4.26

4.22

g/l

0.27

210

1242

Diseases of peritoneum

281

1780

1.62

12.51

2.2

2.4

4.02

4.21

g/l

3.50

261

1619

Generalized skin eruption due to drugs and medicaments

116

565

2.14

12.49

4.7

2.6

4.29

4.20

g/l

0.60

108

522

Polycystic ovarian syndrome, consortium definition

1502

7023

1.23

12.48

2.0

2.2

4.33

4.27

g/l

1.64

1327

6410

Other disorders of patella

316

2049

1.56

12.47

2.2

2.5

4.30

4.26

g/l

0.27

291

1916

Malignant melanoma, including Hilmo

462

3243

1.45

12.46

2.6

1.4

4.06

4.22

g/l

5.35

412

2921

Right bundle-branch block

114

552

2.15

12.46

2.7

2.3

4.13

4.19

g/l

0.34

108

495

Malignant melanoma

417

2873

1.48

12.45

2.6

1.4

4.06

4.21

g/l

4.57

372

2591

Follicular lymphoma, hilmo

146

775

1.97

12.45

1.6

2.7

4.05

4.20

g/l

1.38

136

708

Sacroiliitis, not elsewhere classified

413

2.31

12.43

2.1

1.9

4.22

4.31

g/l

0.51

387

Gonarthrosis, primary, with knee surgery

1688

10905

1.22

12.43

2.2

2.5

4.26

4.19

g/l

2.90

1524

9912

Lyme disease, including avohilmo

833

6409

1.32

12.41

2.5

2.4

4.16

4.25

g/l

1.65

749

5892

Lyme disease

833

6409

1.32

12.41

2.5

2.4

4.16

4.25

g/l

1.65

749

5892

Eating disorders

160

865

1.87

12.38

2.3

1.9

4.25

4.29

g/l

0.26

151

811

IBD patients in KELA-register

475

3348

1.44

12.38

2.2

4.25

4.23

g/l

0.20

448

3122

Parkinson's disease, strict definition, excluding more controls

356

2217

1.53

12.31

1.8

2.5

4.09

4.14

g/l

0.64

315

2015

Mental and behavioural disorders due to sedatives or hypnotics

149

793

1.92

12.31

1.4

2.1

4.35

4.25

g/l

0.82

133

742

Ovarian cyst

701

2972

1.36

12.31

2.1

2.2

4.34

4.25

g/l

0.81

645

2702

Total colectomy

113

548

2.14

12.29

2.6

2.5

4.33

4.20

g/l

0.74

107

509

Total colectomy operation

113

548

2.14

12.29

2.6

2.5

4.33

4.20

g/l

0.74

107

509

Retinal vascular occlusion

373

2526

1.51

12.28

2.5

2.4

4.16

4.19

g/l

0.29

340

2268

Disorders of orbit

126

637

2.05

12.25

3.4

2.5

4.28

4.27

g/l

0.07

120

588

Exposure to other and unspecified inanimate mechanical forces

180

1020

1.81

12.17

2.8

2.3

4.16

4.21

g/l

0.38

175

946

Clear cell adenocarcinoma of kidney

143

758

1.96

12.16

1.5

1.4

4.28

4.22

g/l

0.24

132

678

Colonic or urogenital fistula

658

4914

1.36

12.13

2.5

2.4

4.26

4.22

g/l

0.64

595

4513

Type of accident

710

5360

1.34

12.12

2.0

2.3

4.35

4.21

g/l

1.62

612

4924

Excessive, frequent and irregular menstruation

754

3018

1.35

12.11

2.0

2.2

4.31

4.26

g/l

0.88

673

2738

Other abnormal uterine and vaginal bleeding

530

2725

1.42

12.11

2.1

2.2

4.28

4.25

g/l

0.30

440

2455

Superficial injury of thorax

387

2642

1.49

12.09

1.6

2.3

4.22

g/l

0.00

344

2427

Menorrhagia

707

2936

1.36

12.03

2.0

2.2

4.33

4.25

g/l

1.44

608

2658

Carbimazole or st.post thyroidectomy, condition for graves disease

482

3431

1.43

11.97

2.4

2.2

4.19

4.26

g/l

0.97

445

3141

Malignant neoplasm of other connective and soft tissue

354

2.44

11.96

4.0

1.4

4.01

4.25

g/l

1.68

319

Inguinal hernia

1485

8097

1.23

11.95

2.7

2.2

4.11

4.20

g/l

4.30

1378

7414

Parkinson's disease, excluding more controls

375

2347

1.50

11.81

1.8

2.5

4.09

4.14

g/l

0.63

331

2135

Other psoriatic arthropathies

255

1601

1.63

11.78

1.9

2.4

4.40

4.23

g/l

2.06

238

1484

Retinal vascular disorders

375

2564

1.50

11.77

2.5

2.4

4.16

4.19

g/l

0.25

342

2302

Otalgia

205

1217

1.72

11.77

2.0

2.3

4.19

4.24

g/l

0.37

180

1116

Pain and other conditions associated with female genital organs and menstrual cycle

362

2033

1.50

11.76

2.0

2.2

4.28

4.30

g/l

0.18

325

1870

Emphysema

229

1405

1.68

11.72

2.6

2.5

4.18

4.12

g/l

0.45

211

1272

Other and unspecified injuries of lower leg

176

1002

1.79

11.71

2.3

2.4

4.29

4.23

g/l

0.27

165

921

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

304

1985

1.55

11.68

1.9

2.3

4.36

4.26

g/l

1.37

278

1872

Secondary thrombocytopenia

177

3.11

11.64

4.0

1.7

3.78

4.30

g/l

3.80

166

Viral and other specified intestinal infections

351

2303

1.50

11.62

2.2

2.0

4.21

4.23

g/l

0.21

333

2126

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

530

3848

1.39

11.60

1.9

2.2

4.31

4.24

g/l

1.10

483

3599

Infection due to other mycobacteria, including avohilmo

239

2.75

11.55

2.0

2.3

3.94

4.22

g/l

1.73

213

Lung cancer and mesothelioma

505

3087

1.41

11.46

2.1

2.0

4.19

4.20

g/l

0.08

462

2771

Symptoms and signs involving emotional state

322

2.44

11.44

1.7

2.1

4.39

4.24

g/l

0.80

296

Suggestive for eosinophilic asthma

250

1577

1.62

11.38

2.3

4.21

4.17

g/l

0.32

239

1451

Crohn's disease NAS

144

779

1.89

11.36

1.9

2.4

4.22

g/l

0.02

134

723

Other or ill-defined heart diseases

128

666

1.97

11.36

2.2

4.18

4.22

g/l

0.20

113

603

980

6684

1.28

11.33

2.3

4.22

4.17

g/l

1.01

847

5971

Colectomy operation

478

3439

1.42

11.32

2.7

2.4

4.21

4.19

g/l

0.14

441

3106

Carcinoma in situ of other and unspecified digestive organs

145

793

1.90

11.28

1.8

2.6

4.14

4.19

g/l

0.42

138

726

Cardiomyopathy, Hypertrophic obstructive

236

2.73

11.26

1.8

2.7

3.96

4.17

g/l

1.16

214

Mental and behavioural disorders due to opioids

294

2.48

11.17

1.8

4.19

4.25

g/l

0.20

282

Alcohol-induced acute pancreatitis

101

488

2.15

11.16

2.1

2.6

4.12

4.19

g/l

0.35

458

Artificial opening status

164

933

1.82

11.13

3.2

2.2

4.26

4.22

g/l

0.21

154

855

Deviated nasal septum

797

6181

1.30

11.11

2.7

2.4

4.22

4.20

g/l

0.39

738

5733

Other disorders of nervous system

195

1166

1.72

11.06

2.8

2.5

4.16

4.21

g/l

0.43

176

1074

Hypothyroidism, strict autoimmune, 3 medication purchases required

2041

11669

1.18

11.02

2.1

2.3

4.27

4.21

g/l

1.30

1853

10642

Superficial injury of wrist and hand

430

3043

1.43

11.02

1.9

2.2

4.24

g/l

0.03

395

2817

Allergic contact dermatitis

281

1830

1.56

11.01

1.7

2.3

4.33

4.28

g/l

0.44

258

1681

Acute pharyngitis

261

1652

1.58

10.99

2.8

2.0

4.37

4.23

g/l

1.61

248

1551

Speech and linguistic disorders

129

652

1.92

10.82

2.1

2.0

4.21

4.22

g/l

0.05

120

602

Carcinoma in situ of skin of upper limb, including shoulder

107

539

2.11

10.82

2.6

4.05

4.18

g/l

0.76

102

480

Fracture of neck

186

1107

1.73

10.77

3.1

2.3

4.21

4.18

g/l

0.16

170

1014

Inflammatory bowel disease, strict (require KELA)

475

3434

1.40

10.77

2.2

4.25

4.23

g/l

0.20

448

3207

Anti-inflammatory and antirheumatic products, non-steroids

642

2406

1.35

10.71

2.6

2.3

4.16

4.15

g/l

0.08

591

2204

Infections with a predominantly sexual mode of transmission, including avohilmo

640

4420

1.33

10.70

2.1

2.0

4.20

4.26

g/l

1.28

594

4132

Other specified and unspecified personality disorders

173

1006

1.75

10.70

1.9

2.2

4.15

4.24

g/l

0.76

162

942

Impacted cerumen

335

2285

1.50

10.69

2.4

4.13

4.20

g/l

0.84

251

2090

Diseases of tongue

161

920

1.80

10.67

2.6

2.0

4.25

4.24

g/l

0.08

147

827

Alcohol abuse, main dg, excluding more controls

323

2181

1.50

10.67

1.3

2.5

4.30

4.19

g/l

1.42

292

2050

Traumatic subarachnoid haemorrhage

106

530

2.07

10.67

2.4

2.5

4.08

4.13

g/l

0.25

493

Calculus of kidney and ureter

796

6222

1.30

10.64

2.1

2.4

4.22

4.19

g/l

0.47

731

5713

Bacterial, viral and other infectious agents

181

1069

1.73

10.62

3.2

2.3

4.11

4.23

g/l

1.26

170

1003

Disorders of psychological development

160

842

1.78

10.54

1.9

4.23

4.25

g/l

0.11

150

784

Bullous pemphigoid

396

2.28

10.52

1.4

2.6

4.21

4.11

g/l

0.68

357

Follow-up examination after treatment for malignant neoplasms

243

1550

1.60

10.51

2.5

2.2

4.24

4.18

g/l

0.42

222

1403

Blepharochalasis

804

6305

1.29

10.50

2.0

2.4

4.24

4.23

g/l

0.10

728

5706

Other nonthrombocytopenic purpura

139

3.29

10.47

2.2

2.1

4.30

4.27

g/l

0.06

126

Respiratory disorders in diseases classified elsewhere

205

2.82

10.46

1.7

2.1

4.12

4.26

g/l

0.45

191

Diabetic retinopathy, strict definition

466

2999

1.41

10.45

1.7

2.1

4.11

4.34

g/l

6.91

426

2757

Paraplegia, diplegia of upper limbs

300

2.45

10.44

2.1

2.4

4.27

4.16

g/l

0.54

277

Cryoglobulinemia

13.74

10.43

4.2

1.3

4.31

4.35

g/l

0.07

Malignant neoplasm of digestive organs, including Hilmo

1092

6492

1.25

10.39

2.1

1.4

4.20

4.23

g/l

0.65

987

5837

Propionic acid derivatives

639

2406

1.35

10.36

2.4

2.3

4.18

4.15

g/l

0.27

585

2204

D07AA Corticosteroids, weak (group I)

295

1964

1.52

10.34

1.8

2.3

4.35

4.23

g/l

1.58

266

1820

MS-disease / Multiple Sclerosis

143

796

1.83

10.31

1.7

2.1

4.18

4.31

g/l

1.37

138

742

Suicide or other Intentional self-harm

475

3461

1.39

10.28

1.9

2.3

4.32

4.24

g/l

1.41

435

3230

Other infective otitis externa

159

917

1.78

10.27

2.6

2.3

4.28

4.22

g/l

0.47

144

850

Disorders of myoneural junction and muscle in diseases classified elsewhere

115

3.53

10.25

1.6

2.3

4.04

4.29

g/l

1.00

107

Hyperkinetic disorders, excluding more controls

117

566

1.94

10.23

1.4

1.8

4.19

4.32

g/l

1.01

110

546

Other congenital malformations

158

907

1.77

10.21

2.2

2.3

4.12

4.27

g/l

1.76

153

844

Carcinoma in situ of skin

272

1799

1.55

10.20

2.1

2.5

4.07

4.20

g/l

1.98

250

1627

Xerosis cutis

280

2.50

10.15

1.7

2.6

4.08

4.18

g/l

0.41

256

Ganglion

420

3006

1.41

10.13

2.1

2.3

4.25

g/l

0.06

380

2758

Type 1 diabetes, definitions combined

140

776

1.82

10.05

1.9

2.1

3.89

4.20

g/l

5.01

130

736

Behavioural syndromes associated with physiological disturbances and physical factors

2239

13090

1.16

9.97

2.1

2.3

4.23

4.22

g/l

0.15

2036

12009

Melanocytic naevi of trunk

286

1914

1.52

9.97

2.4

4.10

4.21

g/l

1.84

271

1776

Type 1 diabetes, strict (exclude DM2)

139

771

1.82

9.97

2.0

3.89

4.20

g/l

4.99

129

731

Other orthopaedic follow-up care

148

844

1.80

9.94

1.7

2.0

4.27

4.26

g/l

0.05

137

767

Other/unspecified synovitis and tenosynovitis

255

1666

1.56

9.92

1.9

2.3

4.16

4.23

g/l

0.73

235

1526

Abscess of anal and rectal regions

181

1090

1.69

9.90

1.4

2.2

4.23

4.21

g/l

0.15

168

1015

Disorders of oesophagus in diseases classified elsewhere

328

2.34

9.82

4.1

2.9

4.09

4.21

g/l

0.44

296

malignant neoplasm of male genital organs, including Hilmo

736

3424

1.31

9.81

2.2

1.4

4.13

4.19

g/l

1.36

678

3135

Dermatographic urticaria

145

824

1.80

9.80

2.0

2.5

4.46

4.26

g/l

1.76

138

770

Superficial injury of shoulder and upper arm

286

1921

1.51

9.79

2.3

2.2

4.31

4.21

g/l

0.91

259

1778

Superficial injury of ankle and foot

236

1519

1.58

9.78

1.8

2.3

4.21

4.24

g/l

0.31

218

1424

Exfoliative dermatitis

139

3.16

9.76

1.6

2.4

4.23

4.17

g/l

0.17

124

Crohn's disease of small intestine

145

827

1.79

9.68

1.8

2.4

4.15

4.23

g/l

0.51

135

767

Cholecystitis

390

2786

1.42

9.67

2.2

2.3

4.27

4.16

g/l

1.27

352

2514

Vascular diseases of the intestine

127

700

1.88

9.67

2.9

2.3

4.08

4.17

g/l

0.65

119

631

Other and unspecified disorders of vitreous body

1149

9250

1.23

9.65

2.4

4.21

4.23

g/l

0.31

1043

8449

Pediculosis, acariasis and other infestations, including avohilmo

325

2242

1.47

9.63

1.7

2.2

4.29

4.24

g/l

0.64

309

2091

Unspecified misadventure during surgical and medical care

163

966

1.74

9.63

2.1

2.5

4.31

4.19

g/l

1.02

148

893

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

190

1158

1.65

9.63

1.7

2.2

4.26

4.27

g/l

0.07

180

1080

Other/unspecified enthesopathies, not elsewhere classified

206

1293

1.63

9.61

1.8

2.2

4.29

4.21

g/l

0.34

190

1183

Sulfonylureas

1014

6536

1.25

9.61

1.8

2.5

4.23

4.11

g/l

5.08

914

5839

Other/unspecified disorders of vestibular function

129

716

1.87

9.61

1.8

2.6

4.07

4.21

g/l

1.60

116

660

Allergic bronchopulmonary aspergillosis (ABPA)

8.19

9.60

2.3

2.4

3.98

4.33

g/l

0.35

Monoplegia

208

2.70

9.59

2.2

2.5

4.21

4.27

g/l

0.20

192

Malignant neoplasm of bladder, including Hilmo

324

2213

1.47

9.58

2.3

1.4

4.15

4.16

g/l

0.08

289

1983

Other and unspecified glaucoma

224

1440

1.60

9.58

2.1

2.4

4.13

4.20

g/l

0.68

198

1288

Duodenal ulcer

304

2080

1.49

9.57

1.9

2.4

4.23

4.15

g/l

0.85

283

1892

Arterial embolism and thrombosis

169

1012

1.72

9.56

1.4

2.4

4.14

4.17

g/l

0.16

152

919

Cerebral cysts

130

722

1.84

9.52

1.6

2.4

4.23

4.24

g/l

0.04

118

669

Event of undetermined intent

138

780

1.81

9.52

2.3

4.25

4.21

g/l

0.19

129

727

Visual impairment including blindness (binocular or monocular)

197

1230

1.64

9.47

2.1

2.2

4.19

4.20

g/l

0.07

160

1108

Psychotic depression

134

753

1.82

9.42

2.3

2.7

4.37

4.21

g/l

1.32

119

694

Melanocytic naevi of lower limb, including hip

113

604

1.93

9.41

2.9

2.3

4.04

4.26

g/l

2.48

108

562

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

243

1595

1.56

9.41

2.3

2.4

4.26

4.22

g/l

0.34

215

1456

Attention to artificial openings

122

670

1.88

9.39

2.6

2.0

4.16

4.19

g/l

0.14

106

612

Benign neoplasm: Small intestine

132

745

1.85

9.38

2.3

2.5

4.30

4.23

g/l

0.44

121

682

Other Crohn's disease

137

777

1.80

9.33

1.5

2.2

4.17

4.26

g/l

0.69

128

723

Other follicular disorders

157

926

1.73

9.32

2.5

2.3

4.34

4.22

g/l

1.26

147

865

Inflammatory diseases of female pelvic organs

1285

7301

1.21

9.30

1.8

2.3

4.30

4.28

g/l

0.46

1146

6646

Plantar fascial fibromatosis

219

1406

1.59

9.26

2.5

2.2

4.28

4.25

g/l

0.23

202

1299

Disorders of optic nerve and visual pathways

210

1336

1.60

9.26

2.2

2.5

4.20

4.23

g/l

0.25

194

1236

Urolithiasis

852

6832

1.26

9.26

2.1

2.4

4.21

4.18

g/l

0.34

779

6262

Other superficial mycoses, including avohilmo

208

1320

1.60

9.21

1.9

2.3

4.23

4.24

g/l

0.12

191

1222

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

323

2250

1.45

9.16

2.3

4.31

4.23

g/l

0.92

305

2097

Malignant neoplasm of other connective and soft tissue, including Hilmo

116

633

1.89

9.11

4.4

1.4

4.07

4.22

g/l

1.20

107

568

Bronchitis, not specified as acute or chronic

208

1327

1.60

9.08

2.1

2.4

4.21

4.20

g/l

0.08

189

1198

Scabies, including avohilmo

258

1721

1.52

9.08

1.7

2.3

4.30

4.24

g/l

0.57

247

1618

Asthma and opportunity respiratory infection

149

879

1.76

9.06

2.6

2.7

4.26

4.18

g/l

0.55

141

788

Ulcerative colitis (strict definition, require KELA)

333

2338

1.44

9.05

2.4

2.3

4.32

4.22

g/l

1.04

314

2182

Dissociative [conversion] disorders

350

2.19

9.03

1.3

2.0

4.60

4.28

g/l

2.13

327

Entropion and trichiasis of eyelid

269

1822

1.51

9.03

2.3

2.5

4.12

4.18

g/l

0.70

240

1645

Childhood asthma (age<16), excluding more controls

117

490

1.88

9.02

1.4

4.32

g/l

0.02

110

471

Wet age-related macular degeneration

561

4135

1.33

9.01

2.4

2.2

4.22

4.17

g/l

0.46

485

3642

Conductive and sensorineural hearing loss

2112

12166

1.16

9.00

2.4

4.21

4.22

g/l

0.15

1887

11151

Disorders of breast

1033

7444

1.23

8.96

2.1

2.3

4.27

4.28

g/l

0.11

930

6748

Psoriasis (vulgaris), strict definition

440

2.07

8.93

1.4

2.6

4.62

4.26

g/l

2.54

413

Other renal tubulo-interstitial diseases

264

2.40

8.88

1.8

2.0

4.14

4.29

g/l

0.52

248

Idiopathic pulmonary fibrosis

239

1587

1.55

8.86

2.0

2.4

4.18

4.15

g/l

0.22

223

1430

Other sleep disorders

261

1760

1.51

8.82

1.8

2.4

4.37

4.15

g/l

2.83

228

1629

Cluster headache, strict, including avohilmo

104

552

1.93

8.82

1.6

2.3

4.19

4.28

g/l

0.54

517

Fibrosis of liver

3.55

8.78

1.5

1.8

4.58

4.27

g/l

0.82

Palmar fascial fibromatosis [Dupuytren]

405

2963

1.39

8.76

2.2

2.4

4.16

g/l

0.01

366

2688

Cluster headache, wide,, including avohilmo

110

596

1.89

8.75

1.7

2.3

4.25

4.27

g/l

0.06

102

555

Primary coxarthrosis, bilateral

835

6731

1.26

8.75

2.2

2.4

4.25

4.20

g/l

0.76

755

6048

Acute bronchiolitis

305

2.19

8.73

5.3

1.8

4.04

4.18

g/l

0.60

280

Unspecified/other endometriosis

151

877

1.71

8.72

1.9

2.0

4.28

4.31

g/l

0.21

136

804

Redundant prepuce, phimosis and paraphimosis

443

3230

1.36

8.71

1.9

2.4

4.16

4.19

g/l

0.39

417

3016

Coxarthrosis, primary, with hip surgery

1354

10597

1.20

8.71

2.2

2.4

4.23

4.20

g/l

0.59

1219

9567

Other specified/unspecified spondylopathies

385

2.14

8.68

2.9

2.0

4.17

4.26

g/l

0.42

344

Other specified and unspecified retinal disorders

106

572

1.92

8.68

2.6

4.09

4.22

g/l

1.00

524

Other keratitis

247

1653

1.52

8.66

2.2

4.27

4.22

g/l

0.62

229

1526

COPD, hospital admissions 1, only main diagnosis

993

6996

1.23

8.66

1.9

2.4

4.22

4.16

g/l

1.44

896

6344

Hypopituitarism

144

848

1.73

8.62

2.6

2.4

4.15

4.21

g/l

0.29

135

802

Childhood asthma (age<16)

117

498

1.85

8.60

1.4

4.32

g/l

0.03

110

478

Thiazolidinediones

320

2261

1.44

8.59

1.7

2.5

4.27

4.12

g/l

2.57

294

2053

Chondropathies

320

2255

1.44

8.58

2.1

2.2

4.29

4.24

g/l

0.47

287

2091

Monoamine oxidase A inhibitors

273

1870

1.48

8.56

2.1

2.5

4.25

4.21

g/l

0.38

251

1719

Coronary artery bypass grafting

747

4399

1.27

8.56

1.7

2.5

4.14

4.16

g/l

0.25

683

3923

Carcinoma in situ of skin of trunk

119

672

1.85

8.52

3.1

2.4

4.09

4.17

g/l

0.50

112

603

Benign neoplasm: Parathyroid gland

174

2.78

8.51

2.8

2.0

4.45

4.22

g/l

1.05

164

Scleritis and episcleritis

141

831

1.74

8.48

2.1

2.2

4.29

4.27

g/l

0.13

132

776

Exposure to other and unspecified animate mechanical forces

314

2.23

8.46

2.8

2.1

4.03

4.30

g/l

1.86

302

Acidosis

310

2.26

8.43

1.7

2.4

3.95

4.20

g/l

1.07

285

Carrier of infectious disease

303

2.26

8.40

1.3

2.4

4.10

4.24

g/l

0.61

281

Malignant neoplasm of prostate, including Hilmo

721

3356

1.28

8.40

2.2

1.4

4.13

4.19

g/l

1.16

663

3069

Anogenital herpesviral [herpes simplex] infection, including avohilmo

170

1051

1.64

8.39

2.3

2.1

4.24

4.31

g/l

0.42

158

993

Other and unspecified tonsillitis

521

3288

1.32

8.39

1.8

2.0

4.32

4.24

g/l

1.67

500

3102

Endometriosis

654

2960

1.29

8.34

1.8

2.2

4.26

4.25

g/l

0.10

599

2686

Iridocyclitis in diseases classified elsewhere

254

2.39

8.31

2.0

2.3

4.32

4.24

g/l

0.17

237

Crushed, pushed or stepped on by crowd or human stampede

130

753

1.75

8.25

2.6

2.1

4.21

4.23

g/l

0.10

122

705

Complications of cardiac and vascular prosthetic devices, implants and grafts

347

2.18

8.22

2.3

2.8

4.32

4.14

g/l

0.49

315

Cachexia

4.17

8.21

2.4

1.7

4.08

4.30

g/l

0.41

Deficiency of other B group vitamins

307

2.24

8.19

3.3

2.0

4.21

4.16

g/l

0.19

279

Disorders of magnesium metabolism

110

3.25

8.18

1.3

2.5

4.37

4.23

g/l

0.24

104

Spontaneous rupture of synovium and tendon

204

1330

1.56

8.17

1.9

2.2

4.22

g/l

0.00

183

1216

Bursitis of shoulder

320

2.20

8.15

3.1

2.3

4.17

4.26

g/l

0.41

297

Other and unspecified psoriasis

176

1112

1.62

8.13

2.0

2.5

4.30

4.20

g/l

1.04

166

1027

Lactose intolerance

353

2.13

8.12

1.6

1.7

3.97

4.25

g/l

2.07

324

Congenital malformations and deformations of the musculoskeletal system

139

819

1.71

8.11

1.6

2.0

4.31

4.27

g/l

0.19

133

767

Superficial injury of forearm

208

1366

1.55

8.00

2.2

2.3

4.24

4.22

g/l

0.11

186

1272

Golimumab

375

2.08

8.00

1.3

1.9

4.43

4.36

g/l

0.21

359

Adenomyosis (Endometriosis of uterus)

303

2141

1.43

7.98

2.2

2.3

4.23

4.27

g/l

0.36

281

1934

Autoimmune hyperthyroidism

128

748

1.75

7.94

2.2

2.5

4.15

4.28

g/l

1.20

123

687

Postzoster neuralgia

248

2.38

7.88

3.8

2.0

4.16

4.13

g/l

0.08

222

Chronic hepatitis, not elsewhere classified

483

1.95

7.85

1.9

2.6

4.30

4.24

g/l

0.28

453

Anogenital herpesviral [herpes simplex] infection

104

573

1.84

7.84

2.3

2.0

4.30

g/l

0.01

538

Oesophagitis

142

859

1.70

7.83

2.3

2.6

4.04

4.18

g/l

1.44

135

796

Dermatophytosis

347

2526

1.40

7.81

2.7

2.3

4.19

4.21

g/l

0.23

322

2314

Tobacco use

124

723

1.76

7.80

1.5

2.4

4.44

4.21

g/l

1.19

119

678

Mental and behavioural disorders due to tobacco

203

1337

1.55

7.78

1.8

2.5

4.29

4.21

g/l

0.69

172

1248

Obsessive-compulsive disorder

488

1.91

7.77

1.9

2.1

4.22

4.29

g/l

0.41

466

Hemiplegia

126

740

1.75

7.74

2.0

2.3

4.16

4.23

g/l

0.48

112

678

Benign neoplasm: Descending colon

204

1351

1.55

7.72

2.0

2.5

4.27

4.18

g/l

0.75

177

1246

Other condition

316

2267

1.41

7.72

2.3

2.2

4.39

4.22

g/l

1.70

295

2093

Viral warts

203

1338

1.54

7.71

1.9

2.4

4.17

4.23

g/l

0.28

193

1233

Dislocation, sprain and strain of joint and ligaments of hip

110

624

1.82

7.70

1.9

2.5

4.04

4.17

g/l

0.87

575

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

354

2588

1.38

7.68

2.3

4.31

4.23

g/l

0.88

335

2411

Sleep disorders

2115

12788

1.14

7.66

2.0

2.3

4.24

4.23

g/l

0.29

1923

11733

Melanocytic naevi

667

5320

1.26

7.64

2.6

2.3

4.11

4.23

g/l

3.89

635

4887

Astigmatism

129

763

1.72

7.63

2.3

2.4

4.21

4.24

g/l

0.19

121

700

Other and unspecified rosacea

215

1441

1.52

7.60

2.2

2.4

4.27

4.24

g/l

0.19

202

1330

N06DA Anticholinesterases

784

7406

0.81

7.54

2.0

2.3

4.15

4.17

g/l

0.33

650

6623

Use of anticholinesterases

784

7406

0.81

7.54

2.0

2.3

4.15

4.17

g/l

0.33

650

6623

Panniculitis affecting regions of neck and back

461

1.94

7.52

2.0

2.2

4.30

4.27

g/l

0.14

427

Specific development disorders of speech and language

483

1.89

7.49

1.8

2.1

4.15

4.19

g/l

0.20

441

Nasal polyp

467

3576

1.32

7.48

2.9

2.4

4.23

4.20

g/l

0.34

437

3287

Cardiac murmurs and other cardiac sounds

178

1133

1.57

7.48

2.7

2.1

4.40

4.27

g/l

1.16

166

1025

Other benign neoplasms of skin

941

7805

1.22

7.48

3.0

2.4

4.19

4.22

g/l

0.54

840

7096

Presence of other devices

676

5333

1.26

7.46

2.8

2.3

4.26

4.18

g/l

1.82

604

4803

Viral warts, including avohilmo

425

3210

1.34

7.44

2.1

2.2

4.18

4.24

g/l

0.60

395

2969

Benign neoplasm: Duodenum

452

1.97

7.42

2.7

2.6

4.28

4.20

g/l

0.36

414

Somnolence, stupor and coma

107

608

1.81

7.41

1.6

2.7

4.12

4.21

g/l

0.58

553

Testicular dysfunction

456

1.93

7.40

1.6

2.5

4.16

4.21

g/l

0.31

429

Periapical abscess

1058

8876

1.20

7.39

2.2

2.4

4.26

4.23

g/l

0.84

975

8213

Other ulcerative colitis

120

704

1.74

7.39

1.4

2.4

4.45

4.23

g/l

2.45

113

653

Smoking dependency

203

1353

1.53

7.39

1.8

2.5

4.29

4.21

g/l

0.63

172

1263

Atypical facial pain

127

759

1.71

7.35

2.0

2.4

4.29

4.26

g/l

0.17

116

693

malignant neoplasm of male genital organs

703

3388

1.26

7.33

2.2

1.4

4.10

4.19

g/l

2.24

647

3101

Rosacea

288

2054

1.42

7.32

2.1

2.3

4.44

4.25

g/l

0.77

271

1894

Tinnitus

573

4518

1.28

7.32

2.3

2.4

4.16

4.24

g/l

1.63

532

4160

Complications of genitourinary prosthetic devices, implants and grafts

370

2.05

7.25

1.8

2.1

4.24

4.22

g/l

0.07

335

Other obstructive and reflux uropathy

466

1.91

7.25

1.9

2.1

4.12

4.22

g/l

0.47

432

Necrosis of pulp, including avohilmo

1238

10410

1.18

7.25

2.3

4.26

4.23

g/l

0.45

1159

9640

Bell's palsy

271

1917

1.44

7.23

2.3

4.24

4.22

g/l

0.19

244

1751

Thrombotic microangiopathy

3.57

7.20

3.8

1.5

3.95

4.43

g/l

1.32

Nontoxic goitre/thyroid nodule

724

5876

1.24

7.19

2.2

2.3

4.19

4.25

g/l

1.31

660

5300

Other disorders of iris and ciliary body

421

1.97

7.14

2.1

2.6

4.18

4.23

g/l

0.20

385

Organic, including symptomatic, mental disorders

1544

9397

1.16

7.12

2.2

2.4

4.18

g/l

0.02

1332

8523

Visual field defects

219

1496

1.49

7.11

2.2

4.14

4.19

g/l

0.51

198

1369

Congenital malformations of the circulatory system

275

1900

1.42

7.04

1.8

2.3

4.17

4.22

g/l

0.53

254

1762

Paget disease

3.49

7.03

2.5

1.3

4.20

4.46

g/l

0.50

Other secondary coxarthrosis

524

1.85

7.01

1.6

2.4

4.28

4.23

g/l

0.23

484

Open wound of abdomen, lower back and pelvis

346

2.05

7.01

1.9

2.5

4.38

4.24

g/l

0.64

327

Follicular cysts of skin and subcutaneous tissue

426

3252

1.33

7.00

2.5

2.3

4.21

4.22

g/l

0.10

399

2999

Arthropathy in hypersensitivity reactions classified elsewhere

15.21

6.97

1.6

1.2

4.95

4.69

g/l

—

Malignant melanoma of skin

296

2142

1.40

6.97

2.6

1.4

4.06

4.22

g/l

3.93

265

1938

Malignant melanoma of skin, including Hilmo

353

2627

1.36

6.95

2.5

1.4

4.07

4.21

g/l

3.67

318

2374

Thyrotoxicosis with diffuse goitre

285

2047

1.41

6.95

2.2

2.3

4.26

g/l

0.00

266

1883

Malignant neoplasm of mesothelium and soft tissue

107

622

1.77

6.91

3.5

1.4

4.09

4.18

g/l

0.54

555

Other and unspecified vascular occlusions

268

1913

1.43

6.90

2.4

4.12

4.18

g/l

0.62

244

1723

Melanoma in situ

138

861

1.65

6.88

2.3

2.6

4.05

4.20

g/l

1.46

117

782

Extreme obesity with alveolar hypoventilation

107

623

1.77

6.88

2.1

2.7

4.47

4.18

g/l

2.81

571

Alzheimer’s disease (Late onset), excluding more controls

425

2097

1.33

6.85

2.0

2.5

4.09

4.13

g/l

0.53

364

1889

Thyrotoxicosis with toxic multinodular goitre

170

1113

1.57

6.84

1.8

2.3

4.07

4.24

g/l

2.39

152

998

Abnormal blood-pressure reading, without diagnosis

108

630

1.75

6.84

2.2

2.3

4.18

4.30

g/l

0.76

101

570

Unspecified lump in breast

349

2599

1.36

6.83

1.9

2.3

4.32

4.30

g/l

0.08

318

2348

Degenerative macular diseases

336

2494

1.37

6.80

2.1

2.4

4.20

4.19

g/l

0.09

304

2238

Ulcerative colitis (strict definition, all Crohn cases excluded)

277

1988

1.41

6.79

2.6

2.3

4.29

4.22

g/l

0.65

260

1856

Procreative management

577

3768

1.27

6.78

1.9

2.2

4.24

4.26

g/l

0.16

550

3515

Arthropathy in ulcerative colitis

157

2.61

6.78

1.5

1.9

4.27

4.31

g/l

0.09

150

Malignant neoplasm of prostate

695

3320

1.25

6.75

2.2

1.4

4.10

4.18

g/l

2.00

639

3035

Varicose veins

1553

10197

1.16

6.73

2.4

2.3

4.29

4.21

g/l

3.06

1404

9256

Hepatocellular carcinoma, including Hilmo

452

1.90

6.70

2.5

1.4

4.33

4.10

g/l

2.09

400

Lactose intolerance, other/unspecified

318

2.07

6.70

1.6

1.7

3.97

4.24

g/l

1.80

293

Hyperaldosteronism

431

1.92

6.69

3.3

2.6

4.18

4.23

g/l

0.23

398

Achilles tendinitis

223

1545

1.46

6.69

2.6

2.2

4.16

4.23

g/l

0.70

204

1437

Fracture at wrist and hand level

732

5969

1.23

6.69

2.4

2.3

4.19

4.23

g/l

0.61

662

5505

Other symptoms and signs involving general sensations and perceptions

107

628

1.75

6.67

2.2

2.6

4.27

4.23

g/l

0.18

573

Drug-induced hypoglycaemia without coma

214

2.34

6.67

2.2

2.4

4.03

4.19

g/l

0.56

196

severe traumatic brain injury, does not include concussion

598

4797

1.26

6.66

2.3

4.16

4.17

g/l

0.09

524

4337

Sensorineural hearing loss

2010

11850

1.14

6.61

2.4

4.20

4.21

g/l

0.35

1793

10845

Disorders of speech understanding and production

394

1.93

6.59

1.9

2.3

4.16

4.15

g/l

0.01

355

Postmenopausal bleeding

640

2682

1.26

6.56

2.2

2.3

4.31

4.25

g/l

0.86

570

2417

Orchitis and epididymitis

221

1536

1.46

6.55

2.0

2.4

4.19

4.17

g/l

0.16

205

1412

Postprocedural disorders of digestive system, not elsewhere classified

506

1.83

6.55

1.8

2.6

4.27

4.19

g/l

0.33

466

Combinations of oral blood glucose lowering drugs

728

5976

1.23

6.54

1.8

2.6

4.37

4.14

g/l

12.16

680

5474

Autonomic disorders

329

2.04

6.51

1.9

2.4

4.01

4.24

g/l

1.61

302

Other aneurysm

150

967

1.59

6.48

2.2

2.5

4.18

4.15

g/l

0.10

143

888

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

130

810

1.64

6.47

2.0

1.4

4.36

4.16

g/l

1.77

115

715

Portal vein thrombosis

217

2.31

6.47

2.1

2.5

4.23

4.19

g/l

0.09

204

Crohn's disease of large intestine

104

610

1.74

6.47

1.6

2.3

4.24

4.25

g/l

0.04

566

Hydrocele

291

2128

1.39

6.45

2.4

2.5

4.00

4.16

g/l

3.33

269

1960

Other and specified injuries of hip and thigh

345

2.01

6.42

1.6

2.3

4.18

g/l

0.02

316

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

163

1072

1.55

6.41

3.6

1.4

4.15

4.21

g/l

0.47

150

952

Chondrocostal junction syndrome [Tietze]

547

1.78

6.37

2.3

2.2

4.21

4.27

g/l

0.35

499

Orthopaedic devices associated with adverse incidents

341

2.04

6.37

1.4

2.2

4.54

4.19

g/l

1.04

310

Open wound of hip and thigh

394

1.93

6.36

1.3

2.4

4.18

4.23

g/l

0.21

375

Alcohol abuse, main dg

323

2405

1.36

6.35

1.3

2.3

4.30

4.19

g/l

1.42

292

2252

Other and/or unspecified nontoxic goitre

205

1416

1.48

6.34

2.3

4.21

4.23

g/l

0.10

191

1287

Sudden idiopathic hearing loss

258

1858

1.41

6.32

2.1

2.3

4.17

4.19

g/l

0.21

226

1709

Alzheimer disease, excluding more controls

477

2408

1.30

6.31

2.0

2.5

4.11

4.14

g/l

0.39

407

2181

Thyroiditis

156

1019

1.56

6.31

2.2

2.4

4.20

4.25

g/l

0.34

140

938

Later onset COPD

869

5836

1.21

6.31

1.7

2.4

4.19

4.14

g/l

1.04

779

5236

Other noninflammatory disorders of vulva and perineum

193

1317

1.49

6.28

2.0

2.3

4.14

4.29

g/l

1.57

174

1200

Urethral stricture

155

1014

1.56

6.27

2.1

2.5

4.18

4.15

g/l

0.16

140

929

Benign neoplasm: Other and unspecified parts of mouth

536

1.79

6.27

3.1

2.6

4.28

4.22

g/l

0.28

493

Ulcerative enterocolitis

354

1.97

6.26

1.9

2.3

4.16

4.23

g/l

0.27

328

Other and unspecified bullous disorders

164

2.52

6.26

3.1

2.2

4.22

4.30

g/l

0.22

150

Insomnia

2035

12575

1.13

6.25

2.0

2.3

4.23

g/l

0.01

1851

11542

Use of donepezil

416

5084

0.77

6.21

1.7

2.2

4.23

4.16

g/l

1.08

340

4492

Injury of eye and orbit

283

2072

1.38

6.19

1.9

2.2

4.11

4.21

g/l

1.35

256

1940

Lichen simplex chronicus

478

1.83

6.19

2.5

2.8

4.37

4.24

g/l

0.48

441

Other epidermal thickening

115

704

1.67

6.16

1.9

2.5

4.14

4.21

g/l

0.39

105

647

Assault

208

1444

1.45

6.16

1.9

2.1

4.20

4.25

g/l

0.39

191

1375

Malignant neoplasm of breast, ER-positive, including Hilmo

683

4150

1.23

6.15

2.1

1.4

4.31

4.30

g/l

0.16

599

3716

Other otitis externa (chronic)

157

1034

1.55

6.14

2.5

4.17

4.22

g/l

0.39

131

954

Disorders of ocular muscles, binocular movement, accommodation and refraction

981

8241

1.19

6.14

2.1

2.3

4.20

4.24

g/l

0.91

908

7579

Use of antiglaucoma preparations and miotics

227

1610

1.44

6.13

2.2

2.4

4.16

4.22

g/l

0.52

198

1432

Malignant neoplasm of breast, HER-positive

681

4144

1.23

6.12

2.1

1.4

4.31

4.30

g/l

0.13

597

3711

Left ventricular outflow tract obstruction (LVOTO), broad definition

202

1400

1.46

6.10

1.8

2.4

4.33

4.22

g/l

0.96

189

1313

Amenorrhoea

567

1.73

6.07

1.9

2.1

4.23

4.35

g/l

0.84

531

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

188

1289

1.49

6.06

2.1

2.4

4.17

4.22

g/l

0.25

171

1180

Alzheimer’s disease (Early onset)

850

0.45

6.05

1.2

2.1

4.21

4.17

g/l

0.10

756

Other disorders of optic [2nd] nerve and visual pathways

146

950

1.57

6.04

2.3

2.5

4.14

4.20

g/l

0.51

133

875

Injury of muscle and tendon at hip and thigh level

222

1569

1.44

6.04

2.0

2.4

4.22

g/l

0.00

206

1471

Retinal detachment with retinal break

337

2550

1.34

6.03

2.9

2.4

4.15

4.18

g/l

0.22

304

2330

Leisure time condition

413

3210

1.30

6.01

1.7

2.2

4.36

4.23

g/l

0.84

337

2940

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

127

800

1.61

6.00

1.7

2.2

4.52

4.26

g/l

0.46

121

741

Aortic valve malfunction, age under 60 years

193

1332

1.47

5.98

1.9

2.3

4.33

4.22

g/l

0.99

180

1251

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

229

2.18

5.96

1.6

1.8

3.97

4.29

g/l

2.04

218

Nonsuppurative otitis media, including avohilmo

538

3722

1.26

5.95

2.2

2.1

4.20

4.24

g/l

0.66

508

3451

Complications of other internal prosthetic devices, implants and grafts

114

704

1.66

5.94

2.7

2.3

4.21

g/l

0.00

108

638

Bicipital tendinitis

114

703

1.66

5.94

2.0

2.4

4.16

4.21

g/l

0.39

107

660

Diabetic maculopathy

318

2259

1.35

5.90

1.5

2.1

4.13

4.32

g/l

4.03

295

2070

Other misadventures during surgical and medical care

363

1.94

5.90

1.8

2.8

4.27

4.15

g/l

0.55

335

Other salmonella infections

515

1.77

5.89

2.8

2.2

4.10

4.24

g/l

1.01

473

Type 1 diabetes, strict definition

489

1.77

5.86

1.5

1.7

3.76

4.26

g/l

7.91

472

Irregular menses

811

5082

1.20

5.85

2.1

2.2

4.31

4.29

g/l

0.20

748

4708

UC patients in KELA-register (code 208), prior to 1994

106

648

1.68

5.76

2.4

2.6

4.31

4.21

g/l

0.61

100

602

Episcleritis

111

685

1.65

5.75

2.1

2.2

4.33

4.28

g/l

0.27

105

643

Seborrhoeic dermatitis

231

1660

1.41

5.75

2.4

4.26

4.21

g/l

0.49

210

1521

Injuries to the wrist and hand

2399

14326

1.11

5.75

2.2

2.3

4.20

4.22

g/l

0.64

2206

13133

Otitis externa, unspecified

232

1668

1.41

5.73

2.1

2.3

4.45

4.23

g/l

0.74

213

1541

Pulmonary oedema

297

2.03

5.71

2.8

2.5

4.28

4.12

g/l

0.68

265

Gluteal tendinitis

102

618

1.69

5.70

2.0

2.3

4.29

4.25

g/l

0.20

571

Disorders of parathyroid gland, other and/or unspecified

117

2.77

5.70

1.5

1.8

4.23

4.36

g/l

0.31

109

Alcohol dependence

614

5030

1.23

5.67

1.6

2.5

4.26

4.18

g/l

1.77

553

4692

Paralytic ileus

597

1.70

5.67

3.8

2.3

4.11

4.19

g/l

0.35

542

Other disorders of penis

220

1571

1.42

5.65

1.7

2.5

4.08

4.17

g/l

0.95

199

1450

Excessive earwax

1636

13120

1.14

5.63

2.5

2.4

4.22

4.21

g/l

0.14

1449

11988

Benign neoplasm of urinary organs

128

824

1.59

5.63

1.9

2.6

4.20

4.19

g/l

0.09

119

755

Infective dermatitis

254

1861

1.38

5.62

1.7

2.4

4.34

4.21

g/l

1.28

230

1713

Other disorders of pigmentation

114

715

1.63

5.59

3.0

2.2

4.16

4.22

g/l

0.36

108

652

Cholangitis (primary sclerosing, PSC)

154

1033

1.52

5.58

1.9

2.4

4.32

4.17

g/l

1.28

141

944

Other, unspecified and serous retinal detachments

502

1.76

5.58

2.2

2.7

4.24

4.18

g/l

0.28

463

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

645

5320

1.22

5.55

2.5

2.3

4.25

4.21

g/l

0.71

592

4918

Other deformities of toe(s)

502

1.76

5.55

2.4

2.3

4.13

4.25

g/l

0.70

453

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

412

3192

1.28

5.54

2.1

4.17

4.25

g/l

0.93

382

2973

Other congenital malformations of skin, including avohilmo

154

1033

1.51

5.53

1.9

2.3

4.20

4.24

g/l

0.31

142

955

Malignant neoplasm of breast, including Hilmo

836

4500

1.20

5.52

2.1

1.4

4.28

4.30

g/l

0.22

742

4051

Burns and corrosions

265

1959

1.37

5.52

2.0

2.2

4.13

4.21

g/l

1.14

246

1827

Benign neoplasm of major salivary glands

239

1742

1.39

5.52

1.9

2.4

4.24

4.20

g/l

0.31

221

1592

Malignant neoplasm of breast, HER2-negative, including Hilmo

836

4501

1.20

5.51

2.1

1.4

4.28

4.30

g/l

0.24

742

4052

Glucosamine medication

1306

9106

1.15

5.50

2.4

4.19

4.21

g/l

0.28

1178

8174

Malignant neoplasm, without specification of site, including Hilmo

120

764

1.60

5.50

2.9

1.4

4.06

4.20

g/l

1.05

110

670

Chronic iridocyclitis

112

702

1.63

5.49

2.1

2.4

4.45

4.24

g/l

1.11

106

645

Excessive attrition of teeth

1279

11050

1.15

5.47

2.4

2.3

4.23

g/l

0.02

1180

10228

Premature rupture of membranes

134

1445

0.66

5.46

1.9

2.0

4.38

4.32

g/l

0.19

126

1372

Impotence

142

942

1.54

5.45

1.9

2.4

4.16

4.18

g/l

0.09

129

863

Pustulosis palmaris et plantaris

103

635

1.66

5.43

2.2

2.4

4.57

4.26

g/l

1.44

593

Seborrhoeic keratosis

644

5335

1.22

5.37

2.5

2.3

4.11

4.22

g/l

3.18

591

4821

665

5156

1.22

5.37

2.2

4.23

4.17

g/l

0.88

573

4568

Other and unspecified nonorganic psychotic disorders

317

2416

1.32

5.34

1.7

2.3

4.21

4.24

g/l

0.23

289

2266

Malignant neoplasm of colon, including Hilmo

457

3638

1.26

5.34

2.6

1.4

4.22

4.21

g/l

0.11

412

3254

Hordeolum and other deep inflammation of eyelid

130

849

1.56

5.33

2.5

2.6

4.21

4.26

g/l

0.31

114

792

Other other unspecified disorders of the circulatory system

571

1.69

5.28

2.1

2.5

4.19

4.21

g/l

0.07

521

Pneumothorax

169

1169

1.47

5.27

2.5

2.3

4.11

4.16

g/l

0.42

157

1079

Other salmonella infections, including avohilmo

586

1.67

5.25

2.7

2.3

4.11

4.24

g/l

0.98

541

!Aliquae complicationes praecoces traumatis

102

633

1.65

5.23

2.7

2.4

4.25

4.20

g/l

0.21

590

Early complications of trauma

102

633

1.65

5.23

2.7

2.4

4.25

4.20

g/l

0.21

590

Recurrent dislocation and subluxation of joint

102

631

1.64

5.22

1.9

2.3

4.31

4.26

g/l

0.17

599

Other and unspecified trigeminal disorders

184

2.26

5.21

1.9

2.0

4.36

4.28

g/l

0.24

170

Moderate visual impairment, binocular

505

1.73

5.20

1.7

2.1

4.26

4.17

g/l

0.43

453

Acute laryngitis and tracheitis

158

1060

1.48

5.19

1.6

1.9

4.34

4.24

g/l

0.50

147

990

Brachial plexus disorders

156

1063

1.49

5.19

2.4

4.23

4.27

g/l

0.33

150

1007

Malignant neoplasm of breast, HER2-negative

820

4465

1.19

5.18

2.1

1.4

4.29

4.30

g/l

0.14

726

4016

Postpartum haemorrhage

183

2129

0.70

5.16

1.9

2.1

4.27

4.30

g/l

0.20

169

2007

Ulcer of oesophagus

172

1200

1.46

5.15

2.3

2.6

4.23

4.16

g/l

0.52

155

1098

Other specified/unspecified disorders of bone/cartilage

358

1.87

5.14

2.8

2.1

4.01

4.27

g/l

1.76

338

Postprocedural musculoskeletal disorders, not elsewhere classified

188

1335

1.44

5.12

2.8

2.4

4.20

4.21

g/l

0.06

178

1217

Disorders of tooth development and eruption

283

1731

1.34

5.12

1.9

2.1

4.27

4.22

g/l

0.52

260

1593

Tongue abnormality

153

1046

1.49

5.11

2.7

2.4

4.27

4.24

g/l

0.25

139

951

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

120

776

1.56

5.10

1.9

2.3

4.27

4.26

g/l

0.07

105

729

Malignant neoplasm of breast

820

4471

1.19

5.09

2.1

1.4

4.29

4.30

g/l

0.14

726

4022

Injury of muscle and tendon at lower leg level

334

2586

1.31

5.09

2.5

4.23

4.21

g/l

0.21

316

2415

Retinal breaks without detachment

391

3092

1.28

5.07

2.4

4.24

4.22

g/l

0.10

351

2842

Benign neoplasm: salivary glands, exclude unknown (D119)

213

1548

1.40

5.05

1.9

2.5

4.24

4.21

g/l

0.23

197

1420

Spontaneous abortion

582

4721

0.82

5.01

2.0

2.3

4.35

4.28

g/l

0.52

544

4331

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

204

1274

1.40

5.01

1.4

1.6

4.24

4.28

g/l

0.37

191

1216

Familial hypercholesterolemia, with ischemic heart disease

260

1954

1.35

5.00

2.0

2.4

4.25

4.18

g/l

0.52

233

1746

Drug-induced neutropenia

174

1224

1.45

5.00

3.5

2.5

4.02

4.23

g/l

2.87

169

1127

Colitis, primary sclerosing, strict definition

100

2.71

4.99

2.7

2.4

4.31

4.34

g/l

0.06

Monocytic leukaemia

3.52

4.99

3.6

1.4

4.01

4.37

g/l

0.85

Ulcerative proctitis

118

766

1.56

4.99

1.4

2.2

4.28

4.24

g/l

0.19

109

708

Malignant neoplasm, without specification of site

503

1.71

4.98

2.8

1.4

4.12

4.18

g/l

0.26

439

Postprocedural disorders of nervous system

111

710

1.58

4.98

2.3

2.0

4.24

4.31

g/l

0.48

103

669

Inflammatory disease of uterus

226

1659

1.37

4.95

1.8

2.2

4.26

4.30

g/l

0.42

202

1536

Diffuse brain injury

398

1.79

4.95

2.5

2.0

4.09

4.15

g/l

0.24

373

Other retinal artery occlusion

401

1.81

4.93

2.1

2.8

4.30

4.10

g/l

1.02

367

Colitis, primary sclerosing

131

2.45

4.90

2.5

2.1

4.30

g/l

0.01

125

Use of memantine

637

6119

0.83

4.89

1.9

2.3

4.10

4.16

g/l

1.13

508

5442

Use of other anti-dementia drugs

637

6119

0.83

4.89

1.9

2.3

4.10

4.16

g/l

1.13

508

5442

Post-traumatic wound infection, not elsewhere classified

364

1.83

4.88

2.4

2.5

4.37

4.23

g/l

0.49

338

Colorectal cancer, including Hilmo

653

5092

1.20

4.88

2.5

1.4

4.20

4.21

g/l

0.18

588

4549

Pustular psoriasis

110

709

1.59

4.86

2.2

2.3

4.52

4.26

g/l

1.26

103

656

Benign neoplasm: Pituitary gland, craniopharyngeal duct

113

733

1.57

4.83

2.8

2.5

4.11

4.25

g/l

1.28

106

678

Flat foot [pes planus] (acquired)

186

1332

1.41

4.78

1.8

2.6

4.23

4.25

g/l

0.14

167

1219

Oesophageal obstruction

587

1.64

4.78

3.1

2.7

4.18

4.17

g/l

0.02

535

Nonsuppurative otitis media

354

2407

1.28

4.77

2.0

2.1

4.21

4.22

g/l

0.09

332

2223

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

139

2.37

4.76

5.0

1.9

4.00

4.28

g/l

0.89

130

Nontoxic multinodular goitre

465

3779

1.24

4.75

2.1

2.4

4.15

4.24

g/l

1.78

414

3405

Central retinal artery occlusion

391

1.80

4.74

3.6

2.5

4.14

4.11

g/l

0.11

354

Other obstetric conditions, not elsewhere classified

319

1547

1.31

4.73

1.6

1.8

4.22

4.33

g/l

2.06

300

1482

Asthma mixed form (mode), excluding more controls

547

1.65

4.73

2.0

1.6

4.34

4.25

g/l

0.62

486

Nail disorders

176

1252

1.43

4.73

1.9

2.3

4.13

4.24

g/l

1.16

164

1157

Type 1 diabetes, strict definition, subgroup 1

447

1.71

4.69

1.4

1.6

3.74

4.26

g/l

7.02

431

Salpingitis and oophoritis

346

2722

1.28

4.69

1.8

2.5

4.30

g/l

0.01

316

2495

Dystonia

121

803

1.54

4.68

1.3

2.5

4.34

4.23

g/l

0.98

112

743

Crohn disease (strict definition, require KELA, min 2 HDR)

110

714

1.56

4.67

1.9

2.2

4.08

4.27

g/l

1.76

102

665

Other blood glucose lowering drugs, excl. Insulins

405

3251

1.26

4.67

1.8

2.4

4.43

4.13

g/l

2.56

374

2919

Crohn disease (strict definition, require KELA)

112

731

1.55

4.64

1.9

2.2

4.08

4.26

g/l

1.75

104

682

Atrophic disorders of skin

334

2623

1.29

4.60

2.1

2.2

4.26

4.29

g/l

0.22

308

2378

Other arterial embolism and thrombosis

462

1.71

4.59

1.4

2.5

4.04

4.15

g/l

0.50

420

Other disorders of cornea

225

1676

1.36

4.59

2.0

2.3

4.21

4.24

g/l

0.25

208

1535

Lagophthalmos

202

2.13

4.58

2.0

2.2

4.21

4.30

g/l

0.25

186

Benign neoplasm of middle ear and respiratory system

187

1354

1.40

4.58

2.5

2.4

4.25

4.19

g/l

0.49

175

1244

Disorders of optic nerve, not elsewhere classified

329

1.86

4.57

2.5

2.7

4.14

4.23

g/l

0.34

303

Convalescence

112

735

1.55

4.56

2.1

4.29

4.26

g/l

0.16

672

Dislocation, sprain and strain of joints and ligaments at neck level

263

2003

1.32

4.55

2.2

2.3

4.29

4.24

g/l

0.46

245

1873

Corneal scars and opacities

403

1.76

4.53

2.8

2.6

4.13

4.24

g/l

0.68

370

Complications of labour and delivery

895

5762

0.86

4.51

2.5

2.2

4.33

4.29

g/l

0.79

835

5258

Burns and corrosions of external body surface, specified by site

205

1508

1.37

4.50

2.1

2.3

4.14

4.21

g/l

0.55

188

1409

Spasmodic torticollis

435

1.72

4.46

1.4

2.1

4.44

4.31

g/l

0.76

407

Acute suppurative otitis media

350

2580

1.27

4.44

3.0

2.1

4.22

4.24

g/l

0.18

327

2420

Other predominantly sexually transmitted diseases, not elsewhere classified

239

1803

1.33

4.41

2.2

4.22

4.29

g/l

0.82

219

1699

Benign neoplasm: Kidney

584

1.62

4.40

2.0

2.7

4.13

4.21

g/l

0.47

536

Benign neoplasm: Liver/bile ducts

347

1.80

4.39

2.2

2.0

4.25

4.28

g/l

0.10

327

Other and unspecified mononeuropathies, also in other diseases

422

1.73

4.39

2.0

2.3

4.14

4.20

g/l

0.25

385

Disorders of refraction and accommodation

512

4218

1.22

4.37

2.0

2.2

4.23

4.24

g/l

0.16

475

3912

Benign neoplasm: Parotid gland

189

1383

1.39

4.37

2.0

2.4

4.23

4.20

g/l

0.19

176

1272

Other noninflammatory disorders of vagina

158

1120

1.43

4.36

2.3

4.18

4.29

g/l

1.06

141

1014

Status post-ami

705

4547

1.19

4.34

1.7

2.4

4.18

4.16

g/l

0.14

633

4054

Single delivery by forceps and vacuum extractor

834

0.63

4.34

1.6

4.24

4.30

g/l

0.36

790

Epiphora

357

1.79

4.32

2.3

2.4

4.08

4.30

g/l

1.53

326

Retinal haemorrhage

440

1.71

4.32

4.0

2.7

4.04

4.17

g/l

0.68

401

Senility

126

2.37

4.32

1.7

2.0

3.95

4.20

g/l

0.46

113

Other neurotic disorders

106

697

1.55

4.32

1.6

2.6

4.26

4.21

g/l

0.15

635

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

303

1477

1.30

4.31

1.5

1.8

4.20

4.34

g/l

2.66

285

1417

Benign neoplasm of meninges

255

1955

1.32

4.31

1.9

2.4

4.14

4.23

g/l

1.00

225

1769

Other lesions of median nerve

425

1.72

4.30

1.2

2.3

4.31

4.25

g/l

0.28

380

Lichen planus, including avohilmo

447

3662

1.23

4.28

2.5

2.3

4.24

4.23

g/l

0.07

411

3337

Other and unspecified follicular disorders

532

1.63

4.28

3.0

2.4

4.31

4.21

g/l

0.52

501

Secondary parkinsonism, excluding more controls

335

1.80

4.27

2.9

2.1

4.21

4.11

g/l

0.46

309

Hyperfunction of pituitary gland

516

1.63

4.27

2.7

2.0

4.22

4.28

g/l

0.30

486

Contact with heat and hot substances

102

667

1.55

4.24

1.9

2.3

4.05

4.25

g/l

1.72

620

All dysplastic lesions of the cervix uteri, vagina or vulva

415

3286

1.24

4.24

2.2

2.0

4.23

4.30

g/l

1.05

383

3056

Viral infections of the central nervous system

140

977

1.45

4.23

2.3

4.13

4.24

g/l

0.85

127

899

Lichen ruber planus, wide definition including periferal and oral lichen planus

527

4393

1.21

4.22

2.4

4.25

4.24

g/l

0.07

484

4009

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

117

788

1.50

4.22

1.9

2.3

4.09

4.26

g/l

1.68

109

733

Benign neoplasm: Spinal meninges

175

2.16

4.21

1.4

2.0

4.08

4.27

g/l

0.54

158

Corns and callosities

152

1079

1.43

4.21

2.4

2.3

4.23

g/l

0.02

140

992

Triptan medication for migraine, min. 3 purchases

925

6005

1.15

4.21

2.2

4.26

4.28

g/l

0.16

870

5590

Lateral epicondylitis

241

1836

1.32

4.20

1.8

2.2

4.22

4.24

g/l

0.16

223

1699

Maternal care for other conditions predominantly related to pregnancy

254

1898

1.31

4.17

2.0

4.29

4.31

g/l

0.16

243

1803

Status epilepticus

490

1.64

4.14

1.6

2.6

4.26

4.14

g/l

0.50

446

Malignant neoplasm of head and neck, including Hilmo

221

1669

1.34

4.14

2.7

1.4

4.14

4.20

g/l

0.63

204

1491

Meralgia paraesthetica

483

1.65

4.13

1.4

2.4

4.54

4.24

g/l

0.73

447

Disorders of synovium and tendon in diseases classified elsewhere

266

1.89

4.12

1.8

2.1

4.18

4.25

g/l

0.16

247

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

282

3587

0.78

4.11

1.8

1.5

4.37

4.21

g/l

1.66

259

3234

Arterial embolism and thrombosis of lower extremity artery

610

1.58

4.11

1.4

2.6

4.23

4.15

g/l

0.25

554

Lichen planus

308

2436

1.28

4.09

2.8

2.3

4.26

4.22

g/l

0.37

282

2216

Subacute thyroiditis

508

1.63

4.08

2.6

2.3

4.18

4.27

g/l

0.54

467

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

157

1129

1.41

4.05

1.9

1.4

4.32

4.18

g/l

1.35

140

1002

Other disorders of electrolyte and fluid balance, not elsewhere classified

118

2.39

4.05

1.6

4.43

4.26

g/l

0.38

104

Campylobacter enteritis

356

1.75

4.04

2.1

2.4

4.23

4.20

g/l

0.13

329

Other noninflammatory disorders of uterus, except cervix

482

2656

1.22

4.04

2.4

2.3

4.36

4.25

g/l

1.53

431

2390

Contusion of other and unspecified parts of foot

555

1.59

4.03

2.0

2.3

4.16

4.27

g/l

0.63

521

Malignant neoplasm of bladder

165

1197

1.40

4.02

1.9

1.4

4.03

4.15

g/l

1.37

149

1057

Ectropion of eyelid

116

792

1.50

4.01

1.6

2.5

4.16

4.17

g/l

0.06

100

703

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

584

4054

1.19

3.99

2.2

1.4

4.16

4.20

g/l

0.63

535

3638

Burns and corrosions of multiple and unspecified body regions

262

1.88

3.97

1.9

2.7

4.17

4.25

g/l

0.32

248

Congenital iodine-deficiency syndrome/hypothyroidism

458

1.66

3.97

3.2

2.0

4.33

4.21

g/l

0.40

414

Disorder of external ear, unspecified

489

1.63

3.95

2.7

2.6

4.23

4.22

g/l

0.01

455

Uterine polyps

573

2810

1.20

3.95

1.9

2.3

4.30

4.25

g/l

0.63

515

2543

Acne, including avohilmo

224

1372

1.33

3.94

1.7

1.8

4.29

4.27

g/l

0.14

212

1294

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

267

2080

1.29

3.93

2.1

4.21

4.29

g/l

0.82

245

1963

Benign neoplasm: Liver

300

1.81

3.92

2.2

2.1

4.22

4.26

g/l

0.14

283

Benign neoplasm: Skin of ear and external auricular canal

100

666

1.54

3.91

2.4

4.17

4.18

g/l

0.06

608

Viral infections of the central nervous system, including avohilmo

149

1068

1.41

3.91

2.2

2.4

4.15

4.24

g/l

0.67

135

984

Other disorders of bone density and structure

301

1.80

3.86

1.9

2.1

4.13

4.27

g/l

0.61

283

Other female pelvic inflammatory diseases

311

2481

1.26

3.84

1.7

2.4

4.37

4.30

g/l

0.62

258

2261

Carcinoma in situ of skin of ear and external auricular canal

304

1.82

3.83

1.8

2.4

3.71

4.09

g/l

4.23

268

Benign neoplasm of eye and adnexa

250

1945

1.30

3.83

1.8

2.4

4.18

4.21

g/l

0.28

223

1782

Dissection of aorta

542

1.59

3.81

2.2

2.6

4.08

4.14

g/l

0.30

497

Malignant neoplasm of digestive organs

928

6225

1.15

3.79

2.2

1.4

4.20

4.23

g/l

0.69

833

5590

Allergic contact dermatitis due to drugs in contact with skin

319

1.77

3.77

2.1

4.24

g/l

0.01

298

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

535

4513

1.19

3.76

1.8

2.3

4.20

4.24

g/l

0.47

492

4198

Acquired absence of limb

142

2.21

3.76

2.4

1.8

4.18

4.26

g/l

0.13

132

Complications peculiar to reattachment and amputation

2.55

3.75

1.9

2.6

4.15

4.29

g/l

0.29

Single spontaneous delivery

665

4097

0.85

3.75

2.6

2.1

4.30

4.26

g/l

0.66

612

3658

Congenital malformations of cardiac septa

108

712

1.49

3.73

1.6

2.3

4.06

4.25

g/l

1.68

663

Pre-eclampsia or eclampsia

337

2722

1.25

3.71

2.4

2.2

4.33

4.31

g/l

0.13

314

2522

Haemangioma and lymphangioma, any site

189

1422

1.35

3.69

2.7

2.4

4.25

4.23

g/l

0.12

177

1311

Focal epilepsy, strict definition

428

3548

1.22

3.68

2.0

2.3

4.13

4.20

g/l

1.02

379

3251

Pneumonitis due to solids and liquids

204

1554

1.33

3.67

2.2

4.15

g/l

0.03

172

1410

Pre-eclampsia or poor fetal growth

419

3452

1.21

3.62

2.3

2.1

4.27

4.31

g/l

0.38

391

3213

Assault by bodily force

109

748

1.47

3.62

1.9

2.2

4.21

4.26

g/l

0.26

101

716

Pedestrian injured in transport accident

143

1033

1.40

3.62

1.7

2.3

4.24

4.22

g/l

0.08

131

951

Benign neoplasm: Skin of eyelid, including canthus

371

3042

1.23

3.61

3.2

2.3

4.21

4.22

g/l

0.09

330

2767

Amyloidosis of skin

7.27

3.61

3.0

1.1

4.90

4.51

g/l

—

Malignant neoplasm of colon

364

2978

1.23

3.61

2.8

1.4

4.24

4.21

g/l

0.36

329

2652

Disturbance of activity and attention

112

753

1.46

3.60

1.4

1.6

4.20

4.31

g/l

0.67

105

725

Focal epilepsy

453

3785

1.21

3.58

2.0

2.3

4.13

4.21

g/l

1.24

402

3468

Malnutrition

317

1.75

3.57

1.7

2.1

3.65

4.23

g/l

4.32

286

Degeneration of nervous system due to alcohol

340

1.73

3.57

1.2

2.7

4.35

4.14

g/l

0.93

314

Procedures for purposes other than remedying health state

309

1.76

3.57

1.9

1.7

4.07

4.33

g/l

2.11

290

Other disorders of Eustachian tube

424

1.64

3.56

1.6

2.3

4.02

4.25

g/l

1.53

394

Polyp of the female genital tract

593

2854

1.18

3.56

1.9

2.2

4.30

4.25

g/l

0.60

540

2581

conjunctival haemorrhage

187

1415

1.34

3.55

2.4

2.3

4.16

4.21

g/l

0.45

172

1293

HSIL lesion of the cervix uteri, vagina or vulva

270

2137

1.27

3.55

2.1

2.0

4.30

4.32

g/l

0.16

246

1991

Other facial nerve disorders

378

1.68

3.54

2.1

4.19

4.26

g/l

0.29

346

Contusion of toe(s) without damage to nail

272

1.80

3.54

1.2

2.5

4.31

4.30

g/l

0.03

261

Crohn disease (strict definition, all UC cases excluded)

582

1.53

3.54

1.7

2.4

4.09

4.25

g/l

1.06

542

Other disorders of the genitourinary system

304

2448

1.26

3.53

2.2

2.3

4.26

4.24

g/l

0.12

276

2206

Other congenital malformations of the digestive system, including avohilmo

586

1.53

3.52

1.5

2.5

4.13

4.23

g/l

0.63

541

Delivery

671

4099

0.86

3.51

2.5

2.1

4.31

4.26

g/l

0.71

619

3660

Sixth [abducent] nerve palsy

537

1.56

3.51

2.6

4.25

4.17

g/l

0.21

486

Viral encephalitis, not elsewhere classified/unspecified

274

1.80

3.50

3.3

2.4

4.22

4.19

g/l

0.07

252

Sequelae of injuries of neck and trunk

395

1.65

3.49

3.2

2.6

4.19

4.23

g/l

0.18

368

Benign neoplasm: Pancreas

507

1.58

3.48

2.5

2.8

4.16

4.21

g/l

0.22

463

Degeneration of the brain due to alcohol

343

1.71

3.47

1.2

2.7

4.35

4.14

g/l

0.93

317

Hyperkinetic disorders

117

799

1.43

3.46

1.4

1.6

4.19

4.30

g/l

0.77

110

767

Use of rivastigmine

318

3889

0.81

3.46

2.5

2.3

4.03

4.17

g/l

3.34

269

3430

Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

5.66

3.45

2.8

1.1

4.87

4.37

g/l

—

Sequelae of injuries of head

103

708

1.48

3.45

2.7

2.4

4.14

4.23

g/l

0.60

658

Haemangioma, any site

177

1334

1.34

3.45

2.5

4.25

4.23

g/l

0.12

165

1228

Nonspecific lymphadenitis

106

734

1.46

3.41

1.8

2.2

4.18

4.27

g/l

0.58

101

688

Vascular dementia

270

2078

1.27

3.39

2.6

2.3

4.19

4.15

g/l

0.39

228

1843

120

1668

0.71

3.39

1.3

2.3

4.17

4.15

g/l

0.08

1531

Other and unspecified mononeuropathies of upper limb

375

1.66

3.39

1.6

2.4

4.17

4.26

g/l

0.35

353

Brain meningioma, including Hilmo

114

803

1.44

3.38

2.2

1.4

4.16

4.28

g/l

0.95

105

706

Acute alcohol intoxication, ICD10

400

3330

1.21

3.33

1.4

2.4

4.31

4.20

g/l

2.06

364

3120

Postpartum hemorraghe, parous women as controls

183

2003

0.76

3.32

1.9

2.1

4.27

4.32

g/l

0.42

169

1899

Medial epicondylitis

447

1.59

3.32

1.4

2.2

4.32

4.29

g/l

0.12

421

Other specified disorders of kidney and ureter

480

1.57

3.31

2.4

2.7

4.18

4.22

g/l

0.14

446

Other problems related to primary support group, including family circumstances

142

1010

1.38

3.31

1.8

2.1

4.12

4.30

g/l

1.61

132

951

Melanoma in situ of trunk

273

1.79

3.29

2.3

2.7

4.05

4.17

g/l

0.61

250

Chorioretinal inflammation

410

1.62

3.28

1.6

2.2

4.29

4.24

g/l

0.18

382

Strabismus

503

4267

1.18

3.27

2.2

2.3

4.19

4.23

g/l

0.62

464

3924

Paralytic strabismus

163

1226

1.35

3.26

2.1

2.4

4.19

g/l

0.02

149

1128

Macular cyst

572

1.52

3.25

2.3

2.7

4.25

4.19

g/l

0.16

525

Reduction defects of unspecified limb

9.30

3.24

1.0

4.47

4.36

g/l

—

Malignant neoplasm of liver and intrahepatic bile ducts

491

1.56

3.23

1.9

1.4

4.38

4.13

g/l

1.40

438

Prepatellar bursitis

620

1.49

3.22

2.5

2.3

4.15

4.18

g/l

0.16

572

Schizophrenia or delusion, excluding more controls

519

4375

1.18

3.22

2.0

2.4

4.24

4.23

g/l

0.09

467

4066

Appendectomy

1314

11329

1.11

3.19

2.4

2.3

4.23

4.24

g/l

0.09

1209

10472

Malignant neoplasm of small intestine, including Hilmo

477

1.56

3.19

2.1

1.4

4.17

4.24

g/l

0.30

425

Trigeminal neuralgia

125

905

1.40

3.18

2.4

2.3

4.18

4.23

g/l

0.32

116

828

Hereditary angioödema type 1

6.90

3.18

10.1

1.0

4.30

5.27

g/l

—

Other and unspecified disorders of skin and subcutaneous tissue

138

1016

1.38

3.18

1.8

2.4

4.32

4.24

g/l

0.48

111

932

Congenital malformations of heart and great arteries

214

1623

1.29

3.17

2.1

2.3

4.15

4.23

g/l

0.65

195

1509

Injury of nerves and spinal cord at neck level

321

1.69

3.16

2.6

2.8

4.13

4.18

g/l

0.16

294

Inflammatory diseases of prostate (prostatitis)

287

2327

1.25

3.16

2.1

2.5

4.17

4.18

g/l

0.09

270

2155

Residual foreign body in soft tissue

622

1.48

3.16

2.0

2.4

4.17

4.21

g/l

0.19

583

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

283

1.74

3.16

3.3

2.4

4.22

4.19

g/l

0.07

261

Postpartum hemorraghe, all women as controls

183

2314

0.77

3.15

1.9

2.0

4.27

4.31

g/l

0.33

169

2193

Brain meningioma

110

781

1.43

3.15

2.3

1.4

4.15

4.29

g/l

1.09

101

687

Other and unspecified mononeuropathies of lower limb

407

1.61

3.14

1.7

2.1

4.12

4.28

g/l

1.20

373

Haemorrhagic disorder due to circulating anticoagulants

247

1.81

3.14

1.9

2.4

4.13

4.19

g/l

0.16

222

Alzheimer disease

801

6479

0.88

3.14

1.9

2.3

4.09

4.17

g/l

2.33

672

5764

Alzheimer’s disease (Atypical or mixed)

208

2607

0.78

3.14

1.8

2.2

4.12

4.16

g/l

0.23

174

2290

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

170

1292

1.33

3.14

2.2

2.4

4.18

4.15

g/l

0.18

154

1187

Polypectomy (DHB20)

144

1070

1.36

3.13

2.7

2.4

4.12

4.18

g/l

0.42

137

993

Melanocytic naevi of upper limb, including shoulder

314

1.69

3.13

1.9

2.3

4.02

4.26

g/l

1.26

295

Physiological and behavioural disorders associated with sexual development and orientation

8.12

3.12

1.0

5.8

3.97

4.08

g/l

—

Asthma mixed form (mode)

607

1.48

3.12

2.0

1.7

4.34

4.23

g/l

0.84

542

Malignant neoplasm of head and neck

179

1374

1.32

3.10

2.1

1.4

4.16

4.19

g/l

0.26

166

1230

Vulvovaginal ulceration/inflammation in other diseases

105

740

1.43

3.10

1.8

2.3

4.31

4.30

g/l

0.10

693

Endocrine disorders, other/unspecified

246

0.36

3.10

1.4

2.2

4.60

4.28

g/l

—

233

Medical abortion

1239

6049

1.11

3.07

1.8

2.4

4.30

4.27

g/l

0.33

1111

5468

Maternal care related to the fetus and amniotic cavity and possible delivery problems

486

3344

0.85

3.06

2.6

2.1

4.39

4.30

g/l

0.53

461

3116

Corneal ulcer

361

3006

1.21

3.04

2.3

2.2

4.22

4.23

g/l

0.11

334

2768

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

175

1.92

3.04

2.6

2.2

4.06

4.26

g/l

0.59

166

Benign neoplasm: Cerebral meninges

226

1795

1.27

3.03

2.0

2.4

4.14

4.23

g/l

0.94

203

1630

Noninflammatory disorders of female genital tract

691

3020

1.15

3.01

2.3

2.2

4.29

4.26

g/l

0.48

624

2740

Arthropathy in Crohn disease

114

2.18

3.01

1.0

2.3

4.31

4.33

g/l

0.05

109

Focal brain injury

127

931

1.38

3.00

2.1

2.4

4.20

4.13

g/l

0.34

108

862

Palindromic rheumatism

121

2.14

2.99

1.4

1.9

4.32

4.30

g/l

0.05

111

Graves disease, strict definition

182

1407

1.31

2.99

2.5

2.2

4.27

4.30

g/l

0.13

168

1306

Myocardial infarction, with ST-elevation

441

3749

1.19

2.98

1.8

2.3

4.13

4.15

g/l

0.33

406

3382

Sequelae of injuries of upper limb

187

1453

1.30

2.97

2.6

2.5

4.28

4.24

g/l

0.24

169

1347

Other diseases of gallbladder

106

758

1.42

2.95

2.6

2.5

4.64

4.20

g/l

0.66

685

Schizophrenia

179

2299

0.77

2.93

2.4

2.3

4.25

4.23

g/l

0.20

160

2148

Graves ophthalmopathy, strict

305

1.68

2.93

1.1

2.0

4.24

4.35

g/l

0.48

285

Other disorders of conjunctiva

336

2794

1.21

2.92

2.7

2.3

4.21

4.20

g/l

0.02

311

2545

Recurrent and persistent haematuria

109

2.19

2.92

1.3

2.5

4.15

4.33

g/l

0.43

101

Tracheo-bronchomalasia

4.24

2.92

1.7

3.8

4.31

4.63

g/l

—

Benign neoplasm of breast

243

1956

1.25

2.90

2.2

4.24

4.29

g/l

0.32

217

1761

Other and unspecified acute skin changes due to ultraviolet radiation

393

1.59

2.87

2.1

2.3

4.14

4.23

g/l

0.29

355

Conductive hearing loss, unspecified

169

1303

1.31

2.87

2.2

2.3

4.20

4.22

g/l

0.11

156

1200

Lung diseases due to external agents

340

2836

1.21

2.87

2.8

2.3

4.20

4.16

g/l

0.37

297

2571

Dislocation of lens

239

1.76

2.85

2.7

2.5

4.21

4.19

g/l

0.04

225

Congenital obstruction of the pelviureteric junction

2.25

2.84

3.3

2.4

4.09

4.23

g/l

0.31

Other puerperal infections

537

1.48

2.83

1.7

4.39

4.35

g/l

0.13

515

Benign neoplasm: Prostate

118

2.15

2.83

3.7

3.0

4.09

4.15

g/l

0.12

104

Other factor of the environment

159

1.94

2.82

3.4

1.9

4.15

4.30

g/l

0.31

149

Examination and encounter for administrative purposes

156

1193

1.32

2.81

2.5

2.3

4.25

4.20

g/l

0.28

146

1098

Ventricular septal defect, a heart condition

158

1.92

2.81

1.5

1.8

4.09

4.25

g/l

0.34

150

Benign neoplasm: Larynx

492

1.51

2.80

2.5

2.6

4.28

4.16

g/l

0.53

452

Leiomyoma of uterus

1267

6455

1.10

2.80

2.3

2.2

4.30

4.27

g/l

0.32

1129

5849

Ingrowing nail

689

1.43

2.80

2.1

2.4

4.17

4.26

g/l

0.50

638

Other peripheral vertigo

212

1689

1.27

2.80

1.8

2.5

4.18

4.23

g/l

0.54

190

1546

Benign neoplasm of other and unspecified intrathoracic organs

160

1.95

2.79

2.8

2.2

4.21

4.37

g/l

0.48

147

Atopic conjunctivitis

499

1.50

2.79

1.5

2.0

4.21

4.30

g/l

0.45

465

All dysplastic lesions of the cervix uteri

329

2695

1.21

2.78

2.1

4.25

4.31

g/l

0.89

307

2523

Mental and behavioural disorders due to cannabinoids

173

1.87

2.78

1.7

1.6

4.61

4.32

g/l

0.95

167

Malignant neoplasm of oral cavity, including Hilmo

657

1.44

2.78

2.3

1.4

4.13

4.23

g/l

0.76

587

HSIL lesion of the cervix uteri

224

1793

1.26

2.77

1.9

2.1

4.30

4.31

g/l

0.06

207

1683

Other diseases of spinal cord

420

1.55

2.77

2.6

2.7

4.19

4.23

g/l

0.16

390

Ulcerative rectosigmoiditis

144

1091

1.33

2.77

1.9

2.4

4.35

4.20

g/l

0.87

131

1021

Non-small cell lung cancer, including Hilmo

355

2796

1.20

2.77

2.0

1.4

4.18

4.20

g/l

0.21

324

2501

Malignant neoplasm of endocrine gland, including Hilmo

154

1179

1.32

2.76

2.7

1.4

4.24

4.28

g/l

0.29

142

1053

Vertigo of central origin

257

1.72

2.75

2.0

2.7

4.42

4.26

g/l

0.62

232

Abnormal spermatozoa

215

2672

0.80

2.74

2.0

2.5

4.24

4.11

g/l

2.02

198

2459

Thyroiditis, unspecified

197

1.82

2.74

1.3

1.8

4.05

4.26

g/l

1.02

184

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

278

2283

1.22

2.73

2.1

2.2

4.35

4.28

g/l

0.70

258

2100

Proteinuria and renal glomerular damage; focal glomerulonephritis

4.66

2.72

1.3

3.0

4.17

4.15

g/l

—

Laparoscopic right hemicolectomy

150

1150

1.33

2.72

2.4

2.5

4.24

4.19

g/l

0.29

130

1044

Pre-eclampsia

294

2429

1.22

2.72

2.6

2.2

4.32

4.31

g/l

0.08

271

2254

Vascular dementia (subcortical)

101

729

1.41

2.72

3.3

2.2

4.15

4.16

g/l

0.05

647

Hereditary sideroblastic anaemia

2.82

2.71

2.8

1.5

4.40

4.36

g/l

0.04

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

6.59

2.69

1.0

4.22

4.40

g/l

—

Colorectal cancer

557

4661

1.15

2.69

2.7

1.4

4.21

g/l

0.04

502

4158

Foreign body entering into or through eye or natural orifice

147

1123

1.32

2.69

2.6

2.3

4.14

4.20

g/l

0.38

133

1051

Unspecific neurodegenerative disorder

1058

7990

0.90

2.68

2.0

2.4

4.13

4.17

g/l

1.01

875

7193

Blindness, monocular

141

1.99

2.68

4.3

2.0

4.34

4.33

g/l

0.01

131

Lifestyle-related condition

148

1.95

2.67

3.6

1.9

4.11

4.34

g/l

0.54

137

Alzheimer’s disease (Early onset), excluding more controls

609

0.60

2.67

1.2

2.2

4.21

4.11

g/l

0.32

544

Delivery, wide proxy

560

3410

0.87

2.66

2.4

2.0

4.32

4.25

g/l

0.85

512

3004

Other drug-induced secondary parkinsonism

156

1.93

2.65

2.3

4.29

4.25

g/l

0.10

145

Personal history of certain other diseases

127

2.00

2.63

1.2

1.6

4.04

4.35

g/l

0.91

118

Granuloma annulare

200

1.80

2.62

1.9

4.26

4.39

g/l

0.53

187

Seminoma of testis, including Hilmo

2.36

2.62

1.6

1.4

4.01

4.21

g/l

0.68

Moyamoya

7.81

2.61

1.2

1.0

3.78

5.97

g/l

—

Pyoderma

253

1.70

2.61

1.9

2.3

4.30

4.25

g/l

0.14

237

Myopia

190

1506

1.27

2.60

2.0

2.3

4.27

g/l

0.00

180

1407

Osteochondrodysplasia with defects of growth of tubular bones and spine

5.84

2.60

1.0

1.2

4.27

4.19

g/l

—

Chromophobe cell carcinoma of kidney

2.39

2.59

2.3

1.2

3.95

4.15

g/l

0.44

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

4.98

2.59

11.9

1.1

4.34

5.05

g/l

—

Other acquired deformities of musculoskeletal system and connective tissue

651

1.42

2.57

2.4

2.3

4.12

4.24

g/l

0.90

601

Other changes in lacrimal passages

4.23

2.56

2.9

1.6

4.20

4.87

g/l

—

Use of disulfiram, acamprosate or naltrexone

151

1166

1.31

2.56

1.6

2.3

4.32

4.21

g/l

1.03

135

1098

Melanoma in situ of other and unspecified parts of face

249

1.71

2.53

2.2

2.6

3.81

4.16

g/l

2.75

226

Meningitis

669

1.41

2.53

3.1

2.3

4.22

4.25

g/l

0.11

622

Injuries involving multiple body regions

486

1.48

2.53

2.3

4.15

4.22

g/l

0.31

452

Other maternal disorders predominantly related to pregnancy

757

5308

0.89

2.52

2.3

4.31

4.30

g/l

0.18

707

4907

Septal defects

672

1.40

2.51

1.7

2.3

4.02

4.27

g/l

2.32

626

Acute alcohol intoxication

536

4691

1.15

2.51

1.5

2.5

4.26

4.18

g/l

1.33

486

4361

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

112

833

1.36

2.50

1.7

1.4

4.35

4.16

g/l

1.40

735

Triptan medication for migraine, single purchase ok

1425

8874

1.09

2.50

2.2

2.3

4.25

4.26

g/l

0.08

1330

8203

Migraine, single triptan purchase ok & required. ICD-code if available is included

1425

8874

1.09

2.50

2.2

2.3

4.25

4.26

g/l

0.08

1330

8203

Benign neoplasm: Choroid

156

1217

1.30

2.50

1.7

2.6

4.14

4.22

g/l

0.68

137

1115

Malignant neoplasm of pancreas

1226

0.72

2.48

1.7

1.4

4.09

4.20

g/l

0.58

1090

Unspecified mental disorder

738

6591

1.12

2.47

2.0

2.3

4.28

4.23

g/l

0.99

681

6078

Diseases of appendix

1572

13000

1.08

2.47

2.6

2.3

4.23

4.22

g/l

0.12

1444

11990

Alkalosis

3.57

2.46

2.0

2.6

4.02

4.52

g/l

—

Ménière disease

210

1700

1.25

2.45

1.9

2.5

4.29

4.22

g/l

0.66

191

1551

Malignant neoplasm of thymus, including Hilmo

2.55

2.44

4.7

1.2

3.61

4.49

g/l

2.96

Convergent concomitant strabismus

589

1.42

2.44

2.3

2.2

4.32

4.27

g/l

0.12

548

Bitten or struck by other mammals

188

1502

1.26

2.44

3.0

2.4

4.17

4.26

g/l

0.73

178

1395

Respiratory tuberculosis, confirmed

274

1.64

2.43

1.8

2.4

4.18

4.15

g/l

0.08

247

Car occupant injured in other and unspecified transport accidents

317

2670

1.19

2.43

2.0

2.2

4.26

4.24

g/l

0.16

291

2477

Systemic sclerosis,strict definition

125

1.99

2.42

1.4

1.8

3.96

4.45

g/l

1.95

118

Focal epilepsy, mode (most common among epilepsy diagnosis)

389

3338

1.17

2.40

2.1

2.3

4.15

4.20

g/l

0.70

340

3060

Respiratory tuberculosis, confirmed, including avohilmo

283

1.63

2.40

1.9

2.4

4.18

4.14

g/l

0.12

255

Other and unspecified primary disorders of muscles

2.17

2.39

1.4

2.6

4.46

4.32

g/l

0.27

Congenital varicose veins

2.93

2.39

2.4

2.1

4.01

4.55

g/l

0.90

Malignant neoplasm of small intestine

347

1.56

2.38

2.5

1.4

4.14

4.25

g/l

0.62

309

Corneal degeneration

276

1.64

2.38

1.4

2.4

4.05

4.24

g/l

0.79

253

Contact with and exposure to communicable diseases

384

3275

1.17

2.38

2.2

2.1

4.25

4.27

g/l

0.21

373

3084

Presbycusis

402

3422

1.17

2.37

2.5

2.2

4.09

4.16

g/l

1.05

345

3043

Chondromalacia

380

1.53

2.35

1.5

2.2

4.18

4.29

g/l

0.51

363

Other and unspecified abdominal hernia

680

1.39

2.35

1.6

2.1

4.23

g/l

0.02

623

Acute appendicitis

1439

12342

1.08

2.34

2.6

2.3

4.23

4.22

g/l

0.07

1327

11398

Explicit viral Sepsis

6.79

2.34

1.2

1.0

4.72

5.94

g/l

—

Effects of foreign body entering through natural orifice

468

4081

1.15

2.33

2.3

2.4

4.25

4.22

g/l

0.40

428

3792

Explicit viral Sepsis, including avohilmo

6.56

2.32

1.2

1.0

4.72

5.94

g/l

—

Malignant neoplasm of thyroid gland, including Hilmo

135

1045

1.30

2.30

2.6

1.4

4.27

4.26

g/l

0.06

123

933

Disorders of lacrimal system and orbit in diseases classified elsewhere

342

1.55

2.29

1.1

2.0

4.25

4.35

g/l

0.44

320

Neovascular glaucoma

683

1.38

2.29

2.4

2.3

4.17

4.18

g/l

0.07

621

Dronedarone medication

465

1.47

2.29

2.3

2.6

4.03

4.21

g/l

1.12

414

hereditary angioödema type 3

6.24

2.29

1.0

4.34

6.01

g/l

—

Dentofacial anomalies [including malocclusion]

1343

9689

1.09

2.28

2.3

4.26

4.25

g/l

0.07

1234

8963

Non-small cell lung cancer, adenocarcinoma

144

1127

1.29

2.28

1.8

1.4

4.13

4.20

g/l

0.73

131

1001

Other acute skin changes due to ultraviolet radiation

532

1.43

2.27

2.0

2.3

4.36

4.24

g/l

0.26

487

Injury of other and unspecified intrathoracic organs

134

1039

1.30

2.27

1.9

2.3

4.04

4.17

g/l

1.06

125

956

Hypertrophic disorders of skin

666

1.38

2.26

2.5

2.2

4.28

4.26

g/l

0.10

620

Carcinoma in situ of other and unspecified sites

106

798

1.35

2.26

2.9

2.5

4.35

4.10

g/l

1.19

734

Varicose veins of other sites

124

952

1.32

2.25

2.7

2.3

4.30

4.22

g/l

0.58

108

882

Perforation of tympanic membrane

198

1609

1.24

2.25

2.3

4.27

4.21

g/l

0.36

179

1471

Graves ophthalmopathy

344

1.54

2.24

1.1

2.0

4.25

4.34

g/l

0.39

320

Glaucoma secondary to other eye disorders

686

1.38

2.24

2.4

2.6

4.17

4.18

g/l

0.06

623

Open wound of wrist and hand

901

7906

1.10

2.23

2.4

2.2

4.20

4.21

g/l

0.14

840

7332

Use of galantamine

139

1766

0.78

2.23

1.6

2.4

4.27

4.16

g/l

0.90

107

1561

Acute appendicitis, no complications

1061

9652

1.10

2.23

2.7

2.3

4.22

4.23

g/l

0.06

984

8962

Diseases of middle ear and mastoid

1067

7969

1.10

2.22

2.5

2.2

4.23

g/l

0.04

995

7338

Alport

4.66

2.21

1.5

3.8

3.87

4.15

g/l

—

Burn and corrosion of wrist and hand

426

1.47

2.21

1.6

2.3

4.05

4.24

g/l

1.08

400

Nontoxic single thyroid nodule

149

1176

1.28

2.20

2.4

2.3

4.25

4.23

g/l

0.07

140

1076

Appendicitis, broad definition

1547

12901

1.08

2.19

2.6

2.3

4.23

4.22

g/l

0.12

1423

11901

Other disorders of breast

243

2022

1.21

2.18

2.4

2.3

4.30

g/l

0.02

213

1845

Carcinoma in situ, bladder

725

1.36

2.18

3.1

2.6

4.38

4.10

g/l

1.23

668

Pedal cyclist injured in noncollision transport accidents

204

1669

1.23

2.18

1.8

2.3

4.17

4.22

g/l

0.49

185

1555

Contact with other and unspecified heat and hot substances

2.17

2.18

4.9

1.9

4.02

4.42

g/l

0.91

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

110

834

1.33

2.18

2.1

2.4

4.24

4.35

g/l

0.91

105

789

Hepatocellular carcinoma

347

1.53

2.17

2.2

1.4

4.38

4.08

g/l

2.43

306

Inguinal or femoral hernia, bilateral

250

2091

1.21

2.16

2.7

2.4

4.07

4.16

g/l

1.04

225

1918

Abdominal aortic aneurysm (AAA)

243

2010

1.21

2.15

1.8

2.3

4.14

4.12

g/l

0.10

217

1800

Inguinal hernia, bilateral

246

2055

1.21

2.15

2.7

2.4

4.06

4.16

g/l

1.15

221

1884

Otitis media, unspecified

143

1036

1.28

2.12

2.8

2.1

4.32

4.23

g/l

0.70

138

962

Vascular dementia (undefined)

108

816

1.33

2.09

2.1

4.24

4.12

g/l

0.77

717

Benign lipomatous neoplasm

640

5740

1.12

2.09

2.5

2.4

4.27

4.22

g/l

0.65

591

5250

Acute nasopharyngitis (common cold)

192

1556

1.23

2.08

1.9

2.1

4.18

4.25

g/l

0.51

181

1461

Malignant neoplasm of stomach, including Hilmo

125

973

1.30

2.08

1.3

1.4

4.06

4.17

g/l

0.96

114

857

Felty syndrome

2.15

2.08

1.7

2.2

4.68

4.24

g/l

0.62

Respiratory tuberculosis, bacteriologically and histologically confirmed

286

1.57

2.08

1.8

2.5

4.18

4.14

g/l

0.09

257

Atrial septal defect

389

1.47

2.05

1.9

2.1

4.09

4.26

g/l

0.88

362

Other and unspecified disorders of orbit

2.24

2.04

1.5

2.6

4.32

4.42

g/l

0.18

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

128

1003

1.29

2.02

2.4

1.4

4.21

4.24

g/l

0.14

115

895

Hypertrophic scar

603

1.37

2.02

2.6

2.2

4.24

4.26

g/l

0.08

559

Abrasion of teeth

739

6693

1.11

2.01

2.5

2.4

4.17

4.26

g/l

3.17

679

6151

Other strabismus

366

3163

1.16

2.01

2.2

2.3

4.22

4.25

g/l

0.26

339

2921

Cysts of oral region, not elsewhere classified

113

873

1.31

2.01

3.0

2.4

4.20

g/l

0.01

103

810

Pilonidal cyst

115

889

1.30

2.00

2.0

2.1

4.22

4.25

g/l

0.19

107

845

Schizoaffective disorder

117

908

1.30

1.99

1.8

2.3

4.40

4.24

g/l

1.48

107

853

Benign neoplasm: Skin of other and unspecified parts of face

234

1963

1.20

1.98

3.5

2.4

4.17

4.21

g/l

0.41

208

1789

Maternal care for known or suspected abnormality of pelvic organs

218

1768

0.83

1.98

2.7

2.1

4.44

4.31

g/l

0.34

204

1666

Malignant neoplasm of endocrine gland

129

1017

1.28

1.96

2.2

1.4

4.25

4.26

g/l

0.04

121

908

Suppurative and unspecified otitis media

540

4258

1.13

1.96

2.8

2.1

4.26

4.23

g/l

0.39

508

3953

All dysplastic lesions of the vagina

339

1.50

1.95

2.4

2.0

4.20

4.31

g/l

0.43

319

Malignant neoplasm of bronchus and lung, including Hilmo

500

3700

1.13

1.94

2.1

1.5

4.19

4.21

g/l

0.23

457

3314

Follow-up care involving plastic surgery

506

1.40

1.94

1.7

2.0

4.36

4.29

g/l

0.24

466

Fall on and from ladder

162

1316

1.24

1.92

3.4

2.5

4.14

4.16

g/l

0.14

149

1217

Tuberculosis, IBD comorbidity

158

1280

1.25

1.92

2.2

4.38

4.18

g/l

0.51

137

1152

Pleural plaque without asbestos

760

1.33

1.90

2.0

2.5

4.19

4.11

g/l

0.46

686

Benign neoplasm: Other parts of oropharynx

137

1.81

1.88

3.2

1.8

4.12

4.26

g/l

0.36

128

Recurrent dislocation of patella

333

1.48

1.87

1.5

2.0

4.43

4.29

g/l

0.78

318

Carcinoma in situ of skin of lip

2.32

1.86

1.2

1.4

3.69

4.20

g/l

2.93

Other disorders of skin and subcutaneous tissue related to radiation

3.30

1.86

1.1

4.53

4.45

g/l

—

Oral lichen planus

452

1.42

1.86

2.7

2.4

4.18

4.25

g/l

0.26

418

Contact with other hot metals

183

1.67

1.85

1.5

2.4

4.13

4.23

g/l

0.29

169

Alzheimer disease, including avohilmo

946

7114

0.92

1.85

1.9

2.3

4.10

4.17

g/l

2.11

796

6355

Hereditary lymphedema, including avohilmo

2.96

1.85

1.0

1.6

4.33

4.18

g/l

—

Endometriosis of pelvic peritoneum

241

1852

1.19

1.84

1.5

2.3

4.25

4.29

g/l

0.46

219

1699

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

539

4680

1.12

1.84

3.0

1.4

4.19

4.22

g/l

0.35

493

4229

Maternal care for known or suspected fetal abnormality and damage

161

1108

1.23

1.83

1.8

1.9

4.26

4.33

g/l

0.72

156

1062

Use of peginterferon beta-1a

2.85

1.82

1.9

1.3

4.10

4.72

g/l

—

Glaucoma suspect

766

8375

0.91

1.81

2.3

2.4

4.20

4.22

g/l

0.16

694

7562

Contraceptive management

522

4079

0.89

1.81

2.3

2.2

4.23

4.27

g/l

0.50

487

3846

Occupational exposure to risk-factors

522

0.64

1.80

3.4

2.7

4.75

4.16

g/l

0.70

488

Other sideroblastic anaemias

2.34

1.79

1.2

1.4

4.30

4.12

g/l

0.29

Malignant neoplasm of stomach

107

835

1.29

1.79

1.3

1.4

4.06

4.18

g/l

0.93

739

Other disorders of male genital organs

488

1.39

1.79

1.6

2.5

4.12

4.20

g/l

0.53

452

Ankle and foot

117

1.85

1.79

1.5

2.2

4.23

4.32

g/l

0.21

109

Foreign body in alimentary tract

106

828

1.29

1.77

1.6

2.4

4.31

4.18

g/l

0.63

761

Embedded teeth, including avohilmo

756

1.30

1.77

2.6

1.9

4.28

g/l

0.02

712

Tuberculosis, wide, including avohilmo

166

1367

1.23

1.75

2.2

2.4

4.37

4.18

g/l

0.51

144

1231

Amblyopia ex anopsia

456

1.40

1.75

1.4

2.1

4.30

4.27

g/l

0.08

427

Use of levodopa decarboxylase inhibitor

356

3125

1.15

1.74

2.0

2.4

4.11

4.18

g/l

1.12

314

2811

Chalazion

211

1777

1.20

1.74

3.1

2.4

4.21

4.23

g/l

0.18

192

1642

Other intracranial haemorrhages

561

1.36

1.73

2.1

2.5

4.21

4.13

g/l

0.32

506

Benign neoplasm: other/unspecified salivary gland

434

1.41

1.71

1.5

2.4

4.28

4.21

g/l

0.31

394

Malignant neoplasm of oral cavity

510

1.37

1.71

2.0

1.4

4.15

4.24

g/l

0.47

455

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

693

0.70

1.71

1.9

2.2

4.54

4.30

g/l

0.67

642

Other specified disorders of external ear

623

1.33

1.71

2.0

2.6

4.06

4.18

g/l

0.74

580

Benign mammary dysplasia

286

2475

1.16

1.71

2.6

2.3

4.21

4.30

g/l

1.27

256

2225

Congenital malformations of genital organs

111

870

1.27

1.70

1.7

2.0

4.32

4.29

g/l

0.16

104

821

Myositis ossificans

2.70

1.69

2.1

2.5

4.46

4.33

g/l

—

Mixed conductive and sensorineural hearing loss

286

2479

1.16

1.68

2.5

2.3

4.25

4.18

g/l

0.85

249

2255

Colorectal neuroendocrine tumor and carcinoma

165

1.67

1.68

4.4

1.3

4.13

4.35

g/l

0.84

150

Other diseases of peritoneum

712

1.31

1.68

1.7

2.5

4.30

4.21

g/l

0.52

652

Other diseases of biliary tract

195

1639

1.20

1.67

2.3

2.4

4.19

4.17

g/l

0.08

177

1487

Injury of muscle and tendon at shoulder and upper arm level

831

7649

1.09

1.67

2.3

2.4

4.18

4.20

g/l

0.34

763

7066

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

268

2313

1.17

1.66

2.6

2.3

4.27

4.23

g/l

0.30

245

2142

Other contact dermatitis

136

1103

1.24

1.66

1.8

2.5

4.30

4.23

g/l

0.51

118

1013

Maze procedure for atrial fibrillation

2.05

1.65

1.3

1.9

4.02

4.30

g/l

0.55

Benign neoplasm: Endocrine pancreas

106

1.86

1.64

1.8

2.4

4.25

4.36

g/l

0.22

100

Cytomegaloviral hepatitis

2.63

1.63

1.9

2.3

4.06

4.73

g/l

—

Malignant neoplasm of hypopharynx, including Hilmo

1.97

1.63

4.1

1.2

3.89

4.15

g/l

0.96

Parkinson's disease, including avohilmo

400

3557

1.13

1.62

1.8

2.4

4.10

4.17

g/l

1.15

351

3206

Neuroendocrine tumor and carcinoma of rectum

2.30

1.61

4.6

1.1

4.18

4.26

g/l

0.14

Tuberculosis, wide

162

1344

1.22

1.61

2.2

2.4

4.38

4.18

g/l

0.52

140

1210

Renal cell carcinoma of kidney

490

1.36

1.61

2.2

1.5

4.13

4.17

g/l

0.18

429

Other and unspecified intracranial injuries

430

1.39

1.61

1.9

2.4

4.18

4.16

g/l

0.06

393

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

447

1.38

1.61

1.6

2.3

4.16

4.22

g/l

0.28

416

Colon adenocarcinoma

273

2367

1.16

1.61

2.8

1.4

4.24

4.20

g/l

0.39

243

2102

Benign neoplasm: Heart

2.22

1.61

1.5

1.9

4.43

4.41

g/l

0.03

Oral lichen planus, including avohilmo , including avohilmo

146

1200

1.23

1.60

2.5

4.30

4.27

g/l

0.11

133

1103

Other and unspecified degenerative diseases of nervous system

526

1.35

1.60

2.1

2.5

4.19

4.13

g/l

0.22

478

Papillary adenocarcinoma of thyroid gland

708

1.30

1.60

1.9

1.4

4.29

4.30

g/l

0.03

638

Transient global amnesia

153

1843

0.82

1.59

2.6

2.4

4.19

4.22

g/l

0.19

133

1692

Dislocation, sprain and strain of joints and ligaments of knee

1140

9612

1.07

1.58

1.9

2.4

4.25

4.23

g/l

0.21

1045

8930

Malignant neoplasm of respiratory system and intrathoracic organs

492

3670

1.12

1.58

2.1

1.5

4.15

4.20

g/l

0.71

446

3295

Oligomenorrhoea

355

1.42

1.58

1.8

2.3

4.31

g/l

0.02

327

Glaucoma-related operations

139

1141

1.23

1.57

2.6

2.5

4.20

g/l

0.03

125

1021

Vasomotor rhinitis (mode)

140

1149

1.23

1.56

2.2

2.6

4.23

g/l

0.01

123

1055

Benign neoplasm of male genital organs

332

1.44

1.56

2.6

2.7

4.03

4.12

g/l

0.31

306

Tonsillectomy and adenotomy

688

5230

0.91

1.55

1.9

2.1

4.26

4.25

g/l

0.21

641

4919

Pregnancy, childbirth and the puerperium

506

2933

0.90

1.55

1.9

2.1

4.24

4.26

g/l

0.14

456

2560

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

2.26

1.55

1.2

4.54

4.42

g/l

0.14

Disorders of endocrine glands in diseases classified elsewhere

3.52

1.55

1.0

1.1

3.92

4.50

g/l

—

Macular hole

142

1170

1.23

1.55

1.9

2.6

4.13

4.20

g/l

0.65

127

1066

Other specified and unspecified disorders of lens

170

1.64

1.54

1.5

2.6

4.33

4.20

g/l

0.36

155

Benign neoplasm: Skin of trunk

633

1.31

1.54

3.0

2.4

4.20

4.22

g/l

0.05

587

Lesion of radial nerve

511

1.35

1.54

2.2

2.3

4.28

4.22

g/l

0.18

473

Maternal care for (suspected) damage to fetus from alcohol

2.95

1.52

1.2

1.4

4.67

4.89

g/l

—

Caught, crushed, jammed or pinched in or between objects

616

1.31

1.52

1.5

2.4

4.29

4.19

g/l

0.53

579

Transient acantholytic dermatosis [Grover]

2.56

1.52

1.2

2.3

4.12

4.18

g/l

—

Erectile dysfunction

189

1603

1.19

1.51

2.4

4.06

4.10

g/l

0.39

175

1465

Calculus of lower urinary tract

119

966

1.25

1.50

2.2

2.6

4.21

4.13

g/l

0.42

107

886

Separation of retinal layers (serosa)

601

1.31

1.49

2.3

2.5

4.27

4.23

g/l

0.14

560

Non-small cell lung cancer, squamous, helper endpoint

970

0.77

1.49

1.8

2.4

4.21

4.11

g/l

0.62

876

Contact with other hot fluids

334

1.42

1.49

1.5

2.3

4.03

4.24

g/l

0.96

316

Other or unspecified paralytic strabismus

1.89

1.49

1.1

2.6

4.14

4.26

g/l

0.32

HSIL lesion of the vulva

252

1.50

1.48

3.8

2.1

4.25

4.32

g/l

0.17

235

Vascular dementia (other)

125

1.73

1.48

1.7

2.4

4.30

4.14

g/l

0.43

111

Parkinson's disease, strict definition

356

3166

1.13

1.47

1.8

2.4

4.09

4.18

g/l

1.64

315

2858

Malignant neoplasm of thyroid gland

117

949

1.24

1.47

2.2

1.4

4.28

4.26

g/l

0.11

109

849

Chronic postrheumatic arthropathy [Jaccoud]

3.34

1.47

2.2

1.9

4.42

4.16

g/l

—

Generalized epilepsy, strict definition

203

1.55

1.47

1.7

2.2

4.33

4.30

g/l

0.05

194

Seminoma of testis

2.01

1.45

1.8

1.4

4.04

4.25

g/l

0.53

Other and unspecified injuries of shoulder and upper arm

430

1.36

1.45

1.9

2.5

4.21

4.19

g/l

0.07

397

Secondary parkinsonism+Parkinsonism in other disease

457

1.35

1.44

2.9

2.6

4.21

4.16

g/l

0.17

417

Benign neoplasm: Lip

329

1.42

1.44

3.6

2.2

4.35

4.21

g/l

0.54

298

Pedal cyclist injured in transport accident

405

3631

1.12

1.44

2.1

2.3

4.22

4.23

g/l

0.20

370

3368

Endometriosis ASRM stages 1,2

250

2175

1.15

1.43

1.5

2.1

4.26

4.30

g/l

0.35

226

2015

Long labour

221

2168

0.86

1.41

2.4

2.1

4.25

4.29

g/l

0.25

210

2040

Disturbances of smell and taste

651

1.29

1.41

3.4

2.8

4.01

4.27

g/l

2.63

601

Maternal care for other known or suspected fetal problems

164

1223

0.84

1.41

1.5

1.9

4.27

4.32

g/l

0.34

158

1168

Benign neoplasm: Orbit, unspecified

1.86

1.41

3.3

2.2

4.05

4.47

g/l

0.88

Fibrosis and sclerosis of liver

3.25

1.41

1.4

1.5

4.72

4.37

g/l

—

Alzheimer’s disease, strict definition

625

5493

0.91

1.41

1.9

2.3

4.07

4.17

g/l

2.61

527

4873

Malignant neoplasm of nasopharynx

2.29

1.40

1.2

4.26

4.24

g/l

—

Cerebral aneurysm, nonruptured

172

1457

1.19

1.40

1.9

2.4

4.17

4.23

g/l

0.51

156

1345

Hereditary corneal dystrophies

617

1.30

1.40

1.8

2.6

4.16

4.24

g/l

0.47

562

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

1.90

1.40

1.7

2.2

4.04

4.38

g/l

0.67

Benign neoplasm of bone and articular cartilage

140

1164

1.21

1.40

1.8

2.4

4.21

4.25

g/l

0.25

121

1080

Lack of expected normal physiological development

2.26

1.39

1.0

1.1

4.31

4.37

g/l

—

Varus deformity, not elsewhere classified

135

1.66

1.38

1.4

2.5

4.50

4.32

g/l

0.42

125

Endometriosis of ovary

279

2309

1.14

1.37

1.8

2.2

4.28

g/l

0.03

247

2106

Other rupture of muscle

1.91

1.37

1.0

2.1

4.22

4.31

g/l

0.14

Discharge from other and unspecified firearms

0.00

1.37

0.0

2.3

—

4.39

—

Lichen sclerosus et atrophicus

225

1952

1.16

1.36

2.2

4.32

4.28

g/l

0.22

203

1750

Benign lipomatous neoplasm of other sites/unspecified

184

1573

1.18

1.36

2.9

2.3

4.21

g/l

0.04

175

1434

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

110

895

1.24

1.36

2.1

2.3

4.24

4.32

g/l

0.55

105

843

Dislocation, sprain and strain of joints and ligaments of head

435

1.34

1.35

1.8

1.9

4.34

4.27

g/l

0.30

403

Disorders of globe

419

1.36

1.35

2.7

2.6

4.24

g/l

0.01

383

All dysplastic lesions of the vulva

602

1.29

1.35

2.5

2.3

4.14

4.31

g/l

1.08

560

Benign neoplasm: Long bones of lower limb

384

1.37

1.35

1.8

2.1

4.09

4.26

g/l

0.86

362

Outcome of delivery

168

869

1.19

1.34

1.8

1.9

4.31

4.33

g/l

0.05

161

833

Unspecified chronic bronchitis

576

1.30

1.34

1.8

2.7

4.26

4.17

g/l

0.40

521

Glaucoma

1463

11759

1.06

1.34

2.3

2.4

4.19

4.20

g/l

0.18

1312

10638

Secondary parkinsonism

446

1.34

1.33

2.9

2.5

4.21

4.17

g/l

0.14

406

Single delivery by caesarean section

161

1088

0.84

1.33

2.2

1.6

4.34

4.29

g/l

0.36

152

1034

Any dementia, excluding more controls

1005

6454

1.07

1.33

2.2

2.5

4.17

4.16

g/l

0.11

859

5807

Other acantholytic disorders

2.12

1.33

1.4

2.6

4.00

4.10

g/l

0.19

Alcohol withdrawal state with delirium

132

1099

1.21

1.32

1.3

2.3

4.14

4.20

g/l

0.32

112

1026

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

160

1356

1.19

1.32

2.0

2.5

4.18

4.23

g/l

0.44

147

1247

Other fall from one level to another

410

3698

1.11

1.32

2.3

4.26

4.20

g/l

0.86

379

3423

Deep bite

149

1099

1.20

1.31

2.4

2.3

4.30

4.25

g/l

0.19

135

1030

Tooth eruption problems

130

1042

1.21

1.31

2.3

1.8

4.30

4.27

g/l

0.16

123

982

Endometriosis diagnosis and infertility diagnosis occurring together

131

1090

1.21

1.31

1.6

2.3

4.30

4.35

g/l

0.33

117

1027

Small plaque parapsoriasis

2.14

1.30

1.9

2.0

4.34

4.50

g/l

—

Gestational diabetes (for exclusion)

313

2420

0.89

1.28

1.8

2.0

4.37

4.29

g/l

1.03

292

2305

Whooping cough, including avohilmo

138

1.61

1.27

1.4

2.3

4.09

4.30

g/l

0.50

133

Reduction defects of lower limb, including avohilmo

2.30

1.26

3.3

3.4

4.38

4.18

g/l

—

Undefined dementia

225

2369

0.87

1.24

2.1

2.3

4.31

4.15

g/l

1.24

193

2064

Other articular cartilage disorders

296

1.40

1.24

2.2

2.3

4.20

4.19

g/l

0.02

273

Vascular dementia (mixed)

383

1.35

1.23

2.4

2.1

4.14

4.13

g/l

0.01

341

LSIL lesion of the vagina

180

1.52

1.23

1.2

1.8

4.03

4.30

g/l

0.91

172

Benign neoplasm of brain and other parts of central nervous system

121

1008

1.21

1.23

2.2

2.5

4.17

4.23

g/l

0.42

102

926

Radial styloid tenosynovitis [de Quervain]

664

1.26

1.22

2.6

2.3

4.09

4.30

g/l

1.92

622

Dysplasia of cervi uteri

342

2155

1.12

1.21

2.2

2.1

4.27

4.28

g/l

0.12

310

1970

Pleural plaque

237

2089

1.14

1.20

2.2

2.3

4.18

4.11

g/l

0.72

213

1887

Calcaneal spur

157

1.55

1.19

1.9

1.8

4.19

4.37

g/l

0.52

145

Non-small cell lung cancer

229

1990

1.14

1.19

1.8

1.4

4.15

4.20

g/l

0.49

208

1763

Peritonsillar abscess

320

2870

1.12

1.18

3.1

2.2

4.29

4.23

g/l

0.84

301

2669

Tuberculosis of other organs, strict, including avohilmo

412

1.33

1.18

2.7

2.5

4.09

4.19

g/l

0.49

369

Aneurysms, operations, SAH

348

3139

1.11

1.18

2.0

2.3

4.16

4.22

g/l

0.92

307

2873

Struck by thrown, projected or falling objec

632

1.26

1.18

1.5

2.5

4.32

4.20

g/l

0.81

595

Tuberculosis of other organs, strict

404

1.33

1.17

2.7

2.5

4.12

4.19

g/l

0.31

361

Labour and delivery complicated by fetal stress [distress]

167

1263

0.86

1.16

1.7

1.8

4.25

4.30

g/l

0.35

160

1205

Tuberculosis of other organs

344

1.36

1.15

2.6

2.4

4.09

4.20

g/l

0.48

308

Ductal carcinoma of pancreas

114

0.43

1.15

1.0

1.2

4.58

4.34

g/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

131

1543

0.84

1.14

3.3

2.4

4.20

4.21

g/l

0.06

122

1429

Disorders of eyelid in diseases classified elsewhere

458

1.30

1.14

1.2

2.6

4.19

4.27

g/l

0.28

422

Parkinson's disease

375

3405

1.11

1.13

1.8

2.3

4.09

4.18

g/l

1.59

331

3075

Ovarian dysfunction, other/unspecified

2.00

1.13

2.7

2.2

4.28

4.44

g/l

—

Hypertrophy of breast in women and men

317

2852

1.12

1.13

1.9

2.3

4.38

4.27

g/l

0.57

294

2633

Other benign neoplasm of uterus: Corpus uteri

112

1.64

1.11

4.1

2.1

3.99

4.27

g/l

0.84

105

Other vitreous opacities

674

1.24

1.11

3.2

2.6

4.34

4.25

g/l

0.18

624

Gonococcal infection, including avohilmo

433

1.30

1.11

2.1

1.9

4.34

4.28

g/l

0.19

405

Malignant neoplasm of other and unspecified urinary organs

2.02

1.11

1.0

1.3

4.16

4.15

g/l

—

Vertical strabismus

478

1.29

1.10

1.9

2.5

4.17

4.23

g/l

0.22

443

Malignant neoplasm of nasal cavity and sinuses

1.73

1.10

5.5

1.3

4.22

4.31

g/l

0.17

Vestibular neuronitis

176

1531

1.16

1.09

2.3

2.5

4.28

4.24

g/l

0.41

160

1407

Obstructed labour due to malposition and malpresentation of fetus

195

2060

0.87

1.09

1.6

2.0

4.29

4.30

g/l

0.05

188

1952

Bacterial meningitis

470

1.29

1.09

3.8

2.5

4.33

4.24

g/l

0.30

437

Foreign body or object entering through skin

794

1.22

1.08

3.0

2.4

4.22

g/l

0.01

743

Unattended death

151

0.52

1.05

4.5

1.8

4.26

4.20

g/l

—

136

Wilms' tumor, including Hilmo

1.73

1.04

1.0

1.2

4.14

g/l

0.01

Antepartum haemorrhage, not elsewhere classified

697

1.22

1.03

2.4

2.0

4.24

4.35

g/l

0.82

666

Severe visual impairment, monocular

155

1.51

1.03

1.3

2.5

4.09

4.30

g/l

0.41

144

Dementia, including avohilmo

1314

8530

1.05

1.03

2.1

2.4

4.19

4.17

g/l

0.30

1111

7704

Accidental poisoning by and exposure to alcohol

177

0.56

1.02

1.7

2.6

4.52

4.23

g/l

—

167

LSIL lesion of the cervix uteri, vagina or vulva

181

1585

1.15

1.02

2.7

2.2

4.14

4.33

g/l

3.00

168

1478

Pregnancy with abortive outcome

1236

6112

1.05

1.02

2.0

2.3

4.34

4.27

g/l

1.21

1116

5514

Burn and corrosion of trunk

387

1.30

1.01

1.3

2.6

4.23

4.20

g/l

0.08

362

Typhoid and paratyphoid fevers, including avohilmo

1.75

1.01

1.2

1.4

4.28

4.37

g/l

0.09

Pathological resorption of teeth

521

1.26

1.00

1.1

2.5

4.17

4.24

g/l

0.29

489

Unspecified dementia

224

2254

0.89

0.99

2.1

2.3

4.32

4.15

g/l

1.35

192

1995

Malignant neoplasm of other and ill-defined sites, including Hilmo

232

1.40

0.99

1.3

3.98

4.20

g/l

1.38

203

Foreign body in respiratory tract

711

1.22

0.99

2.6

2.4

4.19

4.20

g/l

0.03

655

Malignant neoplasm of hypopharynx

1.91

0.99

1.0

1.2

3.96

4.17

g/l

—

Other complications of labour and delivery, not elsewhere classified

676

0.80

0.99

1.5

1.6

4.40

4.35

g/l

0.23

644

Malignant neoplasm of nasopharynx, including Hilmo

1.90

0.98

1.2

1.3

4.29

4.22

g/l

—

104

874

1.19

0.98

2.0

2.4

4.21

4.14

g/l

0.32

758

Perforation of oesophagus

1.70

0.97

1.1

2.3

4.17

4.39

g/l

0.33

Viral haemorrhagic fevers, not elsewhere classified/unspecified

104

1227

0.84

0.96

3.1

2.3

4.19

4.21

g/l

0.09

1142

Other appendicitis

142

1231

1.16

0.95

3.2

2.4

4.27

4.24

g/l

0.22

127

1148

Benign neoplasm: Scrotum

1.88

0.94

1.3

4.18

4.17

g/l

—

Abscess of Bartholin gland

278

1.34

0.93

3.2

2.1

4.17

4.28

g/l

0.29

262

Exposure to other specified electric current

220

0.63

0.92

2.3

2.1

4.20

4.31

g/l

0.33

209

Ill-defined and unknown causes of mortality

183

2063

0.88

0.92

2.3

4.20

4.15

g/l

0.29

162

1856

Female infertility

403

2219

1.09

0.92

2.0

2.2

4.33

4.29

g/l

0.42

374

2041

Degenerative diseases of the nervous system

938

7108

0.95

0.91

1.9

2.3

4.11

4.18

g/l

1.98

795

6358

Interstitial cystitis (chronic), drug-induced

1.97

0.90

1.1

1.7

4.34

4.23

g/l

—

Malignant neoplasm of ovary, including Hilmo

980

0.83

0.90

3.0

1.4

4.16

4.31

g/l

1.12

871

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

1.65

0.90

1.8

2.2

3.80

4.31

g/l

1.69

Other nonscarring hair loss

119

1.53

0.89

1.5

2.3

3.98

4.35

g/l

0.75

112

Gonococcal infection

422

1.27

0.88

2.2

1.9

4.32

4.30

g/l

0.07

395

Other osteochondropathies

102

868

1.18

0.88

2.5

2.2

4.32

4.24

g/l

0.61

808

2.05

0.88

6.2

3.0

4.37

4.27

g/l

—

Unequal limb length (acquired)

1.88

0.88

2.6

4.29

4.30

g/l

—

Acute poliomyelitis, including avohilmo

192

0.62

0.88

1.6

2.1

4.07

4.29

g/l

0.44

176

Eustachian salpingitis and obstruction

813

1.19

0.87

2.3

2.1

4.10

4.31

g/l

1.76

764

Necrobiosis lipoidica, not elsewhere classified

1.70

0.87

3.3

2.3

4.45

4.37

g/l

0.10

Other mental disorders due to brain damage and dysfunction and to physical disease

284

2588

1.10

0.87

2.7

2.3

4.23

4.19

g/l

0.46

243

2344

Dengue, including avohilmo

2.01

0.86

4.8

1.5

4.00

4.33

g/l

—

False labour

256

1756

0.90

0.86

1.8

2.0

4.28

4.31

g/l

0.28

248

1676

Acute poliomyelitis

191

0.62

0.86

1.6

2.1

4.07

4.30

g/l

0.46

175

Erythema intertrigo

380

1.28

0.85

2.4

2.8

4.31

4.24

g/l

0.20

350

Short Achilles tendon (acquired)

332

0.72

0.85

2.8

2.5

4.29

4.30

g/l

0.04

310

Pedal cyclist injured in other and unspecified transport accidents

189

1687

1.12

0.85

2.3

4.28

4.21

g/l

0.56

173

1563

Anomalies of pupillary function

248

1.34

0.84

2.6

2.2

4.06

4.29

g/l

0.96

233

Carcinoma in situ of breast, lobular

105

1.56

0.84

4.1

2.3

4.04

4.27

g/l

0.68

100

Whooping cough

1.76

0.83

1.0

3.3

4.11

4.45

g/l

—

Contact with machinery

165

1857

0.88

0.83

2.2

2.3

4.16

4.17

g/l

0.09

151

1731

Contact urticaria

1.92

0.83

1.7

1.4

4.53

4.47

g/l

—

Heterophoria

116

1004

1.16

0.82

2.8

2.3

4.18

4.26

g/l

0.56

110

932

Universal erythroderma, KELA reimbursement

189

1.39

0.82

1.4

2.4

4.42

4.21

g/l

0.70

175

Hypertrophy of breast

261

2375

1.10

0.82

1.5

2.3

4.40

4.30

g/l

0.38

239

2192

Specific developmental disorder of motor function

1.89

0.82

1.0

2.3

4.48

4.11

g/l

—

Other helminthiases

0.00

0.80

0.0

3.0

—

4.18

—

Aggressive periodontitis

322

1.29

0.79

2.3

2.5

4.19

4.22

g/l

0.08

300

LSIL lesion of the cervix uteri

129

1130

1.15

0.79

2.8

2.3

4.15

4.34

g/l

2.11

120

1071

Superficial injuries involving multiple body regions

331

1.28

0.78

3.0

2.3

4.21

4.20

g/l

0.02

311

Pregnancy hypertension

580

4876

1.06

0.77

2.4

2.2

4.31

4.29

g/l

0.17

546

4502

Acute appendicitis, with complications

378

3508

1.08

0.77

2.4

2.3

4.23

4.22

g/l

0.08

343

3245

Reduction defects of lower limb

2.24

0.77

4.4

2.7

4.36

4.30

g/l

—

Thromboangiitis obliterans

1.75

0.77

1.1

2.7

4.21

4.33

g/l

—

Divergent concomitant strabismus

113

983

1.15

0.77

2.0

2.3

4.30

4.25

g/l

0.28

106

909

Erosion and ectropion of cervix uteri

459

1.23

0.76

3.1

2.2

4.25

4.26

g/l

0.02

415

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

137

1212

1.14

0.74

1.9

2.2

4.26

4.32

g/l

0.34

131

1118

Gastrointestinal stromal tumor and sarcoma

176

1.38

0.74

1.2

1.4

4.21

4.28

g/l

0.15

158

Burn and corrosion confined to eye and adnexa

254

1.31

0.74

2.3

2.4

4.05

4.32

g/l

1.51

244

Other chromosome abnormalities, not elsewhere classified

2.03

0.73

1.2

2.9

3.92

4.96

g/l

—

Other benign neoplasms of connective and other soft tissue

175

1573

1.12

0.73

2.7

2.4

4.24

4.23

g/l

0.07

158

1445

Pedestrian injured in collision with car, pick-up truck or van

326

1.27

0.73

1.6

2.3

4.40

4.25

g/l

0.37

301

Anomalies of dental arch relationship, including avohilmo

267

2214

1.09

0.72

2.2

2.3

4.30

4.28

g/l

0.14

238

2073

Right side

101

1.53

0.72

1.4

1.7

4.95

4.25

g/l

2.72

Postmenopausal atrophic vaginitis

520

2660

1.07

0.72

2.4

2.3

4.31

4.25

g/l

0.31

473

2406

Abnormal findings in secretions and smears from cervix uteri vagina vulva

754

5269

1.05

0.72

2.2

4.19

4.31

g/l

3.93

699

4839

Fractures involving multiple body regions

1.98

0.72

1.6

1.2

4.32

4.38

g/l

—

Malignant neoplasm of bronchus and lung

415

3243

1.07

0.71

1.9

1.5

4.17

4.19

g/l

0.25

375

2903

Frontotemporal dementia

102

1.51

0.69

2.2

1.9

3.95

4.38

g/l

—

Colorectal adenocarcinoma

438

4056

1.07

0.69

2.6

1.4

4.21

g/l

0.01

387

3628

Gender identity disorders

1.53

0.68

1.0

2.0

4.31

4.33

g/l

—

Dementia due to Parkinson's disease

517

0.80

0.68

1.3

2.4

4.11

4.14

g/l

0.07

465

Acute drug-induced interstitial lung disorder

128

1.43

0.67

9.0

2.0

3.98

4.20

g/l

0.57

118

Hypermetropia

109

957

1.14

0.67

2.2

2.3

4.27

4.24

g/l

0.15

883

Alzheimer’s disease (Late onset)

599

5196

0.95

0.66

1.9

2.3

4.06

4.17

g/l

2.78

503

4599

Injury of muscle and tendon at wrist and hand level

240

2205

1.09

0.66

2.0

2.4

4.22

4.21

g/l

0.03

228

2042

Complications predominantly related to the puerperium

336

3128

1.08

0.66

2.1

2.2

4.31

g/l

0.03

317

2910

Postpartum haemorrhage due to retained placenta

1003

0.87

0.66

2.0

1.9

4.25

4.34

g/l

0.52

955

Lesion of sciatic nerve

765

0.84

0.66

1.3

2.4

4.32

4.17

g/l

1.02

682

Von Willebrand disease

137

1.40

0.65

2.4

2.1

4.06

4.36

g/l

1.25

130

Persistent delusional disorders

107

1213

0.88

0.65

2.2

2.4

4.13

4.23

g/l

0.80

1105

L01XE Protein kinase inhibitors

109

962

1.14

0.65

3.0

2.6

4.03

4.20

g/l

1.83

103

889

Other congenital malformations of respiratory system

1.72

0.62

1.0

1.5

4.42

4.38

g/l

—

Excessive vomiting in pregnancy

814

1.15

0.62

2.1

2.3

4.31

g/l

0.04

766

Tetralogy of Fallot, a congenital heart defect.

1.69

0.62

1.6

2.4

4.36

4.74

g/l

—

Acute and transient psychotic disorders

174

1582

1.10

0.61

2.2

2.3

4.24

g/l

0.03

156

1476

Congenital malformations of eye, ear, face and neck

656

1.16

0.61

3.3

2.2

4.38

4.25

g/l

0.76

608

Disorder of visual pathways, unspecified

0.00

0.61

0.0

1.6

—

4.37

—

Mental retardation, excluding more controls

305

1.24

0.61

1.7

2.4

4.30

4.21

g/l

0.30

283

Myocardial infarction, unclassifiable

486

4585

0.94

0.60

1.8

2.2

4.17

4.14

g/l

0.33

434

4086

Cervical polyps

166

1508

1.10

0.60

2.1

2.3

4.29

4.30

g/l

0.07

158

1367

Female infertility, cervical, vaginal, other or unspecified origin

362

2167

1.07

0.60

2.1

2.2

4.31

4.28

g/l

0.22

337

1992

Malignant neoplasm of pancreas, including Hilmo

140

1551

0.90

0.60

2.1

1.4

4.12

4.20

g/l

0.63

127

1388

Infliximab

157

1.35

0.59

1.2

1.8

4.87

4.35

g/l

0.46

150

Nontoxic diffuse goitre

502

1.18

0.58

3.0

2.3

4.14

4.26

g/l

0.90

455

Kela-code for severe mental illness

623

5942

1.05

0.58

2.0

2.3

4.29

4.23

g/l

1.11

571

5475

Communicating hydrocephalus

328

1.23

0.58

1.5

2.7

4.08

4.20

g/l

0.47

300

Other ill-defined and unspecified causes of mortality

172

1882

0.91

0.58

2.2

2.4

4.20

4.15

g/l

0.28

152

1692

Malignant neoplasm of adrenal gland, including Hilmo

1.50

0.58

2.3

1.2

4.03

4.45

g/l

0.90

Embolic stroke

857

1.14

0.58

1.9

2.5

4.02

4.11

g/l

0.60

782

Dementia in other diseases classified elsewhere

101

896

1.13

0.58

1.6

2.4

4.13

4.19

g/l

0.33

812

Fistulae involving female genital tract

256

1.26

0.58

2.1

2.2

4.51

4.32

g/l

0.57

233

Malignant neoplasm of eye and adnexa

115

1.41

0.58

1.8

1.2

4.35

4.34

g/l

0.02

100

ILD medications: nintedanib

0.57

1.0

1.5

3.76

4.10

g/l

—

Intermittent heterotropia

566

1.17

0.57

2.0

2.2

4.22

4.25

g/l

0.10

525

Motor disorders

1.71

0.57

1.0

2.2

4.48

4.07

g/l

—

Malignant neoplasm of breast, ER-negative, including Hilmo

392

3454

1.06

0.57

2.0

1.4

4.23

4.29

g/l

0.88

348

3062

Diastasis of muscle

0.56

1.2

2.0

4.56

4.49

g/l

—

Supervision of high-risk pregnancy

209

1154

1.09

0.56

1.8

1.9

4.35

4.32

g/l

0.14

196

1102

Unspecified jaundice

803

1.14

0.56

1.6

2.4

4.12

4.16

g/l

0.17

730

Prolapse and hernia of ovary and fallopian tube

693

1.15

0.56

1.8

2.1

4.30

4.24

g/l

0.32

593

Frontotemporal dementia, wide, incl. Pick's disease

116

1.41

0.56

2.1

1.9

3.97

4.34

g/l

1.40

105

Benign neoplasm of other and unspecified female genital organs

687

0.85

0.55

1.9

2.4

4.32

4.30

g/l

0.07

626

Benign neoplasm: Short bones of lower limb

124

0.64

0.55

1.5

2.5

3.76

4.27

g/l

—

118

Sequelae of infectious and parasitic diseases

121

1088

1.12

0.55

2.9

2.2

4.12

4.22

g/l

0.65

113

996

Malignant neoplasm of rectosigmoid junction, including Hilmo

450

1.19

0.55

2.5

1.4

3.97

4.20

g/l

1.42

402

Other and unspecified disease of Bartholin gland

441

1.19

0.55

1.9

2.4

4.30

4.27

g/l

0.12

407

Abnormal findings in bronchial washings nasal secretions pleural fluid sputum throat scrapings

1.57

0.54

1.0

1.6

4.02

4.37

g/l

—

Toxic effects of substances chiefly nonmedicinal as to source

147

1612

0.91

0.53

1.6

2.3

4.22

4.21

g/l

0.03

135

1500

Drug-induced tremor

100

1.42

0.53

1.4

2.4

4.34

4.37

g/l

0.05

Pterygium

508

1.17

0.52

2.3

2.6

4.25

4.18

g/l

0.32

469

Hydatidiform mole

146

0.68

0.52

6.5

2.1

4.11

4.26

g/l

—

139

Presbyopia

123

1111

1.11

0.52

1.5

2.4

4.16

4.27

g/l

0.69

114

1048

Burns and corrosions confined to eye and internal organs

305

1.22

0.52

2.5

2.3

4.07

4.30

g/l

1.47

290

Morphin

342

1.21

0.52

1.7

1.8

4.23

4.14

g/l

0.34

306

Diabetes mellitus in pregnancy

275

1869

0.93

0.51

1.5

2.0

4.34

4.29

g/l

0.44

259

1782

Use of dimethyl fumarate

1.40

0.51

1.0

2.4

4.07

4.44

g/l

—

Use of rasagiline

455

1.17

0.50

1.5

2.8

4.17

4.20

g/l

0.07

415

Anisometropia and aniseikonia

436

1.18

0.50

2.7

2.4

4.23

4.25

g/l

0.10

402

Congenital malformations of breast, including avohilmo

136

1.33

0.49

1.5

2.1

3.98

4.36

g/l

1.63

131

Carcinoma in situ of cervix uteri

104

937

1.11

0.48

2.0

4.29

4.32

g/l

0.20

880

Abnormalities of forces of labour

113

1023

1.11

0.47

1.7

2.1

4.53

4.34

g/l

1.06

107

982

Benign neoplasm of ovary

318

3003

1.06

0.47

2.3

4.26

4.30

g/l

0.51

293

2702

L02BX Other hormone antagonists and related agents

111

1223

0.90

0.47

1.8

2.6

3.94

4.10

g/l

1.48

1122

Malignant neoplasm of palate

1.46

0.47

2.4

1.1

4.23

g/l

—

Poor fetal growth

881

1.11

0.47

1.7

1.9

4.08

4.34

g/l

3.13

839

Oral leukoplakia, including avohilmo

430

1.17

0.47

1.6

2.4

4.23

4.20

g/l

0.09

399

Retained placenta and membranes, without haemorrhage

147

1599

0.92

0.47

2.6

2.2

4.41

4.31

g/l

0.49

139

1482

Neuroendocrine tumor and carcinoma of stomach

1.46

0.46

1.9

1.2

3.79

4.38

g/l

1.21

Postpartum care and examination

671

0.90

0.46

1.8

1.6

4.34

4.36

g/l

0.05

639

Benign neoplasm: Conjunctiva

496

1.16

0.46

1.4

2.6

4.20

4.24

g/l

0.17

462

Valgus deformity, not elsewhere classified

1.44

0.46

1.1

1.9

4.16

4.32

g/l

0.33

Congenital malformations of breast

129

1.33

0.46

1.5

1.6

3.99

4.36

g/l

1.42

124

Maltreatment syndromes

449

1.16

0.46

2.3

1.9

4.18

4.35

g/l

0.86

428

Schizophrenia or delusion

519

4969

1.05

0.46

2.0

2.2

4.24

4.23

g/l

0.03

467

4598

Otosclerosis

139

1276

1.09

0.45

2.0

2.6

4.28

4.23

g/l

0.15

124

1172

Complications following abortion and ectopic and molar pregnancy

553

1.15

0.45

1.5

2.6

4.23

4.26

g/l

0.15

509

Benign leiomyoma with endometriosis

297

2805

1.06

0.45

2.2

2.4

4.23

4.29

g/l

0.74

262

2531

Open bite that required surgery (Lefort1 or BSSO)

1.46

0.44

1.0

1.8

4.32

4.52

g/l

—

Convergence insufficiency and excess

121

1.33

0.44

1.3

1.9

4.27

4.37

g/l

0.27

114

Lesion of plantar nerve

109

992

1.10

0.43

2.3

4.29

4.25

g/l

0.22

898

Primary amenorrhea

1.62

0.43

2.0

1.5

4.18

4.53

g/l

—

Malignant neoplasm of renal pelvis

1.40

0.43

1.3

4.22

4.14

g/l

0.14

Premature separation of placenta [abruptio placentae]

196

0.76

0.43

1.5

2.1

4.41

4.36

g/l

0.08

189

Respiratory tuberculosis, confirmed and not-confirmed

105

955

1.10

0.43

2.1

2.5

4.49

4.18

g/l

0.58

858

Respiratory tuberculosis

105

955

1.10

0.43

2.1

2.5

4.49

4.18

g/l

0.58

858

Malignant neoplasm of nasal cavity and middle ear

1.45

0.42

5.5

1.3

4.50

4.38

g/l

—

Non-allergic asthma

142

1309

1.09

0.42

2.2

2.4

4.31

4.20

g/l

0.45

131

1203

Other congenital malformations of spinal cord

0.00

0.42

0.0

1.1

—

4.90

—

Infections of breast associated with childbirth

295

1.19

0.42

1.3

1.7

4.16

4.34

g/l

0.81

284

Malignant neoplasm of accessory sinuses, including Hilmo

1.37

0.41

4.5

1.3

3.87

4.37

g/l

—

Other congenital musculoskeletal deformities, including avohilmo

0.00

0.41

0.0

1.0

—

5.25

—

Malignant neoplasm of other and ill-defined digestive organs

114

1.33

0.41

1.3

4.17

4.23

g/l

0.07

102

Schizophrenia, schizotypal and delusional disorders

522

5015

1.04

0.41

2.1

2.2

4.24

g/l

0.07

470

4643

Benign neoplasm: Pineal gland

0.00

0.41

0.0

1.6

—

4.88

—

Obstetric embolism

0.00

0.40

0.0

1.1

—

4.24

—

Persons encountering health services in circumstances related to reproduction

899

6210

0.97

0.40

2.2

2.3

4.23

4.26

g/l

0.32

844

5803

Malignant neoplasm of vulva, including Hilmo

205

1.23

0.40

2.5

1.5

4.29

4.37

g/l

0.20

180

Other benign neoplasm of uterus: Other parts/unspecified

788

1.11

0.40

3.0

2.2

4.30

4.26

g/l

0.18

682

Ectopic pregnancy

212

2254

0.94

0.39

1.7

2.5

4.30

4.31

g/l

0.05

195

2107

Mental and behavioural disorders due to use of volatile solvents

0.00

0.39

0.0

3.2

—

4.95

—

Sequelae of infectious and parasitic diseases, including avohilmo

122

1125

1.09

0.38

2.9

2.2

4.11

4.22

g/l

0.74

114

1028

Pre-eclampsia superimposed on chronic hypertension

1.40

0.38

1.0

1.4

4.50

4.59

g/l

—

Serous carcinoma of ovary

113

0.70

0.38

2.0

1.5

4.21

4.45

g/l

—

100

Infections of genitourinary tract in pregnancy

106

1155

0.92

0.38

2.5

2.2

4.34

4.31

g/l

0.11

1066

Other benign neoplasms of uterus

109

1002

1.09

0.37

3.1

2.2

4.25

4.31

g/l

0.31

879

malignant neoplasm of female genital organs

258

2660

0.95

0.37

2.0

1.4

4.29

4.28

g/l

0.03

232

2339

Embedded and impacted teeth

252

1935

1.06

0.37

2.0

4.25

4.24

g/l

0.05

240

1831

Spinal instabilities

346

1.16

0.37

1.3

2.0

4.51

4.30

g/l

0.86

325

Crossbite

562

1.12

0.36

1.4

2.1

4.22

4.27

g/l

0.21

537

Other congenital malformations of limb(s)

1.44

0.35

1.0

1.9

3.90

4.57

g/l

—

Malignant neoplasm of rectum, including Hilmo

233

2207

1.06

0.35

2.7

1.4

4.15

4.21

g/l

0.60

209

1973

Non-small cell lung cancer, adenocarcinoma, helper endpoint

144

1344

1.08

0.35

1.8

2.5

4.13

4.16

g/l

0.24

131

1225

Fitting and adjustment of external prosthetic device

1.38

0.35

1.5

1.3

3.32

4.22

g/l

—

Other and unspecified injuries of abdomen, lower back and pelvis

181

1.22

0.35

2.0

2.1

4.18

4.27

g/l

0.17

168

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

668

5612

1.03

0.34

2.3

2.2

4.29

4.30

g/l

0.09

629

5156

Simple and mucopurulent chronic bronchitis

671

1.11

0.34

1.8

2.4

4.23

4.16

g/l

0.26

599

Endometriosis of intestine

118

1.28

0.33

1.0

2.7

4.43

4.41

g/l

0.03

112

L02BB Anti-androgens

194

2052

0.94

0.33

1.9

2.4

4.11

4.10

g/l

0.04

174

1852

Tooth agenesis EXCLUDE clefts and syndromes

231

0.82

0.33

1.2

1.7

4.13

4.31

g/l

0.55

225

Antenatal screening

230

1220

1.06

0.32

2.0

1.9

4.34

4.32

g/l

0.07

224

1167

Other noninflammatory disorders of cervix uteri

810

1.09

0.31

2.7

2.3

4.39

4.26

g/l

0.75

725

Cervical root disorders

1.32

0.30

1.0

1.9

4.51

4.27

g/l

0.75

Tuberculosis

121

1131

1.07

0.30

2.0

2.4

4.44

4.16

g/l

0.59

108

1012

malignant neoplasm of female genital organs, including Hilmo

318

2909

1.04

0.30

2.3

1.4

4.31

4.29

g/l

0.15

286

2563

Cyst of Bartholin Gland

439

1.12

0.29

2.5

2.2

4.25

4.28

g/l

0.10

413

Kela-code for behavioural disturbances in mental retardation

110

0.72

0.29

1.6

1.9

4.16

4.28

g/l

—

104

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

1.24

0.29

3.6

1.2

4.00

4.21

g/l

—

Mental retardation

342

1.13

0.28

1.7

2.1

4.30

4.27

g/l

0.08

322

Pneumoconiosis due to dust containing silica

1.27

0.28

2.4

2.6

4.45

4.26

g/l

—

Normal-pressure hydrocephalus

979

0.93

0.28

2.5

2.4

4.23

4.18

g/l

0.30

880

Circumscribed brain atrophy

375

1.13

0.27

1.8

2.7

4.14

4.17

g/l

0.15

342

Motorcycle rider injured in noncollision transport accidents

280

1.15

0.27

1.7

2.0

4.21

4.28

g/l

0.19

267

Other specified and unspecified strabismus

131

1.23

0.27

1.9

2.3

4.18

4.36

g/l

0.32

121

Stenosis and insufficiency of lacrimal passages

176

1672

1.05

0.27

2.2

2.5

4.29

4.25

g/l

0.15

155

1517

Postpartum haemorrhage due to anatomy

636

0.91

0.27

1.8

1.7

4.27

4.35

g/l

0.39

608

Other bursal cyst

206

1.17

0.26

2.2

2.1

3.97

4.25

g/l

1.12

190

Carcinoma in situ of middle ear and respiratory system

0.67

0.26

2.8

2.0

4.08

4.07

g/l

—

Unspecified abortion

597

1.09

0.26

1.8

2.6

4.38

4.31

g/l

0.34

566

Malignant neoplasm of gallbladder

1.24

0.26

1.2

1.1

4.74

4.22

g/l

—

Hydrocephalus

134

1417

0.94

0.25

2.2

2.5

4.20

g/l

0.03

114

1277

Malignant neoplasm of eye, brain and central nervous system

588

1.09

0.25

1.8

1.4

4.18

4.25

g/l

0.23

530

Endometriosis ASRM stages 3,4

357

3453

1.04

0.25

1.8

2.2

4.27

4.30

g/l

0.24

319

3134

Benign neoplasm: Short bones of upper limb

198

1.17

0.25

1.7

2.2

4.64

4.35

g/l

0.67

187

Any dementia

1094

7423

1.02

0.24

2.2

2.4

4.14

4.17

g/l

0.46

930

6656

Foreign body on external eye

233

2237

1.04

0.24

2.4

2.3

4.25

4.21

g/l

0.48

215

2101

Disorders of acoustic nerve

436

1.11

0.24

3.2

2.5

4.17

4.19

g/l

0.05

400

Viral infections of central nervous system, not elsewhere classified/unspecified

133

1.21

0.24

1.6

2.3

4.23

4.33

g/l

0.24

125

Mucinous and mucinous cystic tumor, including Hilmo

0.73

0.24

7.8

1.4

4.02

4.52

g/l

—

Chronic suppurative otitis media, including avohilmo

122

1152

1.06

0.24

1.6

2.4

4.25

4.21

g/l

0.26

115

1057

Chronic myringitis

0.70

0.24

3.2

1.9

6.55

4.22

g/l

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

179

1873

0.95

0.24

2.8

1.4

4.16

4.20

g/l

0.37

157

1681

Other and unspecified heterotropia

1.37

0.24

1.8

1.1

4.04

4.55

g/l

—

Use of levodopa decarbox-comt-inhibitor

609

0.92

0.23

1.1

2.7

3.96

4.16

g/l

1.22

557

Impacted teeth

160

1307

1.05

0.23

1.6

1.8

4.19

4.26

g/l

0.54

153

1236

Androgenic alopecia

106

1.23

0.23

1.1

2.1

4.18

4.35

g/l

0.48

101

Dementia due to Parkinsons disease, excluding more controls

380

1.11

0.23

1.3

2.6

4.11

4.06

g/l

0.14

347

Melanocytic naevi, other sites/unspecified

127

1204

1.06

0.23

1.9

2.4

4.17

4.23

g/l

0.35

122

1117

Family history of certain disabilities and chronic diseases leading to disablement

457

1.10

0.23

1.6

2.0

4.23

4.34

g/l

0.49

427

Mental retardation, wide definition

377

1.11

0.23

1.7

2.1

4.30

4.27

g/l

0.10

354

Plasmodium vivax malaria

0.00

0.22

0.0

1.1

—

4.25

—

Plasmodium vivax malaria, including avohilmo

0.00

0.22

0.0

1.1

—

4.25

—

Neurological devices associated with adverse incidents

0.00

0.22

0.0

1.0

—

4.24

—

Myiasis

0.00

0.22

0.0

5.0

—

4.50

—

Inflammatory disease of cervix uteri

108

1021

1.06

0.22

1.4

2.3

4.27

g/l

0.00

929

Thyrotoxicosis from ectopic thyroid tissue

0.00

0.22

0.0

1.8

—

4.42

—

Pseudohypoparathyroidism

0.00

0.22

0.0

1.0

—

5.47

—

Glanders and melioidosis

0.00

0.22

0.0

1.0

—

4.55

—

Glanders and melioidosis, including avohilmo

0.00

0.22

0.0

1.0

—

4.55

—

Female genital prolapse

517

2802

1.03

0.21

2.2

4.31

4.25

g/l

0.81

468

2530

Ethmoidectomy

209

2010

1.04

0.21

2.8

2.3

4.36

4.24

g/l

1.38

194

1871

Congenital heart conduction disorder

0.00

0.21

0.0

1.0

—

4.44

—

Supernumerary ureter

0.00

0.21

0.0

1.0

—

4.06

—

Pinta [carate], including avohilmo

0.00

0.21

0.0

1.0

—

4.22

—

Contact with other specified venomous animals

1.24

0.21

1.1

2.7

4.22

4.46

g/l

0.54

Complications of anaesthesia during pregnancy

0.00

0.21

0.0

1.1

—

5.40

—

Ascariasis, including avohilmo

0.00

0.21

0.0

1.3

—

4.08

—

Other congenital musculoskeletal deformities

0.00

0.21

0.0

1.0

—

5.42

—

Underdevelopment of the second kidney

0.00

0.21

0.0

4.5

—

4.33

—

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

0.21

0.0

1.0

—

4.28

—

Colon adenocarcinoma, helper endpoint

273

2821

0.97

0.21

2.8

2.4

4.24

4.18

g/l

0.64

243

2551

Dementia

1199

8069

1.02

0.21

2.1

2.4

4.19

4.17

g/l

0.28

1010

7277

Birth injury to peripheral nervous system

0.00

0.21

0.0

4.5

—

5.13

—

Constitutional tall stature

0.00

0.21

0.0

1.0

—

4.14

—

Unicornuate uterus

0.00

0.20

0.0

1.1

—

5.07

—

Mild mental retardation

239

0.88

0.19

1.9

2.2

4.46

4.27

g/l

0.56

228

Malignant neoplasm of other and unspecified parts of mouth

1.23

0.19

1.8

1.3

4.18

4.36

g/l

0.44

Other menopausal disorders

474

2579

1.02

0.19

2.4

2.3

4.26

g/l

0.02

441

2356

Premenstrual syndrome

109

1.20

0.18

1.2

2.4

4.34

4.52

g/l

0.48

104

Other obstructed labour

899

0.94

0.18

1.9

2.3

4.48

4.31

g/l

1.32

848

Malignant neoplasm of breast, HER-negative

354

3313

1.03

0.18

2.0

1.4

4.23

4.29

g/l

0.74

312

2929

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1041

8197

0.99

0.17

2.2

2.3

4.20

4.24

g/l

1.11

967

7531

Benign neoplasm of thyroid gland

517

0.93

0.17

2.3

2.4

4.32

4.28

g/l

0.12

479

Alcoholic cardiomyopathy

1.23

0.17

1.3

2.7

4.38

4.26

g/l

—

Senile degeneration of the brain, not elsewhere classified

0.74

0.17

1.2

2.2

4.04

4.33

g/l

—

Other/unspecified mastoiditis and related conditions

0.71

0.17

1.8

2.1

3.76

4.23

g/l

—

Prophylactic surgery

1.16

0.16

5.4

1.3

5.00

4.50

g/l

—

Use of ropinirole

613

1.06

0.16

2.0

2.8

4.18

4.21

g/l

0.08

564

Osteitis due to dental implant

130

1.16

0.16

3.4

1.9

4.25

4.28

g/l

0.06

118

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS